Professional Documents
Culture Documents
Forbid Medicine
Forbid Medicine
" # $%
('
&
&$
#
9
0
:6;
#.)
5
-.)
: "#
; .
$ =
: *$
#( <#
,
$ '93
9$"( )$ $$ 9
; ..$>:" $
$
& 34
A$ 7 @ )
$"
(
$1 B$
.$
8 ..
=
%
" 6$ ,+ C)
)( =
% 1 $"
.."$4 $
3
"
1
"<
*
=
# 9 # (0
>
?
&
?
&
&
&
&
<#
@%. %*
5&
0
*/ 9/#
?
&
; A
5)
SYKOGENE.COM
G@& 300
9
$# >0, '
N , G
:
91 +
A
J P
V* K < 5< . # "0 "0 , &
&
:
W:
H6< 0 "J 5& 5F/
S* E '
,
(0? =% 5)# I6
0
Q/
A 9 +/ , ..E.> # V* ..X / #
I<#
" # 5% " */
9 O& GE// @ 0 & # ? 3/
", , XE& E, ):
?
& < 50 A
9&
8; "6
..."#
..S
"
)
6
)
X=#, 9
)
K
60 9 5
,
6< '
A& G$0 50( $ ) 8 "$) =% + *( 50 A 5) / L 0 P& K <
0
5:
%
! G: 50( (
Y#
, =#
@ E E* ? =%
7
"V 9/ , % ") !
", .&
L
" E <) (5
M*
) Q1
9P \5P 9
* 6 9:( 3/ "0
.300
6 / * 58> ? :$/
=(
A $
51
0 '6 9, " ")0 &
, G& @$# 6 # P "
9)# "3)
:0
"
S1 A */
..9)
9P
'
0? "0 9
6J 6< G9<0 % # 0 , 0 50
" @ 5
3#
T% 6< G5 I, K < !
G8 < 50 <
& " H I6
"V
5% .3%
.+( ; =*/ ? ..$6
GM/
9
@( @ V Q
9
S
"0( "0 ", I, G:& =8%
Q/ A B) ,
G)* L < K
6 L +( I, G)*
< 6< "V / , = "& .@/ I6
5> !: #
9
6< "0
A&
>0, & '
, O& @ @ V( I6
"
A ? G:& =8%
< 6< ..5, "0
A&
Q&J * "%
(
)#
(
.5, "0
A& .. & * A 3;
#
+(
"
GE): E E; "0 G@ I6
!F
7
+( 50 "V 9#
" A V( GP
)
)U
$
0
9<:P&
/
&
# #
" !".."*(
5, ".." @ V )U
G )# 5
( 0 .@6 < <#
"0
G'*/
A >0
$;
X9
$; E:( "V ) 5< .
*/
I, K
60 G =#
I, ."
'
0
"*&
= 0
@(
A P&
3#
. /F " & %
#
0
!
$9 I6
< (H^ A
J ..# //) 0&
" !
G50(
6 1 "0 ",
" !
G$# L _* 6< 50 ", 9) "0 "0
@# I6
:6;
9P
A
J G1 7
*
-.)
;
01 3
/1 A 0
?
a&
& I
)
"/ '
, .<
"0 ? /:
& A
J Q, G)
//F
!
:6;
0(
5#, :( 9 % .//
)
//F
5# 5
5# " :
F
H6< # !F 8(<
:5 0 5& >0
$*
#
" $&
(
+/ 3#"
"</ !
/
=%
", "0
.HL !
@& < 3/
-.)
..@
& Q, < ..@/ 3* @ , "/ /
( A 50
? # (" ,) " ) ".
5. ."*(
" '%, < I6
=%
6< .E 7
."/ &
E//, 9 ? 6
# @#, I6
*
9P
6< .I
)
01 3*
@/ 9 .1 @# A "/ J 50 & * A
J 5/ I6
G
)
*
9P
6< //F A 7$)
"0
G"0, A& , "&# , +*, " "F/ 908 V "N ")% % .Q, -. 5:/ " HL "
!3* I, 9 " !
", < $
&
$()
., .
)
. $*
@*J
0, @P &
, G"()
"
5:, 6 0 */ & /:
)
1
0( 9P) =
9)
/
5
6< " 7
.;
9
)
)
//F
*
9)
5
A +`
/
:)
" # 3.*
"<6, !;
E
9$
/ W 9/ 5#, " < 5#1
.0
1
% A S1 M8 /
>,
" 0
1 9/ 0 $/ 98)
)#
0
* /
0 P M;
1 0( ! G%
! .#
&
A P&
&
/
0 " &
A < )
)
"$(
"//
A */
A
J G(E//,
E0 "0 %
) 9. 5:/ A E0 E>V 0
5:/
"#
) "6
+*1 , ./
//
3
& A& 9 9 5. " "
=$: #$#
#
) G9
9
)
+& , =# :/
$*
* H6< !/F ", < ) 3#
&
@> K
60 .# &
E) / bc " >0, B G0. "# < G
&
5# &
/
I, ? 9
<.0 ", <
&
H6< $/ .E, &
&
) / cd B I6
G;
. "#
" 5F/
I(/? 3*
G0
1 3 # A
J G )8
0
(
, 6L1 "
.9
)
3)( " @/ A I6
*
9P
%. I, @
!
homeopathic E>< E#
) "0 &
4$)
A
/,
9P
, /
M/
# I, K < ) 9
G9ecbf 9)
)
&
?
S ."@
$/ P "0(/ =
6 ") 5*1 0 7/ G
"0
" :; 0 7
5. " $
9P
6< !0 9 G/
M/ @ E *
EP ", (@,) +>1 A ; 0
50 "V ? / A 5)
.9P 60< = 5)
A
5#1 3$
!
9)
A */
Q/ 5)
' ? 0&
5)# .
@& E&# "0 7/ (
5 9)
9 "
!
$*/" G.
I
%? 9P
A 50
*/
"0 G*
H6 .)
(
H6< A ?
"#? "/
" ;
# I, 5*1 5 = /
H6< ", A
J G9) 98)
F .'.8
* 5% " G$&
I,
)( & G&/
01 &
A 50
*/
9 G9ebeg 9)
6
3
9. 0 0
:#, ; 0 0 O G@*J 8 @ ) "0
."L.3.<
%? #? //
7%
%
&
+N ) " 9
@ <( 50 "J .0
.I
Y "
"...5&
G"80
G5
9, 9:^ @ 9 E E?0 >0,
MNOP $ J 0 "J$F L$$" J# & " A
G
0 * J " 5$1 5F/
< Frederick Gates "!L K" 8%
)
$!
.0 //F
9)
. (/
G(Q(
)
= !
H6< A
J "
%
<, Q M%
< @ !& , 3 ") 3# GE
"N " ...5L1
"...(
!Q")
)
9
@ , 0 .$*
9)
5& "; 0" //F 9/ @ 9 I6
(
3&
< /0 9<, "/ 0
./
*
9)
0
#.)
"*
O&2
0 //F" W
9 5$, !$/F "0
/
A (9)
) " /0" G"*
O&2
0 //F" + !# 5$,
G#
3*
5# ""/
"
" A& ? G& ) 9
Q, & A 7$) "N
:
9& 5. ) 9
*/ 50 9 1
", **
3.0
"0 "0
GE / J 5 ($/ $% @( $) scopolamine "?0/
" 9Lj 0 "J ...."
=*/ .!3 2
&
9)* ) @8 0
0 : A ", 9/ *
"0 .!$
: A, # 5$&
G"/, "
0
5) ", 0 3) " 9 ", (
" K:( "&) 9(
$0 = ", 9 L1 =*/ ...B#
" 50 - 9/ =*/ K/
& J 0 E/ @)
>/ 3/ G"/ oU po I6
"
.(
9/
% 0 5)/
H6< G
"
G+;$
*
9/ )
=:(
!
!3)>
5 ",
&
"0 Q, & " .":
**
Q
$ #
"...guineapig I
<
5$ ^ "& 5 G:1 " ( I6
"/
E$
9
) 2"$ =
+" ')
.X"
(
+/ 3/ &
?
* ) 6
.E >.> M / &/1 " *, +*1 5)# G$ &/, & jl,fmi
Q/
A $&
5# 5:1
") &
?
.9
)
5 % A $< >V
."
" ) 9
)
5 % E 68 &
?
$&
9
5
& G
)
?) G9ebmi 9)
50 (
.
50
+*1 3J ) G&
"*/
9s
GJerusalem Burial Society A
"
"9/#" )# %, +
&J M ./ A , A
J
gj
K < +*1 3, O& G9ebmd 9)
0
L
& ( 7P .7
A
J
:" K
>0" &
(, 0 GE
*
" &
&J 5% " K
6 " M&
9 % ".%ig A
J
Q/ G3 5."
5. K
60 G
0 / )
H6< 0 % .National Morticians Association of Columbia.
0
.9ebmc 9 &
0
+*1 3J
"0 ? =:% 0
G(
H6< ")
G'#
, < 7 < M:&
H6< 06 9 #,
5:/
" >0
@ ":
GI
*
@#
6< +(
+*1 " >0
G 0
:>1 ) 90
J GQ# " "0
G
$
!
># ; $ B/ 1 2$ 6$
/
John Braithwaite 6$
$
)
* EF
0&? >0, /
< GAMA 01 *
&? / /
G*
0&? * $"J"
#.)
5:/
$"J .
)
"
I, &1 " 3)( "F( ", "0 E* E#) <>0, 5
"6
AMA 01 *
& ";
5% " 7 ) 9#T 7/ )* */ ^ 3
/, 9/
".E
L
0&
# M/
" @#J 50
H 9/ (E) E*/ E* , E>& "0 6J .50
&
."@ 3
"&
3),
, " "#
)
, 9P)
9 M* " "#
)
, ")*
"#
)
5% " ! #.)
M*
H6< 0
E, , "
9
K8 n G9
"/ "6
+0&
+*1 5% " , 3(1 "#
)
, " &
."Q0
7&
(
/ A *; I)/ I 0./ 9P
F
A +
</
< "
" I#
- P
&
8)
H
</ 0
G<L
/
% "/
5> G1 A %
1 #, 9 , '&
.E.>
0
& " .E//, E "0 G &
5) 0 /#, >0
A +
%
!
< /:
@, 3/ ", EF " I6
."/ &
A ./ E , >0, , #. )% GQ,
" ) 0( .H^ A
J .. E E/ E: E:6L @ 3.
.0
9
)
/, 5% " @
&
*
.H)/ H
E
)
5 " <L #
:
? *?
)
;
0(
7
<
%.)
)
K./? 0 ;
K/ A
J 5$& %
..E# 0
GI/ 9) .9/& 9/& $
*
9%1 9:% " " ;
9% ./ #
8)
0(
H6< " &
&
/
.(
H6< A
9$# , $# " 0,
.
< E: )
...$&
9> &
A 7$)
.&
) < *$
/
+# 6 <) "0 G- /? "/& 9> " G)
30
6< )
9</ ", #,
.5$1 9
< < 6< .K&
&?" M =# 0( 50( A ) P 8 0
G" 0( K0 9
)
3&
) .
1
0( GBorden " 0( GICI
$:0
0( :0(
H6< "$ G":
I0&?
Pet K GNestle @/ GM. W. Kellogg t0 5 9, 0( GGeneral Mills 5 # GCarnation "( 0
5L 0 GWhitehall 5< GBristol Meyers 5/ GSquib and Sons H?, 30/ GMilk
#
8P "$: "0( ) GHoechst and Beyer (< GRoche B GProcter and Gamble
0( K .(J !# +/F0 Fritz ter Meer Fredrich Jaehne"# B "0&
3&
&
?
$:
9/1 7
" Chase Manhattan Bank " ( 7
= ")
"N 0
'
G+
) +# "
E&, +
/0 3&
6 .9
)
+
=
=$# 0, <
.&/1
) 9
)
9, >
>
)
3&
5%
, ".#.I, 0( 0
"
: $ %.
5# I(
":0
$&
)
M8) G"()
&
"
G9
,
= (I0
+
9/ A
J
& 9
)
"0/ =#) 9
)
50 =/ ( 6 < G&
, A ?
.+
)8
IV
S1 " " *
5% " M J
5
50 3*
/ ) $&
< $&
//F $L, A "N 0(
H6< */
9< & & &
, 98 0
GE%> E , >01 #.)
u$
E&, +*1 ) 9
.$*
<)
" +*1 -$ ) .(Q( 50( A 51 V E
L) 9>&1
+
0( A 9
#
%)
1 " 5:
90
3)/ )
"# G1 0( 5% "
*
0
90
"J .@#. / 9> / 3*
A 3#
GM/1 0(
&*
$
", O&
&
=
A
J Q, 6< G1 ): " E//, V 9)
3*
5
&
)
" 5:
" -$
) //, 50( )
")# G9<
<*)
$:0
" ) +*1 +?F< >
. G&
&
" =
6< W: , .1 K ):
8P 80, Gebcf 9 .&/ jff,fff " M/1
$*
&/
'
,
9 .O
>
9
)
$# $&
5#, " $ < 1 " Y jlf a", $
)
$&
A ;/ ? " ) Y 1 H6< " jd $# a"V &
92
)
*
8P &$
ebce
."
+( 9< $: 0( I, Q
# ? .&,
&
"0/
" (
&
+/ A $:
0(
)
$:0
=
# , M &
+/ A P&
=/ / 9< 0(
Q
.A
5 .
&
3/
< "0 E "
, #
)" Y % & &
+/ ( =$#( 7/
5# :
P
#
@& 5. G$#
$)
#
John Braithwaite O "# 0
:1
(
+/ 3/ &
?
* ) 6
.E >.> M / &/1 " *, +*1 5)# .$ &/, & jl,fmi
5# 5:1
") &
?
+*, a"1 * Q, 5 A $< >V
" ) * E 68 &
?
$&
9
5
& G
)
Q/
A $&
."
%
6 G<
)
98)
& 5. )
M1
& " -
% I, 3(
3*
!
:)
P
9P) ) t
5/L *
H6< .X)
#.)
3
/, " O&
@
&
%
& A P&
:< /:
00
.5 @
!
& I 9P A
J , 5
% A 5)
9 G! G50V
(
'
# A
J #
9
)
" 5) ? G9
)
" 5
9
&
_( 9P
6< .P
"2
E @( $ I: 9P " '
, ;
*
9P
", E&
9 $# 0V @
/
<# " *
&
0
Y 9 O& & $# A @
J "
/ G5
G@, "5(
" 7
" !L A 5) P 1 " Y
6 .+
A H/
9P
'
9< % A = I6
", Q G%
! .9<<# 0
" "N /
5"
)*
5
"
5#, " # /
<
G/ #
)
1
0( 5 G"#
) , +*, !
&
9P
6<
*/
$/
5&
#
P
= G/
+ G9 .*/
5
5#, " 5 /
.9
)
A
50 (9
% "6
) @ ":
@ ! I6
%
/
E 3)(
" *
9P
)
& 9</ 5. <
&
" 90 9 ? G6
*/
5
5#, " )
0
6)(
3
/,
.9<, M&
/ O& G
&
@)// < 1 0( @/ I6
0
Y
A '
'
5>
9/%, =# A
J :. 3$/ 0(
H6< M Q " 7(0
GAIDS & A % P
) M& 5#, " K
6 50 G"U 9 G*
!
) < //1 9< G$&
9P Y
./
*
P >
G / J #0 V( ,
$1 8P
G(
/
>
0
1
9
E# 7) "0 @ , " 9L
A .Rockefeller 0 5 G1
% :" ) < G" "&
) ?J
K ( , * " "0 9
@ , ?J G
( >
@.
A
J G"&
&
9 G&
?
//
&$
5& 30
9<, &, < " 1
% " 30 $", " 9L$
A .X 0,
GK
6 = .
E$
& Y "0 G&
I, 5% " @ O&
9 9
0
0
5% " @ 7? 9
GBiworld Publishers
( z ( +/V ">.8>
>
>
@)* "0 )/
H ,%
.Utah H GOrem 9,
u
/ 0( .5
E$# E
) >/
5
!, " %d *) I6
5)
"n GBealle 5 (, 0
G"/
>
G:
0 *J */ 0( Q%, 0, < GSterling Drug, Inc 2
) 9
&
=
&#
1 30 B#
"&#
*
30 "0 G
3&
/ 5. ,
$&
5# #
+ E.) 9/
H6< "& % 5 G1 K >
$) I6
. =
M$/
J 9<F. G0 0( K( 6
5+/ 5? " K < 5< .# " jff "& 9 A& G"01
B#
)
$*
M
5)
30
#
#
01 )
&
30
1 6L1
50(, =# & =% 7 G.
+& , 7 "&
"
F/
" 7?N G&
=
1 30
) 0 //F "
I / ^ ":Beale 5 5 !!!X 1 9/ 9 A =#(
-.)
% G
E ll
5. 0&
//F
?0
)#
!
0
//F
%
)
=# .* "& )
//F
H6< "n =*
.!? 7
A # ;
0
)#
) = 5)
5
& 6< GQ, < K < "0 " ?J G+
5& ) 0
.E
=* G3601 9) " ) 0 A $
W
" GE? c mdl lii u 8 G
):6 *
0 = GHarvard < )# ,
Johns Hopkins 0< "# )# GE? m bjm cff A
& Yale 5 )# .2
0 0( )
...H^ A
J ...H^ A
J .....E? e mfb fmj u 8
0( & @# < 0 G, W " "6
:.)
u
H6< Y$ 0 //F 0
/$/, % 0 0( $", & - /? 0 Bealle 5
O&1 /
/ ">.>
0 .
I, M
!/1 < *
"5, /" 0( 0 =*
.I( 5 / ", "0 $
*J 0, a*
0, @)#
John. D Rockefeller 0 I ."#
% .$
0 *J @ I6
!/, "0 .E/% <# A& , / "N 9 "0
G=#
Q
) GE/( 9<>0, G
; "6
"
"" !(" K 9/ "N 7)
GChase NationaI Bank " *
!(" K < :
@*J
.Chase Manhattan Bank
9/ 9
)
1 =
0( # 0, 0 K 5 G* 1 # A 0 9/, 7% ?
GM/1 E E ejfff " >0, K < $", & , .1 H6< )
@
/, @ 0J 50
.0 0( ) ? , 6 Ga
%)
" )
P //V ebef 9 9> .9)
9)
) M
9/ Gebfl 9 0 //F !/V 9
51 " >0
Y
M*
5. " G9)
9)
) M
& , #& G0 //F 9/
.ebei G, Gel K )(8
:
"
& A 5
&
" "0 0 )
.?
=# "(
&$
V "
+.)
" )
0 # ", _#
" !
GK
6
9
I6
>V
M* " GE^ !
E, G@#
". M* " $9> /
5<1 M* " 80 "/ K
6
. .J (
%.)
9. 5:/ A //F
@0
9 6 , &
?
Q0
0(
", Advertising Age "".
" A/ # O& P, %
H6< " .)
?
"0 K
6 GE? e efl jjl iml A
J 5
". A :* u
eblc
("L ) 0 A
J )# <6
) 0(
'
6 G"L 0 0( G:
u
9
'
, I6
3.
6< G1 &
5:/ 9)
I,$
3.8
P 0 Gu
H6< " :
" >
.M
5#
#
HP 9L M/ % I, " (& >0,
*(
0(
K
)
) + 1 ?0 A )
./ 7&
>0, A&":", & A
J Bealle "5" (
(/1 "
1 H6< "V K8(
" "&
3/ K < !
G<, A 5
&
(Q0
* 7&
%$
) % International Press Service , GUnited Press !
, Associated Press !
E& /
W8
.& + &, "0 G&
."/ O& 6< "0
G&
V 9 ,
New K # ( Arthur Hays Sulzberger L/ <>^ "0 Associated Pres ! (/1
&/ "
9< +
+?F< .0
")
: 5% " > 0 6J ?J 1
/
? )
1 &
" :$
/ 6< .)
9, ) 5%) ", "0
7&
=# &% 50 > 9
3601 " <L
)
3
8
I0/
"*/
A
.# &
?
@<J I)
+
W /
, 5( I6
GEmanuel M .Josephon "/# .9, .5 J 0
(, %
"&
30
*
)#
+, Y %J " 0 +
0( ", A
J (, G ?& ) @J
9 A "% L ")
"&
":
)(
"V G "
5)
%., A + G")
(0? * " 9 G6
. (
)
(0? 1 )
<8P
%
>J , &
.
* :< 9, 9
K , $*
*/
5% "
" E/
/n E& {V* 0, (
0, Q&J GBantam Books (
"9 " 0 6
/ 6<
", 5 G:% A "# # & 30 igff A
J Slaughter of the innocent"+1 '6" " ) 30
J #
0 G(0 */
") L) /
$*
%
") L 30 "& A
J @/
."/
3<L A
J 3<6 M/
" E.) 30
A, % ! 30
( 9/
K < "0 G(FDA) 6L1 1 J 3/& G@8 , = G
<, 1 "
Q86; 7&
K
6 G<& &
?
2
$ #
>V
3/ ebmc 9 (
"% 7
" H
G : ? M/1 Y
:
7
1 9P) $"V ")#(
">
3*
5#
/
&
9L
6J ?J G1 9/ ? I6
-.)
5& &
=% $9
" .5*
Q
A $6F , , K
6 " >0,
")*
"#
)
5% " ! #.)
M*
H6< 0 +/ .& " "6
"0&
7<, 3/ 0
+0&
+*1 5% " , 3(1 "#
)
, " &
, " "#
)
, 9P)
9 M* " "#
)
,
."Q0
7&
E, , "
9
K8 n G9
"/ "6
5) 6 9) "0 9
91 )8*
"V 98) ", I$
" G1
0 //F #
, 9) 9 0
)
G+
0 //F
/
#
<
AMA 2
01 )#
" V GBealle
) ,
<) 9 GK
6 L 9, ) 0 "J Q1 -.)
5:/
"
$# +*, +^ A
+*1 "1
" & %
-.)
5:/ 9P) ", 9)
= .0 //F '
= A( 3/&
K 9
J , 9) 9 9L G#. % , K ? 5:/
H6< ", % 2
01 )#
"
. E.
, 5:/
:
#$ Bealle $ ')
E# ? G3:$
) 5% "
G+
//F /
*
&.
.& "J"
0&
# M/
" @#J 50
H 9/ (E) E*/ E* , E>& "0 6J .50
&
."@ 3
"&
3),
"V S
@ 1 G
. " 0/ " Adolphus Hohensee / << !
, 3*
0& $ G
Q&J
% AMA 2
01 )#
0 .)*
"
" @# A " =$( $$ 6$$(
."I(
9/#
/
" ", &$
)
*
P
% "
$# +*, (
$ % (
H6< ", 9
K
6 " ()
+*1 3$ GH !0 5 0& ( 9#
."
&
, "
)
&
5#
5)
:
:% Bealle 5 , .FDA 6L1 1 J A
J J
B#
=
&#
9)
30
G01 +
"&
J G01 )
&
30 :0 0( A
*
01 G *
O&
)# G&
=
&#
1 30 G
#
#
G01
....9)
G=#
" =/ Q^ A +( 50 M& G0& >01 )
"* ( 9)
*
01 )
&, +
//F K .$*
5#
1 0
7
#
*) G&
5#
K 0( "</
0, +
&, Alfred.N.Richards ( .", .
, < .01 H6< /: ,
.1 M/ +$# " : M& 0
GMerck & Company H0(
G@6 0 //F !: @ 0 0 " G@
/ Richards ( 9% G&
H6< Bealle 5 '
" J.W.Hodge -< . .# 3 E.> *
1 &
8
% .Detlev.W.Bronk K . .7 <
)#
zE zA/ I6
G
W
1 0& "J ":$
0
@$, GK L ?.(
!
E/ * EL P
>0, J GE 9P
0&? Y , >0, * !
G2
01
3#( E/( E#< A G)* ^ 5:/ A
#
)
* I, $"J .
)
=# 8 J *
)
6<
.+< # 0 ) ? $ 60 8 , $#& )#
H6< % 5% "
W
+*, 5% " 5# " * 6)( " @ V 9 W
.& = 7
& ", " -.)
" " " 50
&
G$/
1 )/? " )* 5:/ /
&
A
J < J 5& &
50 ."/
) 9# O& 2
"
)
;*
+?F< " ? 9 G
5
1 G:1 (
." 0 # A
%, A
J
&&
-.)
) G$/ $
& llbd &&
-.)
"
0
0 /
M;/
/ ! /
)*
-.)
)# G/ $
& lfff 5%1 A #
&&
-.)
*
$0
G(
A 5
&
E.<F 3
*
'
A& / 50
/
& 7
, A /
( 9 1 0&
//F "n K
6 = .-8
/
& lijd & 3* L0(
9< 0
E: "0
@: , A )
Y
+# I6
" &
31 E6^ G&
*
"0 0 + G
*
:
!/V 9
."
5
1 3*
/ // ? " lg u 0 0( >/ % .+*/
",
"* " gff Y %J " 0 6J 0 < " // , !/, A 0
H6< !/V $9
"& "6
G+0&
")(
9:*,
3(1 A /
N #.)
M*
=#
/
1 H6< .&
?
*/
1 %)
K ) M
"$
" "%
.3)
H6< A 8/
" #) ", )
#
1 P # Q, # V
/ 9
90 A 3#
M* "
0
1 9#.
) >J " +0&
"
+*1 +?F< "0 9
6J
+?F
/
<, 6 # #: ) "
G$ % 6 /
, )/ G
&
" 5:<
0 ) 9
GE 0 E, #
) 9
"
1 9 (
/ .";
"6)(
&$/
. .
0, 5
"
5> Q, 5 A
J <
3)(
&
G5
3& G7*)
=(1 & "0 @ , < & # A
J ?J
@&
%
/ , ", "0 ? .."
A
J #
5& % .... @>
$ $/
** 5
!
6< "0 .;
< 5
) O&
A
J /
@<6 A
J (, G$
P
9/ P)
@P A M*, .... /
/
@
/V <$ 3&
"0( " 0 Joh.D.Rockefeller 0 .I ."# A Ida Tarbell 5 , @*, I6
7
< 6<
" 5% 6< "0 Gebfg 9 & 50( A Mc,Clure "0" # @( I6
'History of the Standard Oil Company'
)
3&
) "0
.<) @& I6
$(
% A
J ) 5
9
< 0 "0 O& G / ) "
&6
"? 0 " , 0 " / 9.0 I, , E G# , 0, +/ G&, , ", 3)
" "0 >
/
I& ? ."/$/F
9./, /
& "6
)1 0 &, " ? GH
A* A / I6
X6< 5
& 70 "0
G/1 H6
'
Q/ ;
9
)
0 (
9
# A
J G@& E#J E; 5
& / %
0 & / >01 ">&
"0 ", /
"
:< .@/ < <
/
(L0( A
J /0, )# "
, ) @
E0 ) &
, /
H6<) *
/
E)
L @/ 3/ 01 0&
" @ J Gebee / < ")
" 5)
" 0
*J @& 0(
v\5&
6< .0( lf " 0
*
0( # 5& E,
, (
" Q, A 5) 0(
# 0 G%
K
6 A& .O&
5>
M/ 9
#
GP)
G* H6< YV %.
*% ")
+(
5% " 9
A / 0 K
6
=#
5&
H6< A 1 G9#
"0 ", " =/
/ +
5) &
, G
6< )
.
* =/, 9P, &
, ", A
J
E :/ %
K
6 A& 0
G@
"/& A 0 #, ebel 9 O& >
/
O&
%
0 0( ")
5$)
#, = United Mine Workers 9#
5$ & 3
* .9)
I,
P
" "# 9P) 9#
5$ "0 .9() 7P "/& G0 0( Q&J G3
&
0(
e,dc) u
9<#, 0 .= #, 5 0(
<J 9*, |0, " 9< ,
"
0(
) !: 0 A
J "<6 0(
)
"
8?J 7
? / 50( A = (9
E?
0(
0 0 G0(
*/ ! 9<?, "8) G0(
"P " 9< //
0 .Darwin "
Y 1 5
, :5> $ >^ 6 0 <)
5# %
30
)/
580
* " E) 9
A P&
9 0 "6
!/#
9#
!$& "&
" )
K 0(
.$
&? 9P
!L . .K 8%
G0(
E & "0 I6
"? 0 3*? 9#
5$ 9%
"
7
, #V/ O& G0(
" 9<* % G5$)
+?F< =
G0 //F
E "0 I6
*
!&
+/ Ammons , 90&
) %, G&
Baldwin Felts
0 " 3? /0 $%
.3*?
"
5)
" "
9&
9# 5$ "
# / el $
/ 0) 9
# .."
9 G"
"
:% GLouis
Tikas
!0 !
5 W
G
0 *
!&
"..
:&
06
9
< GA&#
" 0 A
J J "
" )
! K < G(5*1 +/
" 9 ij) E
( lg 5 .."
, "
# 9&
9# 5$ ?
$% " (
/ el /
0)
&
&
&
O>#
" 0 A
J
$& .0 0(
")
G&
0( %
0 0(
&
":
0 "*/ 5*1 +/
"0 .
E.> $
3&
( 9
$
% 8 J . 1
I6
Ivy Lee
, < G.
< ". &, #:/ 0 9% A
J >&
H6 =/
Q$,
% }E>& P
0 //F a", Lee
9 .+
*
9
)
$
A
\5 ?) u
0(
Y ", S%, G 5)/ & 9
8 0
: L1 ? " : u
G8*
H6< A
60< .) $)# !: 0 (/G )# G80 A
J (? " "
.7&
$/:
" )
5& ".
= , ,
" )
(
"#)
>V
6" %)
5& +06 L
60
$*
H6< 0
&
&6
L % @8 , , G3
9)
I,
/ % .6< A& :%
?
7&
/:
$
&
MV )/? 0 0( $% "6
"<
7*)
90
3/ 3 #1 "#
vM&
. //F ?* "6
M* " , 5
M* " +/ 7&
=# +( A
J J G&
5# +( a9 G&.
/
$9 % ebji 9 Henry Luce /
I < //,
Time # a"n G60< .0 5V 7&
H6< !/V
@*J "L ) .
50( # J. P. Morgan ."L . .# 5% " */
A
J J GTime # >
>
. ;
H6< A +./? %
0 =$ 9
G
0 7&
H6
E
"0 O& E* el " E
F E0 A
Life # Fortune # (
.Time & Life A 9/ @ *, Rockefeller Center 0
9, 5:, //V $9
Newsweek < Time #
/
#
0 }E, E0( 0 "0
:)
+%
, "^ +, GHarriman "< : GVincent Astor /, / G0 " #
0(
9/ , " " +( "0
/
" 0 B< G@0 '
, 50 A
J .0
.
@>/ o9<, &, &
$& G=%
.! ""0
" ""01" ""8)
" "">
"
8 J * //
0&
A */
0 M& 9
G# .
5 ")
@:<" 9 !/V
"
0 W
P
H6< GMedical Power "*
" E+ G"01 +)
">
A */
.9
O&
o3*
5# , " ") "6
#
, , 5 :# " :# I, A )
0 9P 9
" I, 5
& 9
:E# ) 3# & K <
.J A E
& )
GTime #
&
/
!/F
Henry Luce /
I < .
:# " <L
5, 9P) E)* E0(
&6 " E?F/ 0 ", "0 % .@ 3/ M 0 P& G0
" ) Time
# 7.L A "? 0
/
I < = Gebgd 9 G5& , A .:
H
:5> M8 % G"'$ "
M& * I, 5> E G& 0, 5*0 7v U
+8
#? *(
9)U "? 0 & "1 .."
."../
5#
E
M& // I, , 01 B#
E
G/
M8
K
60 "? 0 5& ) A& #
;
K "0 9
#
& :< a", G'
"
.0 .J A ) 8 1
&, "0 I6
ebmb 9 Nilson. A. Rockefeller 0 .I, ."/ < "? 0 + , &, ) G60<
"#/ # " E
( E?F/ "0 I6
0,
Q1 3&
9 3&
"P
,
:/ " G@
) Time
@ 0 % 0,
".. V( " =
H. @# IF "0
.."
:/
<& A P % * H6< < Q ) .Y
9
&(
A
J ...
(
)
)
/
//
.
<J >
) H6< .5/
6<
Q&J K+% 5. .
# 5$, "
< &
<
5 G*J =
0 ? GH,
A
J ...
#
/? 9P
)
0
5> 5)
" >0
# ", 3# G*
" $ . .// < E,
", 06 .$ < H, I6
", ) 6< G5)
H6< # 9
"J .H,
G#
6
J & , % )
"
& "1 G#
) >N & +
'/
GK
:E: 7
V
>.>
" 7
V
0&
*/
E, V 9> G(* 9< !, )$#
%*
)# % (>0,) )# 5)
H6< .*J M ", " ? G)# 6J 5)
H6< =# .8.#
G
5# "0 ? "0
G&/1
)
O& " >
)
% *J 0, 580(
5. " I
)
"/ A */
/
#
3*
+
*J J .(*J S./
A 7)
E# 9
" G
*J 50 "V E
/ 06 % .H# 0 H
@&
M%
.
O&1 I# 9
"J
/ ) "0 ? M:& A 7$) 0
G
/
I
5#
6<
.- /? 9> " 5V
7%
38*
5
)
* >0 ;
&
6< ) .9eilm
" ~+ G / &
/
(
L &
0 L # 9/#V @ & A
J GI(
:6;
9P
#
5n0 G"/ &
*
H6< .1 A
J &
"/
& ; </ " <L Q, #. , G#
G&
7?^ +% 8
5
5. @
6 I6
#
" >0
#
/
?
6
5$*
I)
/
5. P&. "0 ? < * P&. A / %
!
9
@# I6
/
*
9P
"1 G9 50( ;
9
)
&
/ A 0
, .5*
.9
)
+& , % A
J ( ", 5% E?, 0, , " M> 9> 580( !/V % (9
)
. =# A
J ) .
# 6A -$)
@ <
", A
J E# 580( P #.)
3<6
6< !/, , O& G
" , 7/
$/# ", "0 ? #.)
3<6
6 G
3/
06 % G 91 K :/
&
7
"J .9
# 0
$) 7P M
"* I6
G9
E:% ) 9
I6
6< .# @
"0 ", "
.H/ @: A P&
H#
9
9
"& G90 " ) "0 %
K , :/
&
7
5. " <$/#V/
PJ E: 5&
G(# "J) $#
=#
) 9.1 A ? Q/
"$0
? "/& " <P, 7/ "N , .7*
"/&
5)
) = "0
K
&
.&
) " ) % 6< "1 G7*
G 1 G
&
GI#
G"*
:, " #
$) , 0 A
J ) 7/
ef " <% "
& 9
A , '/0 Q, % , " <L GF
A& G!
GM
& I,) "
"0/ " cf,fff " >0, G( =/
"
7
A& .#< 50 5. 0/ " :
jf A
J
G+
6< "0 .XA*/
)
K
.* % ( 5. "*
+ #< " (/ 50 " "
.E, "0/
"0/
" =* 9
H6< 0
@ ... V V V GQ1 :1 " @% E&*
=#
0 % 0 G
0 G / if , jg 50 ", Y
"
"F
&, 5
K &
0 G"
" "%
.50
+
$) 0 +
" &/0 #
$) G
?
5
&
$/ "0
"
"0/ ", O& E# % G" A/
G6
(
%1
#
H6< A =#(
"V "F
&, 5 .&
(
:/
" $) 0
7
" $/
#
@
% .
V 0 E, #
.E& E, "0 ( ? 5
" ) ) "
A P&
"1 GE:% "0
A
J 5#, 5#1 $ G, +& , % E:/ "0 ( !/
"
/, " J. H. Elliott
,.<." 9< 9% ):#
")
7?^ G"&* A& "0V "0V + L1 "0" :
, 5% .)
E# "6 */ 50 0 G"0/
% , .)
3
6 0
>/ ? $)
6< .
/
9#
."">
A "() "6
" 7?N ( V# G+6;
)/, 7* ; 5
& "& .)
%1 6< "0
6
#
...9
A 366 )/1 0 ( !/
( !
"
@ , 9)
= .I1 Y#
&
#
5
&" :5 9elcj 9 ! '/0 I6
+
A <( / |F E#
G!:
=
&
H6< ", 06 .=/ M* A
9
3# "
&
+/" ) 3
0 >0 M*
A
:
&J 780 9
G, "
V 0 G
#
G"/:
/ ",
* ."% "
" "6
"0/
" M
)
"# "
)
"F
A& ."/
.0 " M
9/ ,
.Y#
" "6
A
J ."% 5* "
"0/
H 0 9/ 0 G6% 5:/ + G%*
3 # & M
, GY(
$/ /
&
K 5> G 50( ! 0 &
6F Q, >0
."+
&" G"
@
5. G"/ !
|F
</
K
G3 # A
J E # <8
0 .+
" A
O># +&?
0 & & " 0
O>#
&: 0 90 .O>#
E <+. ) Q/ 3
<*; ? G * 580(
G87
M 87
P &: A
J .*
5*< ) $;
7
9,
G+
&
K "
8)
!
9P) .6
9&: E, +&1 "0/
P /#
K " A
J :
9
% G(0
O>#
90,
G@# , H/# A 1 &, 06 . @
E
( 50 .9& $
A& &/ 9
= 0 0 *% G* ( 90,
9)
)
"+
3&" / )
3;(
5, 0, .3;(
5,
,
"
.
( eff,fff & S
9egjl
#? 7P
O& .
K 1 Q
% A M* #6 0 J % " "/ !
@
%
5)
.H0
G ;
\5;
&
H/ "0 " 0 G:/
#? 9
A
J G:0
$;
5&
0 ."&/
" 5 <
<1 L, =#
#
/
& "0 9<$& I6
&
"0 !"0/
O> 5)
6)(
&/
9? @# 9 , " Q, +& , Q% K < G0 J
.!E /
H6< 3/ " eff 5
, " ef
") 9
QV ? "6
G"(
+
"0": E.:% 5
* |F
30 G(
*J ) " #"
9
&
"PP& 0
.""
9)*
&
QV
5#, " +(
5* "$# O& "/
)0 +( 50 9/ ,
" " */ 50 ")
"0 GE& +(
5
G, "
(
M*
.P)
H6< A
+ L1 5)# I6
3/
< 6< !!+
.../
9:
9<: = =#
+
"0 7
5
.$#
+
" G"
" <L 0 ":5 |F
5 0 .7
+
"
"0
.":
5
1 "0 .9, ()
"/ 9L 5% " 0
"6
5*1 7
& G, +& , =#
< G5*1
^ /: 3/ K < G6;
+/ G
G)
+/ A
J .)
*
" E+/
90, A "
"0 */ 50 0 9 9<? " 9, "# "6
5*1 " 7?N 7?N ."#
"
... )0 " 0 "N .%*
3 # &
, G5
O
"V 5
G9
P
)
M:&
H % 6J .
K E:/ "0 I6
=%
< 6<
" 9
E
V '
, ", ) .9/#
Q/ < /: 3/ # $/# G@#. , @/ , @ "0
" G/? 9 G6;
+/ G )
G7
5> /
?&
", G+*1 * !
G(
=#
.9/#
A 9/& ( >V
) / ?& " <L ...GK(
G&
" &
3
9:
Y#
9P
)/? "
\56
# A
%, # % A*/
)
3)( " H <( "J
:1 H6< P + 3/
" "N M& )# ?& " <L .... "1 9) 6
$K(
+?F< (
&
& # < 1 :1 H6< 0 6J : &, 5+/ % "0
.1
5 " <L G+6;
G ^ G&
GP & B) I6
I
)
"/
5 ? 6
G3)(
.!X< +
&
+% 5. " (@# / ,) H# 7/ "0
." , H
"0 ? 5F/
6< A 3#
.
8
"#
)
A $3*
/
?
& 5$, 9egfb
.80/
0
E)
( " 50
(3<6
)
% " /, " " 5# 9egeg
.")
A
+&? $* L 0 !/V 9egii
.=/ M* A , ( 1 + 9eggm
.K/0
" $ 5$1 , A
J 5 u
9eggc
.80/
# A
5V %.
% G!
( G /, K 9egdf
!
( /, K
.<& "
jf,fff 5 G, 3 "*
9egdi
.
A& ( # " "/ J " j G0, 3 # 9egdm
.lf,fff 5 ( 5;
) (
5# : 9egdc
.t/L, G
, 80/
0
=
5$, 9egmi
Guillame Baillou " 9?L" /
3*
5% " Pertussis M<(
+ A $ 5$1 7$)
9egmc
.! H( 5.
."
"/ J eg,fff 5 "*
9egbj
. /, "*
( 9egbb
. *
"1
<, 6
V/ &
, , #
E# & < 80/
# ", "(0 " *
9eddf
- V I, A
J 01 )/
" - I, , u
, 80/
"&( = eddf 9)
& " %
.
1 , *
5&/
.0 J =/ 50( "*
( 9edfi
.0, Q, )/ # u
Y 9edej
."
A 5$, S 9edij
.
9& A
J 80/
9
"6
"0/
"V # ' 50( P&
% .0 J '/0
+ 9eddg
.+
6< # dc,fff .06 I6, IV
9
*
G &
"
/
9
5
"/ 9 " W
*
& 3*
, P 9eddm
) ."/ J A
J 7 9 5
& ) K
6 .Q,
" "& "
/
9
5
"& 9 " W
/
quinine "" 0
" 7(0 0 J .
+ P 9edmg
.
.! (90 !,)
( 9edmm
.
&
I#
5& 0, * O& 5$, 9edmc
.M<(
+
7 !( ( "( ! 9edbg
.+
A&
9/ <) 7 . ( # + 9edbb
.E / 5* " jf 0 J 80/
/ 5$) '
, 9emff
0/
Q1 5
0 J " 50 \5/
( # 7 50(
9emff
(
# S# A I#
'% " ) "< M* " K
6 GI#
)
$) > "0
.-.)
6< = # 9
(
D D$) $
F $F " 6A % G
, I#
$
&
)
M> 5$, 9emjl
.$ $# 6
" $9 &$# =
C) $) ) .6$
.5
9emjm
.
, G"
( I#
+ 9emlf
.. +
A&
+ 9emle
.Q, $ . +
A&
+ 9emlm
./ lg,fff &
G / eg 9 0/ '/0 M<(
+ 9emgf
.D& 6$
$) # *, /
H6< "0
. "0/ A
J I#
S
9 9emgl
." 7
= H39
< .$
&$# $
A # ) "0
.. +
A&
+ 9emdj
/ = 9 G6# A
J 3/
3/ % ."0/
" 0 &(
& / '/0 I#
+ 9emdi
. / ! $
0&
5% " 9)*
S
./ I#
9)*
S
/ S/
J '# /
$*
=#
9emdc
.K
" V K
9)*
S
/
//F "& K
+*1 " # 9emmc
.9
<, " 9 "
5*1 ' 9 G
*J 9emmc
.9embf A& 9 G0, G .; J 1 + P 9emcb
.&
?
Y? +
" % 5,
9embf
.
/J @ # eg 5 , / )# " $* ( I( (S8
/ ") # 9embf
#
9 9embc 9)
.
I# GH " ( ec # 9
I6
G@ 9)* 9 # 9embe
.\5/
E
je "/ @ .
I# @)*
$V .$9D 0D
= H3& " $:S 0
W
A C)"
=/ $ 7 9embj
., +& , =# *
80/
)* A
J *(
@ A &
# ,
# 9% .X#
$
&( J$) # 7? 9 G0 J G(//L 9embd
"()
"/ A
'
, ", ) .$ jf '
@)* 9% .I#
' H " >
9)*
.\5/
@
J #
.&
?
I# )/ W 9% 9embc
.!/(/ A
J S8
/ 5 G< )# " G!< "# 9ecff
. /
5* " edf 0 J 80/
K./ 5) 5
9ecff
.=/ 50( '
A ? , 9ecfe
5*2
I# '
0 " 8
9 .I#
S
A @? 50 @ # ef,ff # *
0&
' 9ecfj
.= :)! Y$# =) C 5
$9 G")
Q
&" S
.
I# '
<1 / A
"
=$#( !/(/ ? 9ecfb
.(5>
#
)
) homeopathy >
-.)
7(0 " << 0
9ecef
) I#
3
gig " $)
) ( ( ecef d ) $*
", 50 "
" # 9ecef
# * S#
& egf .( '
) I#
J
& bm " (0 .'
A
Y
.+*, 0 "
" ( G'
5*2
I# '
c 80/
- J 5$) '
, .80/
0 =
gff S G/ =/ M* A 80/
( 9ecej
.E / 5* "
.
80/
n "(; ")8
"0 O& G!
, 80/
9/ "
)
9$& E % 0 J
9eced
.
A
J
(1$ # "0 GI#
S
A @ 9
J @ # jf,fff # ' *
0&
9ecjj
D "D =D
6 $)
'"$ ) Y$# $ B
&( A #$#
-7) $# <#$
A
.(7 6
./ :
;
(&
Y .9 $/
9ecjd
.
0
+ ( 9ecjd
.
= )A
$! = 6A ."
A
J "1 " M
ec,bgd 5 0 J 9ecif
., */ A
J /
0
+ ( 9ecie
.+
// '
)
) "6
" bbg O& G
, Gt I#
+ ( 9ecie
.,
&$# $3 ZOOO '$A G/ G/ 9ecie
." *
*
*
" =( 9 9ecij
.>
-.)
/ _( " << "/0 9ecij
.
H6< 9/ A +*1 $ A
J Q, GK 9 :
;
(&
9ecii
.
(#
) 30/0
#, P 9ecig
5
$
=
# 3
/V0 / % G/ !
9 9/ A
J ( 8> ?& 5$, 9ecid
.)
.0 I#
( 9ecic
/ 0
.<, .0 >
3*
0 +( J 9ecgf
.&
?
A
J <6
:6;
#
I#
&
5& E.
E , * 3* 9ecgf
9
!
9
P
&# * 0 G"
$*
=#
!: * S$# G" M&/J 0
9ecgi
.Q, #8 ( , Y
& 3/ $/
)
", % A G+/
.0 J 3 I#
9ecgi
" %mg '
/
Gecdf A
J ecgi " .,D+ Y$# A
" % 9ecgi
."0/
" %bf G#
.$ 5$1 0 J $0
) 9/ 9ecgi
90
5 *
.$ 5$1 #
+ A
J +
"&
9/ 9ecgi
A
J 3
*
5
//, *( 0 A
J G!/(/ ?
I# '
" % 9ecgg
., (! $"
H39 S #
*$" A / 6< ./
$
" V S$
$/
)
Y & 5
,
* 8# 9ecgg
.$&
=#
.0 J
0
( 9ecgg
I# '
.J (
.S1 " ejf,fff
& " / =/ E( A 0 J '/0 M<(
+ 9ecgc
.&
?
A
J Q, "
& 5:/ I&
5J 9ecdf
[D% G
D" Y$D# D 3$ :)A 7 L9 J$" :"V S$
( ">
) *
/
9ecdf
( I&
"0
." 0
; A " M\
A MO ) X#
'
BS $9
A
J )/
"/ '
(
= ", "/&/
" @ J": &$
O& @$#
$; *
/
"
."@& 5. %) )
H6< 0 9> GH " ()
."0/
" jf,fff G" 9 G0 J I#
'/0 ( > 9ecdi
.6
A * /
* Y / !
9ecdl
."3:
" ) //F" _( ""L I -#" 9ecdg
5% " /(
#
9L G&#
5# P
*
5 "$ -$
9ecdm
."
" *
"&#
&#
5# P
/
7#
) )# +( J <#
" % ) P 3/ 0 J I# '
# " % 9ecdm
"
6< ) " 50 .* E bf 9< # . 6
5*1 A '
A "
6< $ .'
.9
)
5& &
". c
& % .=#, 9
)
'/0 I#
+ 9ecme
" " G)
A
'
" %
) Q M8& 0
0 J 0
!#
=# 9ecme
.H/ &$# % ,
$/ %N_,\ ", & < M&
H#
., M]\,OOO " / jf 5. .I#
I# '
"
$ 9ecmj
. 0 J 5* eb,fff " >0, GI#
=$
5*1 " %cm ' 9 O& G0 J 9ecmj
.( 9ebjg P , )
.$&
$# =
/ $ )
% 9ecmg
K>
M:>
H6 Y$ H&, &, "0
.&1
@.#/ "(0 ? "V @:
" J$
9ecmc
; >J "# / .#/ A ")* "F
">&
S 5 <) G9ebdl 9 ! 5 (
%.1 9) A
J ( <P " <L ? W: 0 # 3. 5
& A
.("/L
# 9ebdi P ,) .)
7$
+/
/ !
#
/
?&
A 50
*/
" 0 ; 0 //F " 9 "0 I6
G
.A
1
)
3&
"6
"01
" eff,fff 5
& e,c < GK
E/ 5$#/
GI80/
+ " #
5$) 9eccf
.(9ebil 9)
eff,fff 5
& eb G9ebee 9)
eff,fff 5 ?& c A
J = % ) "0/
.&
?
, I#
S
& 9eccf
( 50
5* ejf A
J 5)
= %) E /
( 50
5* ej /
80/
K./ 5$) u 9eccf
.(9ebjb 9 E /
u \5/
#
5) ", 9)
= Gb " $)
" B0
1 3*
"0 9eccj
."0/
" eff,fff 5
& imf 9)
K
6
B0
1 3*
) .'
Y 5 *
/
30 ",
$) 7
) " 3T* G0 J 9eccl
<) 30 !G) 3)
1 G
" J$
9 Y$# ", H& - / A
J 5
G
Q/ A G5*
O&
."'
#" 30 "I<
I#" :" ) "0
.syphillis I<
" " I#
9& 9 5* emff " >0, G0 J 9eccl
G
1 '
#
9, '
W: 5& 9 G
1 B#
" Dr. Sobatta / 0
9eccl
D$ Y$D# D D 6$
6 <$
.B G
$ Y$# A 6: .># @ "$
.! % &>(1
&$
$4
"0
( 0
G
1 '
#
9, '
W: 5& 9 G
1 B#
" Dr. Sobatta / 0
9eccl
D$ Y$D# D D 6$
6 <$
.B G
$ Y$# A 6: .># @ "$
.! % &>(1
&$
$4
.&
?
, 30
+ $ '
.& 9eccg
8*L O& G' J ' jg,lml,imf
. 6 "
/ =/ & , 9eccd
P ,) .
& jc,bmb I#
J
& edg,mml P G
K 5. ."0/
5# " %dd 5)
.(9ebgg 9
.:6;
9P
"*/
Y 5 30 ( 0 9J 0
A K " 3* 9eccm
780 G*
; 0 $0 9>#
9
1 9 /
GK (00.9 LJ 0
20 J 9eccm
"0 " &
# 0 .(
I# + (
& M&
*
0&
5% "
:", & A 80, O& GThe History and Pathology of Vaccination "'
1 9 ":" )
.$
Y$# J$
$&
$#
$ 0/ (7 /(
' % . !
6#C 8
6
$ 0
61 % 7 ! ' #
0
) 9eccc
.! #
W
*
! ) 9
)
5& <)
" )
' ? 0&
5)# .
@& E&#
/
H6< ", A
J G9) 98)
!
$*/ G.
I
%? 9P
A 50
*/
"0
@# @)# +( 0 =#
% 9 0 "6
"#? "/
" ;
# I, 5*1 5 =
.L
3/&
.anti-toxins 9$/
= 7(0 " ") GEmil vin Behring u " 5J 9ecbf
9/% +( J A
J Q, &
?
A
J
5 " 7
.
, Gt< 3
0
+ 9ecbj
.K $&
:
) 9)
#
0
#
>
7 5$)
6< . *
K./? 5) % O& G80/
K./ A
1
5& 0, 9ecbj
.9ebjf 9)
.6$C34
1$ <C $ "V S$
Dr.Julius Hensel 5/ < !
#
1 3*
9ecbi
. Allopathic Medicine
1 )
2
J " .*
0< "# / !/V ecbi
.H
9) $ 5$1 9/ &
#
"
/
0
9ecbm
A " @
/ "0 O& "J " G/: < $/
)
" :30 ;/ 9ecbm
E: "0 "V W /
5)# G":00
80/
A @ J 06 5<# ".u
G"
G5&0
!
9 <
! #
A //, 50( )
@P !/F
>
&
H6< GE/ # *& E E>/
.) O&
.= 6$
$ 0
=$"
B
6A $()
Y 9ecbc
Gboard of guardians +
1 !# Q# .0 J
'
D/($ "V 0 J
!# dff " >0, $) G'
"
M* A +
1 I,
9
? I, "$/D D
.
-" 7) #
"
" .Y$# c
1 $
# W"%
; H39 0 .)
&
E/ H 3/&
&
3/&
" ;
, "
.$/ B$ B A
#$
,A 0
/% ,A .$
.9
7(0 Marie Curie I0 I 9ecbc
:0 3*%, E/ 9
, t// )# / G ..- 0
9ecbc
.t
/;
"V 9)
= (
,) / )# # " 9< &
?
PhD H0
( & =# 9ebff
<D$ ,$
2$)$! 6 "T
A $A $$1 T9 <$ .
, Y < H0
(
.($
)
1) ! )
" #
//
H6< 8 9 .Q, / I, K < !
G, / $ =$
$"
9 H39 2"
.&/
B#
5%
-
0 / )# %, > 50( A
!$/V GEugenics " $"
9ebfl
."
University College
G .3
( A G"
< u /
0 " $" 1 %J 9ebfl
.
$ MM $
f 2$()
$9 >
$
.&
?
+
+6;
Y A
J H$ " %
9ebfg
? I, K < !
.K
6 5) ? il GI# '
" % M$* &
?
? ee 9ebfg
9 3/ K
6 G/ )( " I#J '
, '
", 9)
= . * A "&
.'
)
H6<
.&
?
+
+6;
Y E
5 " %
9ebfd
.
$
S Coca-Cola
))
) '
7 6$
6) 6#$# g( -$%
9ebfd
" % 9ebfm
( 50
E / 5* cj K
80/
K./ 5) u 9ebee
.(E /
( 50
5* eei
9)
5)
6< = ) ."* eff,ff 5 c < 80/
# K
5) 9ebee
.("* eff,fff 5 eb A
J ebil
.&
?
,
$ '
W 9ebee
0&
1 =
5& B , 5 I, = G * "$/
" %"
9ebee
."$/" V
.
$!
$F $
"
% $($) C 67 A &
I& *
/
9ebee
C)"D
D" :" S$
G/# " " /, 3* < GRobert Boesler / 0
9ebej
.$"+ $) < C)"
'" # .W =$ A 7 6
D
$ "0 A
!: ."
)# Eugenics " " $"" Y 5&
A 5$, 9ebej
"6
"01 , . 77 "
"0 !: 3: 3
F "6
0 5:, &, .$
7 2$
" "0 . 9F ) G< )# /: 3
" 6
$A 7 9 " "0 3
6< F
. / )# !:
" "&
"
D% .H; L 70, @
# G"/ 9>#
A @ 9 GM<(
+ $ S
5$, 9ebej
% 0 , M<(
0 +( J ) .(D&$ $" =") J
$ X# 39 '$
u# " L
.<"
)7 6# 1" 0 &" <$
(!
=$)
9ebec
/:
3/
< \5/
+ ", & 7(0 E
&
?
)
&
!: 9ebec
.&/
"
(1 * 7
#
, .K
H6< ) GEugenics " " $"" Y 5&
A > 9ebje
"* ( ; 0 ) GO/ 0 GK.0 )# " 50 +/F < < " "0 /
H6
0D
D#i 2
$h $$ = 0
; 0
$ I6
(
H ( "30/( "
9ebji
.@$#
6
91
) 9L K
6 2$$ $
+ 6>
D( '"D$ A C)"D )$ @ , & 7(0 ?, )# " Dr. Seale Harris !< 5/ 0
9ebjl
0D
$D '
A Y($ $) .C)" L &" $(1 J
$
hyperinsulinism $$
"!
G@/ =% " / jg ) G!< 0
:0 9 "0
.!=7
W
=$1 B" <% $
J$9
)
9
9
*; 90&
=*/ # , * < 3/
GAMA 01 *
*
"
.
6
/:
3/
< 80/
", & , .M/
&*
*
0 P& '
0
2$! I.G. Farben ..,A < $
$& = 7 9ebjl
.&
?
.(< G0 0
( jg 5 M
$ S
9ebjl
D
9 ) =7 6# 31A 6$
7%$ *
! 0, +*, 9ebjg
.$
!
%
P ,) # =
6 ] $ 2, / Y$#
/1$ </ (! %\O %A G0 J 9ebjg
.( 9ecmj 9)
.&
?
, \5/
$ '
W 9ebjg
" , B 0( " 50
J W, (t : A) / 9P ) % ..,A )7 9ebjg
E, GWelierter-Meer GHoechst /(< GAgfa L, GBayer GBadische Anilin
. Griesheim Elektron "0
J 9(L
F/ @
: 0
P G%.)
".#.I, 0(
/:
+
!# +, , ./:
".#.I, 0( 5, 0 J < G" 0(
0, Y 9ebjd
5;
G( 0
:)
K *
K !:) 5(
( G 5/, :9 " "0 G
!0
M( G
*& K
J !# !:) t 5 G(0
:)
5, / 0( !:)
) "< G(" 0(
01 Y
, &
//1 5
t
.
P <) &
, G
, V( /
3*
)
)#
9ebjd
&
/ < S*
Y
G91
& G
>
Gt< F 9%, 9ebjm
.'
( # 0 , +& ,
H6< & .K I0 %
01 )
0&
% '
30
9
($
A 9ebjm
9L E.*
", ) (3# A % 3/) )
6, % GK I0 A )
'
#/ 5&
G
$
c17A :) < 0
< $ A "" B":5
< 5
, 30 !"+" ,
5#, " K I0 9) <) % .":)
'+ G
$
H39 < A /! B .B"
+(
) :* 0 5 GE "0 9
K ", < /
I6
1 .
& 5> 5*, 3# J " )
.!/
E% E
* '
, 0 G J , ./
#? :)
: A
J ) 3/
O&
< 5
."
(, g 5 im S# M
&
9ebjm
.DF D$ D$ Ginsulin shock "$
"D! " -. $* 50/ I/
/
3*
9ebjm
)
)
(
=# &
, 9ebim 9)
5. .F+ '"$ $
"! => 6$) 0/
.-.)
/
H6< 9/
,
"V P&
Gvaccine lymph &
/
7
M&
#
"$) *
0&
9ebjm
#
3/ "0 &
9/
glycerinated calf lymph " /;
I
7
"
"0
G" * "/ A ebjj 9)
"0 *
H6< &* 5$, .sleepy sickness 9
. / ! 1 6
0&
3# $#, 5< *
D WD1 b D%A $# $F $ 6 6) GE0 +? A& 5+ * I#
9ebjm
. 39 / W#" $C# $
I,) "DF
" (
30
30 G ;/ +%, &, GEdward L.Bernays .5 9ebjc
+?F< 5% " @ 90&
@# 9 70 #
5 90&
N
5
S( O& G(".
. $) )/ , 0 I<# 5 , 5% M "L "6
.5
$D
A D
$(1 &) &3 >%
)
)7$ $(1 $
$j H3&
)$ $3 T9" : 5
$
D& "
$) )7 %
3A $)7
2
#
% $ . ) $#$# =
# 9
.7 L
." WA &
<"
0D 6A 2WD Y$#
/1 $3 c17! $ encephalitis "k '&" 6
&; 9ebjc
.$$ .$# $ $)7
."/
7(0 f ")A 9ebjc
u /0
,
Dr. Robie 5/ 0
Q GY#? 5. .Eugenics "5/
"/&
" O
>
)
A
9ebjc
D BD$ )$A
$ MP :)A ('+ 0
=# '") $# A 5)
A
J /# !0/, )# "
.low IQ scores )3 $
6D
" 9 P
G(L
+0
** #
<) EEG # 7(0 * 9ebjc
."$F
EEG L
+0
** #
.".#.I, 0( = @0 W ((
/
0( 3&
) I < 9ebjc
.$A ..,A )7 < B$
L7$ $()
..
9ebjc
:0
:6;
The History of a Crime "D$3F!
% / $ *$" " ) "0 30
G(M/1 &* 5% 1
,7D" "( 0 /+ 2
34 $
# '
-$) $( Y/($ GAgainst the Food Law
+0
30 , .& 30 K < ) 9
O& M/1 " L 50( 30
=# "0
.
) A $
+6;
J" 7 @
/ @00 9 G@ 5F/ 0
"0 I6
Bureau of Chemisty 0&
9:
=# .(FDA "+
+6;
30" A/
&
30
7/ < 30
6<) "(&
+
D" &
, ", A
J ) $; ((; :6L
9 , A M
0
)#
."L &"
I
.E / "/ J 50
5* ejf A
J 5
/
80/
K./ 5) 9ebjb
.0( ") M G5
5, / G5
5( G2
".#.I, 0( " 50 9ebjb
Dupont Chemical 0
0( = & 0& % 9 ".#.I, 0( 9ebjb
.&
?
(; 0 ) /
-.)
Wundt * $/ I6
GWilliam Wirt 9
0
9ebif
9 ." / ) O& "* ( $'
A
J 5 GE, K $# % G J "IL"
D$
=TD W ) BS &$
#$
61 $#$ A @ 1 "/
@
J " #
0
9
0
9<06 "6
"
""" 30 ,% ..XE.) " # 3*
6< "0 5< ...()
$'
A
J H, "6
96 9< @*
.&
A 7$) GM(
.+
A&
$ S
$* GMax Theiler > !0 9ebif
.
0 ? ed 5 ij S# M
$ S
9ebif
D%
2"! 0
" <#
&;
"$> '"
9 '7 0 -/ $
( "V 7(0 9ebie
.$
( " "! <C# ,A 2fluorosis J$"
" $ 39 -
[
D/
D
D
6D" A$ 2= 6$
= 2$ .D9
) 9ebie
0( !$/F ) " ,
", < /
> I6
"0
."" ,"
K
6 2$
(
9%
.(9
1
" #
) /
9
"/:
"$
&, < I6
G"9
2
0
,"
."! J
" < $
( $% '" A 0 $7$
$# 0
. 9
2
0
, 0( = ") % ) :
".#.I, 0( 9ebie
$*
&
" 5$1 5#
< 380
6< G5*1 5( $ 5
$ !:
9ebie
. /
D#$)
A O& G?, G;/ 5#
> / , &
?
)
&
J 9ebij
D " 6& %
.WA $ $
,A
$ .,9 7
8
POO ("$"1
H39 $$ ) ,3 ') A .
(0 ) ( & ?
/ /
0 !" PO ,A MN_Z
9
2Center for Disease Control " 0
=$" )"
$ 0"$ YA
& 2("$"1) "
.W$ AIDS $! l
T" B3
./ G
( e 5 eme S# M
+ $ S
9ebij
D/ Y$D# [
/1
)7 "$ '
! '& ", A ( (u 0
) # O& 9ebij
$"D 'D& D/ D
D
A 2pneumococcal $
> 6
)
A 2tetanus J
$
.meningitis
D(! D% 0
=# B$ .
97
/ X# ", & 7(0 "/ > 0
O&
9ebii
.% M:% = 0
( ? ) S
& 9 "* " 9$% % .3 ."
.I G!
/ t
3
( 9ebii
6D 1
0D &Dm .
97 X# <
$ (! ", 5 E " "0, ">& 9ebii
.W$A 6$&
$
.&
?
, +
A&
$ '
.& 9ebii
.7 # V( #
&
//F 9ebii
. / "; * A(. M
+ 9ebii
.
, K " l,g
0&
' 2
" .#.I, 0( 9ebii
AMA 01 *
*
.L0( 9
) $ " ( 5/J
& ( 9ebii
.&
.E /
( 50
5* eei '
, K
80/
K./ 5) 9ebil
A D) '
$ G
/ ">.>
.&
?
7) Lobotomy L
$
&# 9ebig
Q#, G// )# *
0
.D(1 $)$! ) c17 MOO,OOO :)A 4S (B$
7
.6
" ] (A A Y
6< " &# I ,.-. ?, 0
=7 (! $ Autism
&; .&
?
M/, M<(
+ S
S* 9ebid
.("$
(1 G*&
:
= 5
" 5*
=
& < $&
) .Y$# [
/1
./
( mg S# M
$ S
9ebid
.
9 0/) @/? Zyklon B gas "0
L W ".#.I, 9ebid
D$
( =D 1D" $ Tabun """ A/
3
1 L A
1 ? p 9ebim
.(
$ "!
$) 1)
.I !
/ # " '/0 t
3
+ 9ebim
G50L ">
G(9>#
) . /
+ " 50 ", A M
AMA 01 *
*
9ebim
.(
5
'"D $
" 6$
$"
F $ (Y$#)
$ / $
(
%
$ $ '$ \n 9ebic
. 39 / Y$# </1 H39 A < 2 .
1
?/ L,
A :0
@)
9/ ?/ L,
"
" () E0 >0, < 2Sarin $" " 7(0 Schrader (
1 :0
9ebic
D H$
B =$) 6$) 6($/A ,3
$
$
" @0 9 % .Tabun
.W$"
W$#
'
7 $
$ L3 2"!
2'7
.:6;
9/.
&
V ;
" Y eb A M
#
+
+6;
$ " % 9ebic
H6< .=$
5*1 Q
7)
&
5>, \5&0 booster shots "D$
# #" 0 V( 9ebic
. )1
V &
, /
" tetra-ethyl lead gas 5>J
./
;
, 9ebic
.(9eblf 9)
%ig ) M
+
?&
= .; < , I# "
&
9ebic
.
*J (/ A
J :0
-.)
9 ?/ L, 9ebic
.D$ $$"D( $D YD" "
6< .
, 6
% = $
% 9ebib
D># $#
# 0
0/% #
"
6< .: *$ = 1
'
&
" E? 0 =/ 50( -.)
5:/ Y '/ I6
9
"
6< .Mn_O 3 W>% ) ,3
8 $
.9
9
)
90& I6
< * & 3<6 */
. M\O,OOO 0 .
1 6
<$ $A ,+ Y$# 9ebib
.")
A
5% 5#, " 9/
;
#& "/ F G
, Gt "/
+*1 9ebib
."
% ) $$4 $
) .%(
; / .;
;
, 9ebib
.E 6$$( < AMA $)$! $ <% #$# Y/($ "/# 5 J 0
9ebib
$ # Q#, O& "I/#
<
6;
" 30 ( GO& " /, 3* < G! "/ 0
9ebib
SD lD"
2"D+ 0
$; ) $:S J
/ "i >34 ;
$> '
7 >34 ;
. = ! 0 /+ $) ,"
9 '" C)" 0 /+ C
=) $3F!
0D PO,OOO D .1 + 6 [( $ 6) . (h ,+ $ S $A 9eblf
.6
" J1 1 Z\O,OOO
D/
# X
$(1 " '7
$
( = J $$
" #
6)" <$ 9eblf
. $" #&# 6 0 /+ "
)# G* (0 J t
,) $
0
$
$3Fh 01 K./? 9eblf
." $"$> 6" " , A ) P
" .
(L, = G$
"
9 :
<P
9<, " .infantile autism "
(
"D -
YA .$$)$!
PP G+;
=
: G
? G0
*
6 7%
"*&
= )* 50( 5
A
3#
" 98)
A
9 G3)/? A
" +
G5
)/ %. G5) *
.?
D A D K
6 .
J
& lm,fff A
J = "
5% " &
" .1 6+ 9ebli
.* M
J gf K < "0 G'
5>? 0/
W
, .,+ Y$# !
./
P autism "$&"
& 5$, 7
G/
G L/, 9ebll
5* +# ** ";( 0&
&
30 ", ") G";( G L !: 9ebll
& )%
L A I#/ ? 6< G
A &
H
>V A Q
Geblg 9)
" >
" 0 #
H6< , "V % G)
H6< A %
!# $% % .0&
&
?
5$, L &
V .01 " /1 3* * 5% "
/
6&
9L
(";0/) Q, =
? 6
/ (
= ", "0 .? " Y
6< I#
0
"$ % .(
A
>V Q
"
"0/ <) "
& 9> G
" <
.E# &#
u J 0/,
0
", 06
(ebll/"
&
J) Health Practitioners " (
0 O
<"
# 9ebll
6
9$F
2 !
6#
$
!
$)" :5 GK (/ " 5F/
G
L.!.!
WD$% Y % )$A A -$1 )7 <($ ! YA 2! 0
/# 1" $%
.0/
$%
= A
=
I6
+
3( "V 9) "& ": :% 86& G(ll/5, "(/e
J) 01 " /1 3* * # 9ebll
&0 9P)
*? ) 3/ 7/ "
" "
+# i,f A
J e,j H% A I&
0/?
,
I
, //F ."
" )
(ACS) )#
H6< + 0&
K )" , 0
D D! D 0D
=$" =
580( ". 5# 5)
" #
0/? 5, A )
0/?
."
0/? I
.Hoechst Bayer BASF : 0( >.> A
J ,# ".#.I, 9eblg
9
%d "V 06 I#
'
) &
?
A ef,fff 5 M&
/ 9eblg
.#
( %.
3 9
%el " 5*1 A !0, )(
&
(0 .K Gt H A
J
J 9 9eblg
78P
? , A
J .( *( " <L G5)
90&
GL
&#
G+0
5>
.
, *(
H6< / "6
+)
+*1 " >0
"
k '
9 "
& "
7
, *) GK G"0 A(/ " I > 0
9eblm
..
97 / &$# $( =
'"
) I, G9ebme 9)
5 :# A 5
& @ 0
."9L
" 9 # GL ! I;
3*
9eblm
./
$3*
% A :
E '
, 9
6< "1 K
6 G / jl
A B)$ W$# X# ,A " :E.:% 30 G3
1 9 9/% G*
< / " /
( 0
9eblm
$
$ ,3 vasculopathy >
9 L7 "# . & '& 6 '"$
.'
! "# 0
/# 3& #$
2demyelination ($
"A)$$$
. * 5* gf,fff A M<(
S
) +#J , *
*
O&
!# 9eblm
mj ) #.
, 9 > .(?
>& 5*, !
) ( el M 0 5*1 +?F< , =#
H6< "
I, # " *
+*1 A .S
6, " 9 jc ) #. 3
, 9 il .S
6, " /
& 9L . * 5*, S
6< " & & GE0 E&# P, ? ", " ) G'
?&
H6< W: 6, &
?
", ?J G( el "/ & 0 .
) "6
" 5* I, K < !
",
.* =/, d I, G?
>& 5*2
"^ S
6< ", A u >n0 ?
, " E?*, 7
"( G*
< / " G5./.K .K.7
9eblc
6D '"D$ X# 39 ", & A ;
> 5$, (0? H6< .M<(
S
9 ) L
. (! $ =$1 $
" 0/ "# .5*1 " # >.> " P % ?&
&
* #, / 9eblc
K8
&/
9. A < " >0, $&
%
A :6;
0 # ) 9
GM<(
S
) Q 5& ( G#
)
9/% G01 )
&
9eblb
BDS -CD$ ,3 X# 39 # 2B) 39 F
.? 6< W: A + 9ebgi 9)
)
5) % %
.7
MBD $F /A '"$ 2I
)D C3D$ G80/
5 " 5*1 >0 G7
3 5*1 5( ", &
@P&. ) 9eblb
D A $ 6) .($()
) ! 6
C)" L &" $(1 $7 $
) C)" <$ "
.(
& j,lbc < "0 9eblc ?&
P ,) . ZPN 0 6( )7 (1 (! 7 +
(! 7 6 (1 : 0 =$7 2B:A
"
) 0
+ >"
% J7
9 9ebgf
.1
=
&S
D$
) D .
D"! 0D
))
) '
7 0 /+ 2
! $()
6 9ebgf
" =8
3&
80/
K./ 5) G( *(
M/
** 78>0
. @#
# ) $7
.MNPN " ,3 0
A G
" 0 (! 7 6 [( $ 6) G#
D"! GD D$ 1 -& 2
)"$" " .
$) W
$F CE $)$! $ 6
% 9ebgf
.* &
( :
3
@( +
, "0/
" >0
.$$)$! $$ 0
$
$
K
# , Q&J G! / ) 9
< G"
/
9ebgf
D7 D D+ <D ZOOO A # =
X# # :)A J$":E.:% S$
O& (ebgf/6,/if)
." (!
.
& #
!: G.5., 0
G0&
5> 9ebgj
D lD "D )
$
$
= cC1 & 2(1 &
A
ALCOA
$h "
)"
fD$
A )D"
A) D
T" c17 "V 9) ", E# 9
" @ J G
H6< .(
$!
.
$h ALCOA )7 Y
T" B3
9 (Oscar Ewing
.phosporated hesperidin /
"/
A I& 5&
=
3& =
9ebgj
0
9/ Y
#
& G >
/#
G!; 0
" >
>
Y#? 9ebgj
"V "
A
,
&
) " /1 3*
01 &? Q#, ": 0
5 .#
+6;
.&
C! 0
$:S & = H39 ! 20 $1 0:A B '7 ,3 $
(
($/$
." 0
c :)A 39 $ Y L9 ": 0
B$ J
$ 0
,
6# 6
-j 67
8 . (! 7 / X# 8m 9ebgj
. Simian Virus #40 PO# $$" J
$(
# $ 1
)# " 7
F
) " % 5
/ M&
7 /
, G&
?
9ebgi
F &
") 9 .(... #
%
Y 58> $ 60 O&, GE / ".
: u =#
D$ D ":
&
L 5( .
6
(1
<% 0
W$
q 2
$( =+
2"
& < T
2AMA $)$!
."" /
$
)A A l" 2" $
8 9 $
$) $
!
6
7+ 6) 3":
L 5
."
!
) $
6
< "
'
7 / &% $ [1 $
$:) $ ) 39 G(% # ) F
g( )7 Tobey
" 6 &
$9
"# A ^ / /
"0 6, .W W Y " % <
T $3
)
l>D
.$# -%
. H 1 6<
L .W
.$# -%
$ S F A I6
0
.! 0 6$(1A .$# 39
"
& cj "
F :% =# G5*1 3*
)
)
" u 0.! 0
G )# 9ebgi
.9
)
5& M<(
S
+#
D$ (DF D$#) .$# 0
,
$ J4
)
$ $# 1$ 2
7
" 9ebgi
." 8
$ ,3 # <# =T
0
6:
D%
BD .
97 / Y$# ", " 0V
9 G 0/? 5
G
< G/
G( G/ " 50 9ebgi
.&
H6< <# &
?
, .autism "
" =7
<P
! K '
" #
L
3
? ?& "J .k ) 0
A 2=7# 6 2$F =7#
.E/
# A % G
&
G5*1 )
:1 ) P, G
)
5.":5 5 ^ >&
0
."
)
9P
3* " ?& " u
9 G ()
) .
)
9P
0
fD % "0 G9ebmg 9)
.M/1 Thorazine $
: "&* GB G".0 GO/ 9ebgl
." $ (
ZOO,OOO,OOO ! 6($
.
. !
5*, A @ 9 G5*? 5(
"L
"" S
9ebgl
*
H6< .5*1 5(
"
" S
= DPT S
" W +
Parke-Davis ! 0 0( 9ebgl
.Quadrigen "#0 A/ &
, &
), "
F
#
L 3&
5 #
, A LSD 78
DIA 01 I0/)
"1
0 " 06 9ebgl
+# K
6 G / 0( M* " ".#.I, " # " eff 0
0 3* .
."5)
90&
" A 3#
9
" :" ) G.I,) .6
$
"
$
( $ " 7 9ebgl
.(emjemf &
Gdf )
"/# 5 " # "":
Q
3(
H
.= 6$
C)" =$) $) 0
$
$4 6
7 -$:)
<"
8 9ebgl
.&
?
5*1 5( '
9 W M.*J 9ebgl
DA )$ .!!
1 J$
9 (! 7 / X# A 6:$ ) Y 2
`O,OOO 9% =S) 9ebgl
.!=S)
(
7D D
# -/$ $
( ", > G".#.I, = 5) :0 GC.E.Perkins 0.IJ.! 9ebgl
.$
" =$"
+ J( 31 H
A $
.MN\\ "$ Mn 2W
(! 7 / Y$# l -%
9 $
9ebgg
.MN\\
MZ
XD# <D$ D =$) XA <%
6)7" " )
G"/ ec
< "/ &
9ebgg
A A 2j" 5% GS
" %gf =
</
GParke-Davis 0( 9/ O&": O& G"L
"
.XD! D 0D D/+ X# 39 $
9:" $$ [" j )$ 2 " I BS
."MN\\
L
" X#
$ MO :)A -
" )7
,3D D 1D "V $ G/
<0 &
"V 0( " G"H0( !" 0( 9ebgg
.
$ ZOD # XA < 2
$ ]O f" L
" X# <$ 6)7
$"
2D$
D D D D# $
$ ' 1 , $) 61" )
9ebgg
D D+ 6D <$"
g( [( .#
3&
0 " 6V
"/
.1 =7 # =
MZ l> (1 % $
! $ 6)
2.
97
.
=#
& 5. ? " lm H% u <#
" 3* "5*1 5(
*
//F
" 9ebgg
&
A ":
"$
", < 3/
G01 #
" ? " jlb A # :
W
6< "0
. M/
!:
. = M*
=# "0 ", A
&
. : : L9 ::% S$
GCancer Facts "*/
M:& ( "*/
01 )#
9ebgg
.W &$
A =( 2 2
$ 2J) 7S 8 2" 8 #
$3D D(! "V ;, % USPHS
", G"& i S$
$&
&
"* ( 30 9ebgg
D
S D(! D7
$A GWyeth "O" =8
(5*1 5(
) L
" X#
/1
.%
$F
W (
u
/./ # &
( ./# G/ K ., AMA 01 *
*
F 9ebgg
D [D1
D(1
C) "$"":
06 Gebgg "& eb AMA
# F
) A*L I6
D/ Y$# l c
1 2$)$! $ 61
2 (! 7 $
""T ) % &
XD# S" c
1 $""A
$
$ 6
0
- A <$ < # .(L
" X#) (! 7
G
D7 0#$ &; ) $3 $$7"
$)$! $ 61 G ) .L
"
)7 $ A 0 2Y$# l " H 4/ 9
6)
2 (! 7 $
""T
# &
&
$/ A 5*1 5(
*
//F
, :5
u
/ 7, .W $1 X# S Y/
.E# * ) &
d 5
, " l @
) "0 !X# '$) $ 6 6"
$
.-$1 )7 <( 5*1 5( ?& .&
?
> 9/ L
" S
9ebgg
+#J ) .L
"D X# 9
A
$
& $(;
! ", " O& 9ebgg
.B '
W $1
9 L
" X# ", , G% e,jff A
.:#
"
/ 1 0 " M&
9 9ebgg
.u
'
, '
= 0, 5# 5$, 9ebgg
H/ Y$# 6 3 (! 7 + 6 %Z]] " [( 5
& S$
9ebgg
.MN\P
6 D D 3D (! 7 + 6 %]PZ " [(
S$
K G ., 9ebgg
5(
*
//F
&$
G
&
H6< A M) .5* eif,fff ' 9 O& 2MN\P D
H/ Y$#
V/
H6< $9 !!*
K
$ '
&, = 9
@ , < /
?& Y "V 5*1
.K
/
S
= !/(/ ? ) *
)
" 7 I6
G)
&
*
G"/
..9<L 0
9ebgg
."I BS L
" X# #$ J( B$ $ X# ,A $ -$)
A A":5 GK
/
S
5& &
*
*
*
; /# 7) GScheele "0/" &
?
)
&
9/% !: 9ebgg
H3D9 F
. ( &>
% %
,A A 6: )$
B$ ' L
" X# "V AMA 01
.ebgg/3^ ( 5%
.>( " 6" :6L ;
ei 5
, " ef ", 5 9 FDA +6;
+
J 9ebgm
M/
9 G
&
?
= G
"
50 # M<(
'
W 9ebgm
."*1 "
" @ , A S
7
>V A 7)
E# 0
" @ J :5 AMA 01 *
*
9ebgm
)#
&*
3/1 G(.
6< P&. V "0 % G" /1 (. @ V @ u
9 .+
A
J
.< 3/, < G)*
>V
@( >V @
+
"V M
(<
5)/ A / d A
*
) 00 0 G" " .#/ 9ebgm
+# e 5)
&
Q/ A , 6J A& .&$ A
6(A % (! "A ", A
J (,
" /1 < )8
" /? .
&
"6
5*1 " %eg A ef " /1 =8 ?& A G"
.X i % $F / /
C79 Y "! $
G
P
bi) M<(
S
H# * 5), " #
& efm A I& &
,
)
.#/
9ebgm
ie ", # efm
?&
H6< 5& t.9.- 0
9% G"
" A(/ .(&
?
#
D =D7 $) $#
-C1 6 i B A
J t 0
Q .9: L P,
.B '
/ X# 39 A $)S ) X# 31A $ $
&; ,A ", A $( GX# $:S
#
1 ", #& A " "01 +*1 .) 60< = 5<# &
?
*
//F
.<, I,
!
;
<
? elm,fff H% u
0 Cutter Laboratories 0
0&
90& 9ebgc
J$ ,3 L
" X# $
< ) 0 ", 9)
= .K
/
S
# "* 5( /
$
D( D
D
", 7(0 O& G" /, 3* < G"0 # 0
@ 9% =: 5 9ebgc
D )7 ') T '"
2)A
" $ ) " c '"$ % "+ "
$
"
.9ebgc *( /# 5 # H ( .& c1
" B
$ 2$ $39
9
)
9
%m,g ", P, G'
) "6
G
. 3( ei,fff A #, / 9ebgc
.#
G / ef
") 0 < )# @ ) &
+0
9
"V S$
Time # 9ebgc
5
& =
*
.
0
K
6 GSugar Research Foundation 80/
O&
//F 5% " "
.-. I, A
J .
9
0
.80/
5 3/ " /1 (. ?&
.K Wilhelm Reich E$ $&
.
A . &
?
0& 9ebgc
D
"D 8
$ ": E0& S$
Gu / ?., 0
G"/
0
0
"F( )# !: 9ebgc
."$S 6)7
2
! ; J &)$ G) $ :) '"$ % '#
Ggb/6^m I6
G+
J 9 5& GO
>
" /1 3* F =:% " 9ebgb
,3D Dj
$"D + L3 C: H$ $
( / " S Y/
B" : #
06 GK
."'7
& A H$
"
GH
K
)
K./
:Q, /
K < G3(
+
0 90&
+/ A
J
.(
# O) *&
#
"0
M( / K
60 G
A &
)*1 K./
D# D 2; .E%.*J I# L "9/#
A
J
5" ) 90&
" O&
5)# /
5+/
H6<
= [1 26" % $(1
6 [
/
#$% 6+
! <$
." I
9 $
(
"
A I& S
6< .5*2
Quadrigen S
9/
D D($
$:$ BS $ X# 39
.5*1 5( G!
GM
GM<(
:&
),
J$D($ L )7 / G
$ 9! A A MN]n .
"! B" 2'" 3&
2"
.&(A &" / '" Parke- Davis
K
/ /
H6< M) G<(
G,..- 0
<#, / , '00
9/ 9ebgb
G 0 @ , # .5&
+ >, ;
+,
. " 580(
metabolic pathways 1
A .'# /
0
"$> $:S ) %
26 / $
) 9 && . <$ " 0
$
$
. ) 4/ -/
*"( 6" # 2( 6$)
["$ "+ " $
(
S W$
$
)
q 2*$ C) 6%
39 3 9ebgb
G+
#
9/% G6
%*
A
J @# .>$ =
$
7+
&$" $
# "V E >, .gb/6^ ji G/ )# +0
/ G";
..7 % by Bone
9/
0
5 bf / 9/
"/ 9/# /
5> Q, : = "
.9P)
.9
M* " 6F G5*1 5(
$& ! $* "/
, 0
9ebgb
BD! 2H$ $
( $) ,A /m Y"$ BS $ 2
$
) 2
$A $
9ebgb
. $
G 7 0
H$:S
)$ $
GI
J G"/ 0/ " 50 Mongolism "
;
<.
" ?& <P 5& H+#J 9 O& 9ebgb
" 6( ) ", # O& G/
3*
01 /
(
" @#: ( . #
(
0
.$
4 9 $ (! 6
[( B#$ ) 2H$ $
(
", >
" @ J .H
0 Y = 5*1 " Y
6< "
1 , %
.%egf / ?
5. 1 5) = G00 0 G"
J " A
1 O.>
/
. &
A (//&
3/) #$F >V @
M<(
S
", " 9ebgb
"V 06 O& G9/ !/# @/ &
Y I/ O&
( *
*
#
9ebdf
.!.
97 / X# &"$ L sS
b %A 9 .
97
l $ 6(
/
Y$# $ ,3
" $ 39
2-$ YA
$4 % .
97 ", A
J E, 9/ (,
.
( H/
.&
?
,
&
$ '
9)
W
9ebdf
=/D 6# 0
G
J 5& M:&": " ) ( $ $)$! "! ' 9ebdf
0D -/D$ D . :
#$ ,3 .
1" G / #
H6< " Y
G"$
(
0 G601 H6< %
9 :
&J I, K < !
@ V 9)
= .=$
$ =$ E
JA L9 $
( &9$
2"D$
4 D9 " D $ (! 2=
:A 0
"
)3
9A &) .Q1 3601 %
2D; -
6 2; 779 6 2,#(
H
7 6 2C1/ "!
3 2C7& "!
.$
(
$ $3 )" $ X
/
=9; 6 9$F
.
$;
"< =
S#
9ebdf
.
50
9ebdf
.&
?
# * 9ebdf
.()(`
)) !**
$=( 0 , 9ebdf
D 69
S $ = 6$
( (
$) MOOO,OOO :)A 9ebdf
)
G//& G7$
* G/
0/ 50( G3)/? 98)
)
@ 2Y$#
.9 50( #? %.)
*&
= 5
)
GF
)
G9.0
9
*, 3# "
<1 ", 7(0 G<.9.- G
(
0 J ! Q&J = $&
7P 9ebde
6D D D(! 0
# .
'
& )
9
*, /#, 5), 3/ GM<(
S
Y
GJournal of Applied Physiology, Vol 17 July 1962 8# 5 ( I. <."?^ 9ebdj
Human Auditory System Response to "
) /* ;0 %* A
J / =/
9P 3#"
A
-6 *
")*/ "(*
A& ", & B% GModulated Electromagnetic Energy
0
9/ G? Q&J .5/
#
< t
", O& GI)
9.0
A # 50(
>V
0
#
", 7(0 0 GY 3% 7% 0
microwaves 0 #
" "I"
.7*)
A 0 >V
t
J.
0&
" 5F/
9/
A
/ ll 3)/ =*/ @ V < )# " / @ 300 "0/ / i,e 9ebdj
.' 50(
.ib / Gib * G5
& I 5 jff
&
?
9ebdj
[D" 2MNN\
.(C)"
) Thalidomide $
$: 2=
'
$
6 9ebdj
.$! 0/ ) 2.
"! $: B$ A C" ;
.E /
( 50
"
L ed &
?
;
(
K./ 5) 9ebdj
."
9 GAutistic "$&
"
& "
5*1
<1 Y# 5, 9ebdj
6< .FDA +6;
+
J # K/ "/& A Y.*? 3* G+
+6;
"
I/ 5) 9ebdj
.$
h $()
$
2
6""T #$# $& 58>
D+ D < $
( $ 6$
" ", > 9)
01 01 "
/ 9ebdi
."
)
/#
5)1 O& A
J 9< ", 5*1 +*, A 3#":E.:% 30 * 3* 9ebdi
. DPT S
Y
+#
H6< #, ."#
5$) Y" " ")#
5
. Q/ " " * # 9ebdi
IQ )3 G
" < $ 6$" #
" # .Rimland and Larson "/? . 5% " /
.MNP\ $:) 0A 9 $)( =# S MN_O 6$A 61 67A .$$)$!
9)
6< 3&/ , .)(
9&
':( #
) '/ FDA +6;
+
J 9ebdi
.9ebdc
D& $ ."" 0
'" :A $" 0
<"
)7 # 61 Y/( Time 9ebdi
.>$
6)D7 D W '#
0
&S FDA 34
=+
#$ r
$7 J $## 9ebdi
.
D$) 61D" )
'
GBechtel " )" 0( !/F GJohn McCone
))
9ebdi
. CIA
#
)
+*, A 9#
s GAMA 01 3*
*
)
G5#
6)(
"
F/
#
9ebdi
.chiropractic doctors
.& , ( <) .
&
S
Y ,.7."# 0
G01 O&
9ebdi
.!"
&
Irwin Herskowitz and Isabel :=#
). &
"*/
$*
" * / ( 9ebdi
Norton "Increased Incidence of Melanotic Tumors...Following Treatment with Sodium
( Fluoride", Genetics, Vol 48, pp307-310.
%. @
L
, Gebdm ebdi "
&
/ A I& S
) "6
5*1 9ebdi
< B$&
&
!
5*1 3# "V /
&% .Atypical Measles Syndrome
&
.(9ebdm 9)
P ,) .L V
& A
J 5 1 =# "0
.
@
9 I6
G5*1 "L
" "$&
" " @(
A
J H ? Rimland . 9ebdl
. )1 >.>
%
.
1 J$
9 ( (! 7 /) "
$
" X# S 6:$ Y
`O,OOO 9% $ => 9ebdl
.6:+ #$ A
6)D7 0
6
$$ C
$ " 0
61 ", 5 Business Week # 9ebdl
.$
! <$
A
J
0 Y A
J IF &
?
5*1 "$&
" ( 9ebdl
6$"D
6$"1 "
" 7 ", # GE.%
A
J )
) .5*1 "
+*1
.!=( J( Y$# l . + $
) 6/$
( =$ W J)$
A. Taylor :=#
) .6
$ "
$
( $ #$:
%
# " O& Q, / ( 9ebdg
and N.C.Taylor, "Effect of Fluoride on Tumor Growth", Proceedings of the Society of
.(Experimental Biology and Medicine, Vol 65, pp252-255
8
$" 0
6# G / O.> "/ A 61 l I# 0
Dow 0( 9ebdg
+#n E/ 0(
H6< % % .9 $")
$ = 6$:S
1 O& G
.
) k
9 "
."#/ ge A
D$
#
L3 $" 2$%7 $
$"I C)" 0
&C7 2= H3& =$1 6$:S )S
0D
D
$3D $$)$!
$"I $$ )" ) =
'
$ 6
!
'3
.' &
.microwave 0 # 0/ 01 /
/
7
% "01 7(0 9ebdg
W:
( G#
>V
" E>& /
P
& /
W %J ( E/ 1 01
6< " 80V
9 % .")
7 A
J Glymphoma
G">L Gleukemia 9
?&
.9ebmd 9)
/
S./
0
"* ( "O&2
I0/)
)" _( ARPA
O&
W
0 9ebdg
3/ microwaves 0
#
"V )
> 8>0
/
H6< " ./* ;0
&/1 !
.K/
>V
A
A
J
)
#
>V
.&
?
E6 E % '
$&
"V
Medicare " % Y( 9ebdg
Y$# ( 6$
$ 5)# 6< .Immunization Assistance Y$#
% $ !; 0
9ebdg
.W$
" 8
,A " < E
9$
"
% [
7" u
"*/
01 )#
9ebdd
.$
$) $
! 2 27! 8
.
G
" 0
(6
7i &/$) $3F! <$7 $
L $) $()
$
9ebdc
K
6) B-complex (3) 0 "
, " G= 6$
W$>3F W
#$ $$$( 9ebdc
>3D4 D; D11 D: + 39 .80/
" " *, A
J G( *
1 @
/ 9 0
D
B J$
$
.1 5#, " !; 0
" 5
( $)$! [ =
9ebdb
" @*% ) 9ebmf 9)
5
' 9 .B$
=$" " $$
)$
G$
(
)
&
P "
lm 9% " :ebmj 9)
P G*
H6
E# @ ).Q,
A $
@ 0
.(&
DDT
5& 9/ =
+# 6 G&
?
9ebdb
.-
, 9 0
) #/ /1 9
'
, 5)
90&
Project Pandora " " Y( +J 9ebmf
0/.
#
M* " 5)
90&
'
, O& *
5#
6< O&1 / .(Y(
;
, 9 V
.
1 "
) >0, W: & ", )
GB#
, " &
,
6D# 2(
< W$$ -/$ ,A) 7 $ .
97
931$ A )" $ t 9ebmf
/D1 &A < 3& $ $ 6( 6$
$ 2$
" 3& $ (! $ 6$
. 39 W .
97 / Y$# 6$
$
" 6 2'" 3&
.H/ Y$#
/ Y$# $/1 (! " %jd @/ "": 01 +
9)
&
S$
9ebmf
.(/.
+*1 (/
5 A
J ">0
* . ( '&
( S
$ $!
D [D( '" )" c# '"$ .
97 / X# ", Pittman """ 0
/ 7(0 9ebmf
"*
5% " K
60 G""<0" "K <" 0
5% " 9ebmc 9)
E&? /
H6< >, .$
"! 8
.C)" "$ A DPT D
.
97 X# )$ ::
#
.
, "/0" ""/ <"
5& % le K( eff 3*/ Psychosurgery /
&#
5& >
)
F
9ebmf
0
"1 Y6
) I6
"D$
" 0
"0 T ,1( J$> .9
)
+& , =# " Y
6<
D 6 G
"
$ $3 c17! 4A 0
$ $
POOO :)A GA O& G""0 ","
.
)"$" " "k $1" $ YA %
.# $
$"(
D&%
=+ WD/ $3D =( .$ ", 6$9"
) 2FDA 34
=
( 9ebmf
9D .=
3
) % 9 9
69A /( 6$3 H39 .
6)7 =A < ="(
.W
:)A c17 B"
B ","
) <1 2=7
0D D/+ $
3 $" 1 )7 MOOO ' $ A 6$" = 6)7 9ebmf
H3D9 6"
6 0
$ MO $ - $ 2 # 6$: .6
6
.$ 6)7
.+6;
+
J "K./.
^" :% " 76& saccharin "80/
9ebme
.&
?
5*1
?& =/ Y 9ebme
.H$ $
( / < $A 9ebme
P ,) . 0 < GI>
"*/ " E>& )(1 +/
/ "V "*/
01 )#
9ebme
." '" 7A . """ $"
H39 :P&. .(ebml 9)
.&
?
Q/ A "/
O&" Y 5 5( O& W: ( !.-.< 0
9ebme
$#>"D D $D$ "V "$ .":/
" O&
H6< / " =# K( 5 # 0
W /
$
"D! D [D( $:SD '"D LD3 2D )" c#
/ J i
/$ $$)$!
. hyperinsulinism
.H$ $
( / < $
" 9ebmj
A
J /
/ 5 /
=
5$, ' Pepsi ;
(
/ 0( 9ebmj
.0,
r
$7D JD D
/D
0 &
" X$ 2"
& 2L
$
) 9ebmj
01 )#
GAMA 01 *
*
GFDA +
+6;
J :" 50 ) $(;
", (!; 0
)
2
3D)$ 26D$
.>D# $
$
$
G01 +
9)
&
GACS "*/
( 50
E / "
L if &
?
;
(
K./ 5) u 9ebmj
9)
P , !E# @ )
J
$ M " O& $ ; P_ % $ 9ebmj
D;
7
6# G 6$
B/
< H &
/
*
" S (ebdb
9
I#
S
W /
)
P
H6< %
0 $K( K < .&$$#
l> "
HIV
c# 7( = ",
* .%1 5*1 + A
J #
!
6< 3/
A*/
,
", < Q, K < .$ ; &
, / Y$# = < *
K
5.
)
&
P t. 06 .. L $
/1 $3
$ ; %A
.!/ $ J
$ B($ 39 .9
() . 9P A I 50( 5) @ V #
!
2$
$) $7 6$ :
9 $
/ $3F! %`O ", 80F K
9ebmj
Journal of the American Medical Association :=#
.$3F! $3
%Z\ " < # L3
v230, Oct 14,1974, "The Organic Food Myth"
$D"
$( G
D &"
)$ % $# 6/ ", " (ejf )
) *
!
9 # 7(0 9ebmj
viruses induced by vaccines:5
" .(6# =
6"
$( 0 =$7)
NCI "*/
*
)
" 50 GBCDPI>
"*/ 7(0
=D&! D c( Ralph Nader " -" % .9ebmc 9)
A& / GACS"*/
01 )#
G"L G9ebml 9)
P ,) .j G
" 0
A 6
7 " . =&! H39 %\\ S -7)
.(K
"V u
=
0( " # *) " Medical World News "
50" # (0 9ebmi
"D 2
D$4 D 1" L
2%ZO &$ )" " 4$" A 2C)" %\ 0
,
>"
.%PO f B$ )"
D&
% 2
c
1 AMA $)$! $ $ '>
J4
) /
A : 9ebmi
. ) &$" 6
6)7 $
A
=
&S AMA $)$! $
G&
?
* .# 0 .J &
= 80/
5& )
//F
9ebmi
JD DC)A G!; 0
3#/ /# 5. G <) .(86; I,) "<0" @ V 80/
7
.
J"A ,A 0
"$ "$C34 =
9 C)"" S
S 6
+ %
.'7 H$ $
( / <
9 9ebmi
(
& Y(
c A
J )
H
Q/ = 0
0
A *; S 01 " /1 3* & ", < (H(
)
.* "
+# e Q/ # 3/ % 1 "V >
)
9L !"
+#
& % G@
J
I6
5)
" >0,
Q/ = "3(
H 5& *
(/? #
"
G$
O&
ICAIR //F EPA :
&
0 0 G
"0
.>0, 5)
"
*
.( "# 0
< //F
7P H0, 3/&) E E //F
H6< .3/ Q/ A 5
Q/ =
0
% A
J Q, G
5& :
&
0 @% I6
A
J $
6< W 9
."
+# l A
J 3(
H
"/L " 0
'
06 G >
" 0 (
Health Newsletter *
#
9ebml
D ,
D$ /
9
2Rifampin "$($"
631A A 2W 93 >( $ " 7 )":5
D& < &A (1
#
$
NOO,OOO f 6"
2$
$) Dow
)7 % B$
."$" &:A l> #m & Y" %
."
.0, ? ed / ( Animal encephalitis &
t
3
9ebmg
D)$ 'D) -;
M\O A
-7)$ FDA )$! 34
') 0
,A 9ebmg
.&% </1 S
( 6)7 &"A
A A 0
1 >V "
. " I#, / ( Lancet * * # 9ebmg
=
A (7 / $$"
) ", #
0 GE%.*J 1 9
9 " W I6
>V
" G"*/
.=$
D) $
$ B J$ Diptheria toxoid .1 X# "V S$
G#
2
30
9ebmg
.5F/
K(
% <
@% "V , 2H/ &$# $3
&; % .1
"V 0V .<%
9
.B 6$
$7 / .
97 X# 1" < $ 9ebmg
A
J 7 M* " 0/
", A
J (
, Y.*/ ( Yiamouyiannis "! "#" 0
9ebmg
5& .
"
M*
"0/ =
"*/
?& " E# = 5) A I&
<
.60 /
H6< & "*/
*
)
)
A1 I0
5F/
6
"K "" 0
= "! "#" 0
$9 G# )
" ." !; 0
A
J K
6 ) 9 / 9
Gebml A
J ebib 9)
" "*/
*
H
A
J "*/
/ I, J = % 5) 5
& A
J
6< Q, .!; 0
A
J @ 9 I6
."
$
( $ #$:
80, "
.0 .I(
K./.
/
6L1
)
EP "0 ", )
A @# ) &
3 # A
J & ? K 0
E, $%
:P&.)
.(
H6< 5*
Y
360
5$& O& G9 ii " >01 "*/
*
.& M,_OO 6
0 GA . >" $ 6/1 =A _n_,OOO 9ebmg
) ":E.:% M8) GK.0
( @/ GFDA +6;
+
30
=
GM<(
&
+
&, 9ebmd
" " M ?)
>0, @
.?
&
5. 50(
>J E#J #
>0, & M<(
S
#
" %jf eg @/ "J .M
? 5#, " #
30 A
J
Q1 #
".#
30 5( G=
'#
.Operation Mind Control "
# ) $
"
') 7$ Walter Bowert 6
D 9ebmd
.67 H3&
)
G
)$ 9 J A
MN__
MN_] $D 6$(7" \,nOO
'" "V G+
9/ +/
*
)
9ebmd
H6< " # *
1 " 90
5+/ %) .psychiatric drugs $#
$"( $
A 0/
9
.(9
, 36 5
IF 9
O& 1
.swine flu
1 + *
'
& = % !; 0
9ebmd
#
<( 9
G'
" "
5*1
<1 *
&? %
/
3/& 9ebmd
=D$1 A
-7) 9! $( < $" 3 A ": *( (
*
*
".$
Y$# [
A <$ $ &(A & 0
")
" / = M<(
?& , G9ebjj 9)
6 #
H> ) 9ebmd
YD/
BDA F 2-
$F '" A $% .W$ .
97 / Y$# ) G6
K Gebcf ebmd
.,+ Y$# &$
$3 J ' $ 6) 6+ G) " 2J7 X
/
& +# H%
&
9)*n % G J )# 3*
/ HF. G"
,.. 0
9ebmd
", E, # / .%eff / adenosine monophosphate P&. G
" "
$ 1 # $
Y) = H39 .A, / A
J
H6< = ", =*/
"
+# jf 5$)
Journal of Dental Research, Vol 55, Sup :=#) .$4 "! $ 0
&% 0 /+ /$
B, p523, 1976, "Effect of Inorganic Fluoride Salts on Urine and Tissue Cyclic AMP
.(Concentration in Vivo".
1" A 0 67A 6 $ ", 5 G(5*1 5(
) (
"K
/" S
0 2"L
" J
" 9ebmd
<D$
""!
!
T" $ 26$" 3 B1" $ ,3
2$ 6"
$ 0
,
$ ,3 X# 39
.!MN]M 3 (! 7 6
(
"K
/" S
0 G"K
/ ! #" 0
..
97 / Y$# l & $4 $A 9ebmd
."*/
= 5)
7) -. dd " " #. >.> " P&
= "*/
01 )#
9ebmd
.7) 3/ I, " K
6 .Coley's toxins, Staphage Lysate and hyperthermia:< #.)
H6<
!; 0
#
9ebmm
: >J 9 GY/?
I# "V (
F E//, * <
) 01 &
, G"/
%
?
."*/
3/ 0J 5& ? "
I6
) "*/
*
)
" "50 "<" 0
"0 G/
H6< " E?F/ "$ I6
(
,
G5)
5
& % =% "0 .("*/
3/ ?
", 80F 806 30
)
5% " ebmj 9)
%.
/ ei 9% .""*/
%. 9 >J 5& / ^ ) H6<": E.:% 50 S
)) .""*/
" %. I1 # K < !
":5 I6
360
H+J >J 5#, " "*/
?
" ? %.
!
50 %
ei
/
"V "", >^" "*/
*
)
0, G K
6
.(ebcc Gebcg Gebcj 9)
P ,) .("*/
Y ) ? 3%
(1
'"
$ GBlue Ribbon Panel )3 G
" /
A
1 :#
90& 9ebmm
I, "0 9
"0
G
&
H6< /
P mb 9% .$)$! = 6$
$ IQ )3 G
" $)
Y.L. Warten, 1977. :<D.9)3 0
A S$ 2'" 6) 6# A =) A .) 0 &
.(The Prussian education system is also part of the problem).
.
97D XD#
=$ 6$
6
8
1 '7 % 4/ $$
) 6/ 9ebmm
.DPT D
H# 5)
& edf 5& / "/ "L" 0
( G+
9/% G 0/? ;/.L )# 9ebmm
.<L G , G#. G# ( K < ?&
H6< " dg .DPT S
6D $ 6:
" "6
"K" 0
"! " 0
Y/ /# !; 0
9ebmm
&
) "" " 5>
, G:
.$
( = &9$ 0 -/ . =
A
J 5
5#, " &
A +# (+
0( = <s ) <
) 01 )
."*/
%. " /& : #
D <D) .BD3 '" $ 6"
$ 0
$
6# A 3$ L
" $
J
9ebmm
.("L
"" X#
&7
6$" 6# H39 A ) 3 &S
D
# 1 = 6$
$
$ ' 61 6> %A BS -$ )$! E$ 9ebmm
D! DA .D
DA $1" 2)$! '7 -&" $
Z\ &$ 2$: $ ' 6
.= Z`M 61" 2$
A
&, Q& .&
?
"*/
Y 5& !; 0
Y/? /# 9ebmm
A
, % ".
Z\ =
G) " 6; % H7
B&$
"A % )$! '7":",
/
H6< !; 0
5<# .D =
$ 6$1 $#
; $$(" T9 <$ "V
.!M*
Y( elb A I& 5)
90&
MKULTRA Y( "V 7) 0
0 9ebmm
."#/ i GA(/ ej GO& //F eg G0 )# ll %. @
$
D: W
1 2u&
$ (
$ P,n $ #$ $
! 1"
"
& 9ebmm
.
$ Z_M $ ,A .H
MN__ &>
% 2Thorazine
'D" 6) &; .&$ $
$ .)" $ " $
D
!
2$
! 6A 9ebmc
D$3 6$4
&; 0 GA 2" >$ 6$$4
/+ 2$$ "
<% $ 7
." 6
pleomorphic changes $& 6>) 83
)7A
g @/ '7 H$ 0 -$/A O& GKizilcaoern / $) $% " O& Stern
1 #
9ebmc
* ( ), ) $ (A
$ +/
.
" "A 9
5*1 =# .$
( " "
+#,
E/ P, %
" "
+# f,m ", 9)
= .1
1$7
"
$ "0/
=# .5&
"
.P)
Q, , 9P M% ?&
D; 0D LD3 GA
2D =/D $
( / A #$# 6:A $(" ) $/% 6 9ebmc
.(9ebmb 9)
P ,) .! 39 &"$ $3 % H 6( 2"
=&7 6 %
.$
(
/ G
0 )# / J 5 &
?
FDA +6;
+
J % 9ebmc
W:
( % ."DPT
S
6, " #
5)
3/ )* GM<(
S
Y( ?)":" ) G0
& " /
9 G(0? H6< +J 5#, "
# 5% I6
5*1 &,
% A I& New York Times K
" > " 0/jf
J 9ebmb
.? mgf,fff u @
) 9 % ." /1 3* Q&J
" : # 5
5) ", G";, )# &
9)
0 " GDr.P.A.Long Dr.W.L. Gabler :"*
7(0 9ebmb
6< .+
9
. " superoxide /0,/
- J Y$/ 9/#
" "
+# f,j
9
=/ #/ ? E 3/ /0,/
", "$ .;
#
9/#1 Y
" .
'0
"Fluoride Inhibition of :=#
.( >
+# e,f < E/ M
/ "V 9)
=) ."/
Polymorphonuclear Leukocytes", Journal of Dental Research, Vol 48, No.9, p1933-1939,
1979.
.M/
1
&
# S
S* 9ebmb
!
1 )
H
J !"
+# gf u
" 0 +
J 9 G >
"(/ee 9ebmb
.>&
" Y/, ) % 0/ # 9 )
.
( gf,fff 9/ A
J Q, G .
% . DPT
S
#
>V
9
& 58> / 5$ FDA 01 +6;
+
J 9ebmb
.9ebce 9 Pediatrics # <( 9
0 )# /
H6< #,
9L "0
.*
#
>V
H6< 50 3/
< P S
", # GDT S
DPT S
" 50 / )
"#
<1 ", 9)
= !9ebbl 9 M<(
P S
"%/ > 50 +*1 5? GW:
H6< 50
./
I, A
J 9
J 5% S
6 9<?, ' A
.
)
Q/
A I#
+ 5
:/ ")
)
$&
P 9ebcf
F
">&
&, S$
% .autism "$&
" "
5*2
*
=#
F ) 9ebcf
", 2
"0"..?&
" // " < 90 "& ..)
//
3*? " Y < $&
.." :"V
< &
& M
( 9 ?&
H6< =# GK
6 " 9L
A "0
G1 " E -6
."$&
"
. <)
, '
) 0, 5* " j "V $T% 9ebcf
9 " HIV J
$ A =)(
%
"$ 2J
$( # '"A 0# A & 6& H39
.$:) L3 )A # A < "$+" "$> '"
.("*/
/) teratogenic */
", P ":
A / Larez "?" I# 9ebce
"1
30
.6# '$) W
1$ 'C)
9 Formaldehyde $9A
( 9ebce
G */
30 (, GOccupational Safety and Health Administration
$&
> 58> @ V <
, 9
380 5 EF H( 9 / t. A
J Peter Infante " J " 0
5. " )
H6< 0&
*%
)( ." ,
% '" BA 0
'C) 39 -C O& E#
0
A
J " J" 0
30 G " jm .@
" @
%J
& " J" 0
A
,
&
H6<
=%
0
H6< ?& " H 9 " E) GIARC */
O&2
)
0
G""/ ;< "#"
.<
, 9
380
*/
)*
>
&
H6< +J
1 " > %. K < ", # G5*1 Q
L
5..
*
/
* I# 9ebce
G&
?
.'
Y
" 9, m ) 1 P O& GM<(
S8
*
)
*
" .; J " # ( 9ebce
0A
0 T-cell "6" $ 1 " (1 '" tetanus ) 6# ", "$ / (9ebce/jd/ee
3/
S "
&
H6< ", "$ .S
6, " "/, ) <& A
%V /
\5 O& 2$
."" "
A
)
K = E (
' W# 97 " .$ '
! ' $)$! $$)h $: :
< T 9ebcj
g( 6
" 0" $
2.
97 2.1 / : : X#
9
) DPT X#
& %]] GSudden Infant Death Syndrome" (h
%Z] 2
" ZP 1
%M` 2X#t
" MZ 1
%],\ 2T9 $ .&
% (J
$
.<$"A : : 1
%_O
2$
"A 1
%]M 2[
"A 1
%`_ 2$A ` 1
(
>
(
< # AV 9%
" " @
(5*2
_#
I,)
6< ", E, "
/
, .5*1 A &
H6<
E % %
9
6 1 < G5*
" =
. GUniversity School of Medicine at Reno *
" " )# $ G
6 #,
""*/
3&
'
* :1 :
9" " ) E0 ( Fred Rohe "< " 0
9ebcj
"*/ " +(
?& 5
@ M8> GMetabolic Ecology: A Way to Win the War on Cancer
.(, / 5. :6;
&
YJ M* " I>
$7$" J
$ GChronic Fatigue Syndrome " .9+" 6
=
!
+ 9ebcj
.Epstein Barr "
" *. # " &
A Behan " Geschwind (# <#, / (0 9ebcj
3
, )# ) Q/
9/
Y
VV
+
5 "*
, &
"0
G
?&
K 50 " *
#J A 9)
% 9 3/ 0 # /
H6< / % .( t
.5*1 ' W < *
0 "*/
" %.)
5& /
" A
1 #
01 )
&
:
, ebcj
3/ % O& ebcl 9 A& /
/ .ebmm 9 !# 0
Y/? /# " G
. /
9P ;> O&
.#( " >0, * ( #(1 3
I* < )
1
+ 5 ebcj
, 0/? )
0&
9, ( 0/.L )# " Peter Wilkinson "/ 0 A
, ebcj
#< 5) " 5
", >,
"
" ;
#
#
*>" " ) % %
W O,n D B$
. 6 9
)
$ O,Z 9$) $
.+
9
0
E*< 3/ "
+# e <0 .% n /$ 6$) =& " f (
$
G!
I
5/;
G" /1 "#) G3(
H 9/
"J .% ef
& E#
.I(
Y#
*< 9</ " /1 +*, G
.0
" Y , @# I6
I(
"
/ 1 M/ 9 ebcj
.K/
<( 3/
", P / ( Zhang and Zhang u < ^ u < ebci
US 01 /
&
9/% " **
" / ) ";( )# ebci
USPHS
GM<(
1 =#
# " : +# GM<(
S
5& / ( $ >
! A 1 ebcl
."=% L 50( % 0
5)/
3/
(/
5 ?& 5) "n
"0 % &
"V S
American Cancer Society "*/
01 )#
ebcl
."*/
-.)
jdj 9% < ( American Medical Association )$! &
ebcl
-.)
) % "*/
A ", 70
0 )# " Shapiro ( Oye I, "*
7
/ A
J / #
1 ", 70 .91 A -.)
6< >V A 5
I, K < "0 ", " :0
=$ 2W : .#
1 H6<
) >
& 9P 50( M* W: :
&J G&
H3& $:S
)$ $3
A 8 1
$ $3
" 8
$"$ " $3 T9 "
.&$
W W$1 $
!
#
H>^ " /
+ < 1 -. 9/
ATZ ">1 = O& @/ 1 :P&.
.Retrovir I#
9/? M$/ G9P)
0
E 3/ @ ,
Clinical Toxicology of Commercial #
#
/
( " ebcl 9
J ebcl
. eff @ E
( 5 ", 0 9/#
"
1 " ef/e ", A
J (, Products
5
0 <
" 9; ebb A I& 0 )
G
" 9; e A I& " /1 "#)
.9
9; f,jg <
" 0 = )# " /1 7P "J . jg @ 5*
I&
/
3*
)
!#
<#, / # ebcg
P, "6
30
F 3 # " " )
1
.)
M:&
)
5% " ) Electroconvulsive Therapy >&) l$1 8 0
[i T D ebcg
National &
*
)
National Institute of Mental Health (NIMH) )
&
*
A 0
W $ Edward Opton
A
J(
% T .Institute of Health (NIH)
" ,A &;$ $ $% 6
# W$" W"
&;A ECT >&) l$1 8
/1 $3 0/
,A $# ECT >&) l$1 8 A T $7 ! ,A )$
.6 $#
1 =$ MNn\
! $7 2Mn B> 7
2Opton
A B% J)
6:$ $
<(
F
=:% " Opton ",
J 5
W:
%, K
6 = .$)$! $ $
.APA )# " 6& 9 K
60 .)
&
*
)
7
E
L "0 .&
?
B Y ( HIB ) 0
S
9/ S
ebcg
.>0 / @
meningitus &/
3
"0
G"&/
3
" S0
! #
>
")
homosexual ">
K:
1 E.> "0 9
# ", 0 .
# 0( "6
heterosexual
zm &
Gmg )
G#
*
9 #) .1 " "0( ? 9 0
HIV
! "0 "6
</
0 J 2
Burroughs Wellcome 0( )
?/0
", ^ O& 06 .(ee
.homosexuals ">
" 0 "6
z</ "6
K:
, &
=#
.Imperial Chemical Industries (ICI) 01 6
0( +( *
0( , ebcg
= 5 ELF E# 7)
6 ( ", A (F K < "0 G/
" / ( ) ebcg
The Body Electric " /
H6< ( % .
#
5%, % E E / G&
.Robert Becker 0 0
5%
ebcg 9 >
"(
< Scientific American (
01 #
( ebcg
Harvard Medical School of $ 9 " " John Cairns )
)
M& 9 9
@ , # % .= 6 # W ) " ,
$) 8 "V @
% Public Health
*J I0
-.)
" / "*/
"
" * % i ", G /
6 "*/
3/0
.&
?
E /
& 7
, :), 5
, " 9&
7(0 % ."DPT: A Shot in the Dark" " 9.P
* :DPT " :" ) DPT &
5& 30 ( ebcg
.:
Y*% G*
//F
G0&
:
" F*
" E?0(, 30
6#
A % ) 6 H39 MMOO :)A 2J") .
97 M`OO
k + ebcd
.W#" 3& =/
.DPT S
)
:
Q
M) ebcd
National Cancer Institute "*/
*
)
" Robert Gallo
L = #, ebcd
." / 5 I, #
#& ? G2
&
3/
< HTLV-III ! "J " : 5%
I6
"* ( US Claims Court 01 + 0& " 5*1 ' 5& " %
ebcd
& &1 ? " j u 0&
& % .5*1 3
# (
DPT
# " E* P,
.DPT S
W
=
(
; DPT S
)
Connaught Laboratory 0 % ebcd
." !/&
* " " //&
" @/ " 6&
? " M:
(& "V 5 E% American Dental Association 01 " /1 +*, & A ebcd
", ) G9/#
" /
J #& (&
J " ", K
60 ." //&
"
L A
A E* 50(
." %., L '&
L , < G" /1 3* "
-.)
9
Gomel
5L /:
%*
" ) I6
Chernobyl 5 ( 5 # ebcd
./
&?
O& M ", "0" :DPT S
(
Connaught Laboratories 0 7 ebcd
."S
# " # "0 % n 3L1 A G) # >^ " " ) "6
(1 Q
A&
5& /
" " / The General Accounting Office (GAO) 9)
+
& 30 ebcm
.( ebcd 9 P , ) Smith O/ Bailar @
J 5
= W:
+# ."*/
M) :
&J
\O :)A ,A ) " # ! 0
W$
" .( 6)
$ Z m GAO + ') W#
5) 7* Q/ O& 9 O&1 H6< A 9
M " 9L
A .(
)
%
" $ -& " H39 0
$ %
.ebcj 9 A& ebgf 9 6 I, GE ">.> 5.
." "
Hib S
", A
J ( / Centers for Disease Control (CDC) :1 A */
0 ( ebcm
"1 X#
31S$ $3 :)A
" X#
31A $3 (! A $ $ .% le 5)
) P, %
.-/A
HIV+
hepatitis 0
3
S M) *) I, +*J CDC :1 A */
0 ebcm
.+J
%(
5&/
A / & 3
&* @) G) L 3/1 +&
"&
" 0 ebcm
.
(
01
.( /, ) Q/
"/ if "/ &
.%
#& Y)( 6L1 #
)
European Parliament 1 "
ebcm
.)(1 6L1 #
) S/
9/ @ , ") I 0
&
ebcm
.
0&
" ) " "
M<(
S
& " "/ / ebcm
K
-.)
& E jf Q A
s
6 AMA 01 *
)#
", # ebcm
G( 01 &
?
#
/
*
= I6
) "( "
E " @ , 0&
# / .)(
." % L ) #
5# , - I, "n
$
" $#> "! =
7 S $ Swedish Health Board ,$
" J ebcm
."! 6
7 &1"
GNational Cancer Institute "*/
*
)
!: GVincent DeVita I / 0
ebcm
=#
&#
:0
-.)
+#n S/
" 7 "*/
E
eifff 5( P +#n 3
*
." 9/#
H( " P
; GI>
"*/ " " )
+/
M M<(
S
"J " :DPT S
(
A
J 7 Lederle Laboratories 5
ebcc
A& O& =%
" G?&
" % gfzig ) # >^ P .^ S
I, " >0, # V
." / #
9
) ) # >^ 9 P "6
A
Q
!? 0
9% % .6$
#$ ,: "
) -7) A $$
" " 6
ebcc
British Medical Journal *
*
#
S
", 5%
& ljfff / Lars Janzon "/
Wall Street ($ 6%
.I>
)(
9/ " &
3# @ , ebcc 9 " 51 "(
.W B$
T" % 2$# 39
$)$! " $ $
T" A k m = 6$
6 t
9/#1 " %ii " " )
Medical Tribune *
" &
( ebcc
.)* V( 6 (
(
9
) 9
?& " %ii ", A
J ( 6< ."
)*
: '
G"*/
5& / Battelle Memorial Institute 5 5 ) , ebcc
W
A
J *)
5& 9 ." '"$ $)
$
( ", +# GUSPHS 01 )
&
1 9 A
J *)
5 I6
GNational Toxicology Program (NTP) /
*
0 )
*)
76& 7
J ) %
GExperimental Pathology Labs #
Gebcb 9 51 " 0 " !/
1 9 5& 5 # A
J
*)
9 9 .
)
&
: EPA :
& :< ) K
6 50 G
1 *)
A 5)
J " 9 ) I,
( ebbf 9 P , ) .USPHS 01
Joel "0/ 5# 0
GCalgary Health Department I;
0 &
9/% 9, 3* ebcc
W$
$ $
( 4$ M\OO
-
)$ " @ V S
*
(/? #
!: Boriskin
.( %
$ 4$ M\OO :; ) ." # <" -/
$ $3 $4 c17h
"$
($ $
( A "(0 Argonne National Laboratory *
"L, ">& ebcc
> O&
6< ", >
.*&
:
6L1 #
" " G1! $>$$)
"
6 United States National Cancer Institute "*/
01 *
)
9% / @
J
Saint Louis
!
/ )# " Norton " Herskowitz !0/< <#,
ebdi 9
.L
Y 5, # * ebcc
" /1 (& "V S
The US Environmental Protection Agency 01 :
& :< ebcc
/ < G"
" " /1 (& " %gf " >0, M:
50( ./
(
" )
! 0
:">&
" 50 W / % .
G90
G
" / >0, ) .
Department of /
9/% " John Hursh B< "# 0
GThomas Clarkson "/0.0
GUniversity of Rochester /( )# School of Medicine *
/
Toxicology
0/
0 ) " Lars Friberg t !? 0
GMagnus Nylander . ! L 0
" M:
& " ", :#n %
O&1 G/
GKarolinska Institute of Stockholm 9
0/
" : " >0, "J ." M:
K
6 GI.
M:
"/ ) /:
3/
< " /1 (&
.M:
A &
(&
H6< "/
(
'"
9 MN_N
X ,3 $ rubella $! X# A $
" 6:A ebcc
k +
2( Epstein-Barr $7$ J
$ ) Chronic Fatigue Syndrome .9+/
.MNnZ
'/
A
John Seal 5/ "# 0
", A
J ( Robert S. Mendelsohn "/
0
( ebcc
) National Institute of Allergy and Infectious Disease )U
1 !/&
*
)
"
&
3
1 6#
3
) Guillain-Barre @z"aL 3/ ", 0 &
=#" :"V
."( 3/
5#
.E( ec M 5*2
Hib
# S
9/ S
&
?
ebcc
,A &$ &;$ rubella $! / W#
# $3 (! % Z\ A 0 ! A 7A ebcc
$! 6 %_` f
$
.Y$# 6
" J1 = 1
&
0
$
.$# (! G 6&; rubella
G >
"( Gc
< New York Times K &
(
06 ebcc
A E.
) 6< G 6$$7 1
A 0 "$ #9
A k
" ", C-1 &
ebcc 9
.5#
* 9 V
3 " 6 A )T$ National Cancer Institute "
& $# ( *( ) ebcc
.MN\`
) MN_N
3 polio (! 7 6 <$ A Washington Post 6"
7
($ ebcc
.X# &"
9 0 dffff 5
, " * %j ", Washington Post / "* ( &
06 ebcc
."/ ./ A <>V 9 " 0V
.$
/ $F 6; %\O :)A A Washington Post 6"
7
($ 6)3 ebcc
Department of Health Services &
9/% "
06 ebcb 9 G6^ Gif ebcb
% ."
+# lgf u
" 0 A I& L 0( #
)
H
",
0
.E.% "0 % H
H6< 9/ "V "0/
Kenneth Kizer 0 O 0 ?
&
6&
A& ( (&
) 9/
Malathion ">.
" "
L 7
, lm B ) 9 !# , !
ebcb
)
/
5&
#
0
9
30
J " & ( ) I, Gebbf G, Gif
", 7)
" .( Malathion ">.
< <&, ) Organophosphates )
/
Neurotoxicity
. 0/ <P 3/
H6<
Freedom of Information Act )
& " % 9/ Yiamouyiannis ! 0
ebcb
Proctor and 5L ^ 0 0( #, % 0
*/
(1 Q
9P)
"*/
/ ", A
J ebbf 9
.
E#
) ~+
9
"6
/1 &
:" #
A
J & " " ) E0 Gordon Thomas ! "L ( ebcb
Journey into Madness: The True Story of ) "1 9/ +/J 5)
A */
01
.( Secret CIA Mind Control and Medical Abuse
" : I, !
6. " dfff A Hildebolt, et al.
< 0( #, / ebcb
.sodium fluorides 9
9/
A
0 >V " <#,
/
W: Battelle 5 )
, Gebcb G*( Gji ebcb
", < USPHS 01 )
&
: P # " /
H6< L >01 #
.":
06
":
Q
hepatocholangio carcinoma A/
0
"*/ " E# Y O& &
@/ W: Battelle 5 )
, G9)
! " "/ G"( ) .
#
)
O
*/
91
" %. /
P, % ."6#
0 " %.)
A
*
)
9% GBattelle 5 ) *,
/
A 5) 0 .*)
#
A ) %.)
H6<
9/
"
9
"*/
?&
G %
9/ ", A
J 5
Gebcm 9 A& ebmi 9 "
5. @/ ?
K
"
& cfff 5) I, .
9/
M*
%gf A
J
9
"*/
?&
*
@& I6
0
I
3/0
5 L ) 9
, .E / 9)
"*/ 9
"*/
.1 H6 *
:
HIV D J
$" :S Luc Montagnier B$$F
,
-$
2HIV D J
$
(7)$
$" ebcb
."AIDS $! -$ ,3
"
& $ B)$
"V "&
"/
&, , % " Boris Yeltsin "/ ! "V 06 Microwave News &
ebcb
eezm < % (n "/ 3% 7J @ 0 ELF E# # K KGB /
.<
Press Release (
The National Toxicology Program /
*
W
ebbf
%. A
J J Gosteosarcomas 9P)
"*/
"
#J > *) "
( ebbf G >
" 0 ) ."6#
Q
9
"*/ ?)
", , ( The American Dental Association " /1 +*1 01 )#
, ebbf
."0
% Q# 6 0
J G" /1 A P&
) E , >01 *
<
H
#
)"
*)
."" /1 !/
) 5. " 3)(
" /1 &
"/&
) >, %
H
#
) " "V G" "/
G
" # # E, P
/
=# 76& 9 @ G6^ (
:
,
G/
!, I6
GKraybill 50 '
, % . */
91
" %.)
P
/
5<#
< GAmerican Council of Science and Health (ACSH) &
9)
01 !#
E(/
."
>
)) "
& 6J EPA :
& :<
", H E The American Dental Associations ADA " /1 +*1 01 )#
, ebbf
& "
" ( 9
(0 " K (
" /1 "#)
)
) Proctor and Gamble 0(
@%.
5& / W: Proctor and Gamble 0( ( ebbf 9 6^ ."
*/
A /
W: .":
A /
H6< W: )
*)
A 0 ( "6#
Q
) 9P)
"*/
&
% .9
*/ 5T% 9, A
J IF 6L1
# ", > / / = M* "6#
5T% , */ ; 3/ ? "
"V / / = ) Proctor and Gamble 0(
." */
(X H
9/% A/ ? 9
) The Arkansas Department of Pollution !/ 0, O
9/% 9% ebbf
.1 0
:
&/
:. L %bl ", # !/ 0, 1 H
&
*
&
/
&
" " )
Health Consciousness &
# ( ebbf
", 06 H.E.Buttram 9 .I .< 0
( Live Virus Vaccines and Genetic Mutation) ">
" #
G
#
9:
7)
(
3/
"0 % L # 5% " 9/#
S#"
." autoimmune diseases 6
,
GHIV
!
&
#6
*
#
>0
#
" 7(0
/ 9 ebbf
! E
/
0
" & Y 1
9/#1 " 7(0
7 9
&
* ) ELISA
01
Central Broadcast Station *& @) I6
% "/ W ebbf
/
O&2
*
)
, K
6
# .ADA " /1 +*1 01 )#
" A
J % " ) % Institute for Dental Research
( X / L :
9
6
X / 5%, ) ." / 5%, " * 7 G:
*(
", ebbf G Gjj ! <
La Prensa Dominical &
, ebbf
", 06 G01 &
?
9) 9 G5*1 3
0( " 3
(0 % El Salvador
.+1
0 "/ 5*1 +?F< " )
"J .K/0
E / " 5* jffff
A " +*J ", New England Journal of Medicine *
.; J &
06 ebbf
.
?&
" 5 measles
&
"
5*2
) 6
$ G "
$
( $ J
) $
( Battelle Memorial Institute
National Cancer "
& ($ % 97 ( H39
6:A
.Institute
3* "
3&/ New York Dental License Board K " /1 +*,
#
ebbf
" +(
A /
ebcl 9 ,? : " /, (&
n @
Joel Berger L 5# " /1
.rheumatoid arthritis
5
3
5) Y " " )
G51 "( Gef
< Los Angeles Times &
( ebbf
" %gff / % t
"*/
5) ","
+# " )
9
= t
"*/
)
" ">.>
6 u t
"*/
0J ", E/ ) "0" @ , G")
"
"01
.")
9
=
0J ", "N P "0 G)
9
=
%
, 9>
$
# ' FDA $)$!
34 =+ Y"$ $ 39
!
) ebbf
34 =+ $ 39 $$
.L3 &
c17! 0
$
! '$ < $
$)$!
.
."
& X $F
$% 6 6#
A $
S )$! E$
# FDA
. #
A 5
&
"I
" !
" @ , H6< )
&
01
*, GM)
Operation Desert Storm +&
+ >, ebbe
6< A M*, ."*/
3/ w) ! #
" 7?N 3
, (, 5. .#
&/1 #
E&
#
" cfff *, .1 6< "
F/ 01 0&
0 , ." W
3& " 9/ !
9 0 Ganthrax vaccine >
#
E&
#
" E
, egf " >0, *, GBotulism A 9/
H6< =# 0 % .#
5 < Pyristigimine S
I # 7
, gff < u
0V
+*J
.3#
* 1
" " )
ebbe G6^ Gem
< New York Times K &
(, ebbe
0&
", A
J( US Vaccine Plan Uses Welfare Offices) "
30
9/ 01 9)*
*
.
)#
H6<
:
" 9)*
.:)
"& %
The US Public 01 )
&
: (ACIP)
"
&
*
(/? #
ebbe
.Pertussis vaccine M<(
S
9/? )
.&
A +
#
^ = Health Service
E, 3/ S
", A 5
I, K < !
" @ , !/, A *;
#
>N 9P) 0 J 5>
9% >
, &
)8
0(
$
/
" )
A
J 9% / % ."L
.Edward Mortimer J 0
James Cherry I( !# 0
5> S
"#$
(,
01 0(
(/? " ACIP
"
&
*
(/? #
" ".#
"6<
1 M<(
S
" " %. K < !
" @ , >1 0 L & / % % GM<(
S
)
CDC :1 A */
0 < &
?
&
// " 5F/
"J .t
3
/
5<# A ) //
H6< :P&.) .American Academy of Pediatrics 5*1 3*
01 01
.(s
? A G"#
A
M*, Pentagon "L
A
7% A
J Carl Campbell 50 50 5/ ebbe
.Y
'/
*
Edward Higgins ;< J < 01 &
5F/
."@) 90&
%% @ & " % CIA 01
",
0 @&/ M*, I6
Campbell 50 A %
'/ % ."( ) 5*2
@/
=#
Hepatitis B 3 Y 0
3
&
9/ S/
, CDC :1 A */
0 ebbe
.?
6 ) # 5*1 " )
A % .&
?
5*1
&
) . ^ :
" /1 (& "V ") National Institutes of Health &
*
)
ebbe
(W.Post / "* (
Eco- /
:
**
F 5. ) 9
Cobden Club Document 30 "0 > ebbe
.
&
"0/
" 5
E/ & ", 5
A 3# @ V F
+, &
Conference preplanning
.
/, G 0 ) Second Immunization Conference
"
&
>
F
ebbe
=
6 W
$7 :)! '" 9 6# " A Viera Scheibnerova
$$7 $$
) X F
." (! G
" A
1 #
5*1 +*n The US Public Health Service 01 )
&
:
, ebbe
.)
" //
/
)
/
" 9> GE( ec d l &.
#
G"(
DPT S
9/#2
#
#/? 3/ " (, / 5*
# A& " P " 1 5
@ 0 I6
%
." E* >0,
9<# "0 "6
5*1 Q
Annual Conference of the Society of Homeopaths >
-.)
)#
I /
F
) ebbe
.ebbe 5, .0 J G/(
+*2
" s0 " = English National Health Service *
*
&
: ", ". ebbe
.&
5)
# 3/ 9<
S
"
"6
" Lancet " /
British Medical Association *
*
)#
<
&
ebbj
9
M* " A*) "0 I6
polio vaccine 5*1 5( S
", ebbj G6^ Gm @(
G*
)#
/
" ) E> "0 recurrent herpes !0
2&
-.)
)/
7
."01 " HIV ! ( + 3/
"0 %
gg +#
&
md "
Peter Duesberg t/ :#
+&1 9
( G * ebbj
1 "V :
P
& GPharmacology and Therapeutics -.)
1 9 30 "
0
"0 .P
0 50 50(
#
A % HIV ! ", " w) ! " @/
HIV ! 1 "
# :
P
3&
, 9< +)
" HL Robert Gallo
L
5. " " ) "6
(1 ) Q
# !
6< ", < :* P
, A 9P / %
# %\O A &; & 9A 6$> Duesberg k$"
%
.
9<# 9 P
&$ 6) %Z\ " m Duesberg k$"
W#
.HIV J
$( =/ "A &$ $! $ $$)$!
."&"A HIV J
$
L3 $3 $31 2$! &A 0
&($ $
A
$F A W#"
HIV ! # " A
) Q
T .
6 ?& (CDC) :1 A */
0 7 ebbj
American 01 *
)#
&
" ebbj G5, Gb
)
7? 6<
% .9
.Medical Association
&#
9/% !: " ebbj G >
" 0 Gjg
< Vancouver Sun &
ebbj
50(
M -1 0
* #J 9 @ , @
% Ronald Young u
0 )#
)
M)
"0 Young u
E .
)
.
*( 7% t
A
J @# ", -1 &
"0 O& E# M%
.%*
" A, / 9/ %
)
.
0
)#
U.S. National Academy of Sciences (NAS) 9)
*
01 01 ebbj
%, % . 0/
" &
@ "
* E0( E&
"
Royal Society of London "
" Population Growth, Resource Consumption and a Sustainable World " " ) "0 I6
'
: 5:
Malthusian paradigm !>
-6
."0/
" & Q/ 5& @ 0 ? 300
"J ze
.:
0/
"J zj
A & $# )3 American Journal of Epidemiology >
! $)$! ($ ebbj
.DPT X#
&$# $A : : 1 -/A $: $ .
($
$ (!
.&
?
Diptheria M
" ?& =, 7(0 ebbj
I6
Health Care Decisions Act &
& " % # ? )(
:
ebbj
.)
/
$&
" +(
& 0J I, "0 ? " "6
A
A +
7/
.
(
* " " ) 9 %ii ", "& #
O&1 " jff A #, / (0 ebbj
(
G" "N 9)*
5& " " ) G >
"( Gj Washington Post &
+# ebbj
51 " 0 Gel National Vaccine Information Center *
9)*
) 0 "
G* >& emfff " >0V @ I6
FDA 01 +
+6;
J @
, I6
A
J (J
.ebbj G Gie "( 5. >& )# G9)*
G
& igf " >0, "
.>& 7
, em # % I6
&
9%
" >0 5%,
H06 I6
9%
"J
.? egf 3 P&
01 1 K./ % % ebbj
=# E
* FDA 01 +
+6;
n Michael Perrone " 50
/
5
ebbj
34 = 6
&7A "
.:
&/
) ./ )
)
" 9 , Perrone " , 0 .
A I $
( 6/" A 6: 6$ $A L &S FDA
."M/
" &/
H6< "&//
=
6 6>
$
)
$ ZPN < MNNZ
MNnn
$ ebbj
G9)
A
# :S
" #
1 " .; G1! 6 -I 6
26#
< 9 M<(
S
" #
?&
&
)
" )
.5(
A
J J G 7 G# (
.Sudden Death Syndrome (SIDS) _#
" #
(Agracetus) /
01 &
#
0
0(
& Y + ' 01 0&
% ebbj
.E> 5)
"*
# K
6 0
#
0
/ #
) W.R. Grace 0(
)
<$ $ .# [
A $ [
,! W$
W) = H39 Y
.Y? + " , )
$ A <$ $
$
2
3 H39 0
$$/
" < 0
#
.>$ $
" 9"$" ,3 ! 2$7 6$ 1" =
0
.P&
1 "/ &
?
", # " "&
J HIV ! (0 &, Robert Gallo
L 0
7(0 ebbi
9/#
B)
)#
/
=# # HIV ! # A E.
) I6
( jl z3 ) "
&
( / (0 % .ELISA !/, jlz3 " " 7(0
) .Q6, I, 3/ ", "
jlz3 "
9/#1 ", ebcc 9 iec )
New England Journal of Medicine *
.; J
.E
( egf 5
, " &
( #
%
) & %N] 2J$"
7" W ZMn '$$ Epidemic of Pertussis .
97
ebbi
.Pertussis .
97 / W#
31A
.National Childhood Vaccination Program 5*1 9)*
*
W
" " 0 J , ebbi
?
+& , =# 5*1 9)* '/
( S732,S733,HR1460) 9% "
!# 0
, %
*
9)*
.&
.#/ 9:% = A 5)
A
J .? 5<1 M& " ( & G&
.9: , 9)* " "6
5<1 &.
.#/
V 3
* I6
( S.732) "
Y( Edward Kennedy I 0 J /
9% ebbi
I 0 3
* ." 5*1 9)* " % " "
&, A
J J G / d "/ & &
?
5*, =# "
" 0 S% K
60 .9)*
)
/
= G@? " 06 %* " 5* 50 +*n Kennedy
." * * %* " H/, Clinton
.%mf / &
?
)*
3(1 # ) ) ebbi
& 06 .E ^
7
9/ ) /
:* u
=
7
% ebbi
W: ", University of Utah H )# " Om Gandhi I L 9, 0
" Microwave News &
G51 " 0 Gef USA Today &
/
H6
" N" W:
( 9 .+? 6< 9 ? /
H6<
.L E, 3/
7
"V )
9)
M
" 5
P
7
& ebbi
A * I, # ? " @ V ebbi G3^ Gec
Associated Press &
, ebbi
National Research Council *
O&1 !# S
0 G"
#
)
H
K./ " W &
K )# School of Medicine *
/
" Bernard M. Wagner L .9 . 0
+# m 0
E#
) ~+ "( 0, " eij " ", '
+# .New York University
." "
9 7
, eff " " jb
( 7
,eff 50 " " jgf &
?
+ #/
u ebbl
.ecgf
%N\ A The National Academy of Sciences
$
$$)h $# )3 D ebbl
2$"" $ W:I '"
H39 $ A
2
6#7 9
1" $
$)
? FDA +
+6;
J "J ." 0 / 2J(
2,) & W/
% .# 0 =# 06 " ) P L #
"n "
E @ 1
H6<
J =*/
.!/&
3/ G
)
#
/ , A *)
0 " )
7
9
8+ [1 = 0
Agracetus )7 .
W.R.Grace and company )7 6 ebbl
H39 8 #$
.""A >3F
0
=$" &
A 9
.W$:
$
.W$
"
$ Z_ D
$
" A University of North Carolina $7 $
) 6
ebbl
5) 5#
! ")
5#
/
, .%`n " ,: " /
:)A $>&) 6
! =
.)*
5)
" 7), /
Western ", , Gjj "
The Sunday Times &
@, 06 ebbl
.HIV ! "0 ? 9 , # %1 A
" %cg / #J W: A*, HIV ! " 7(0
Blot
", "0 G, ".
3
, I6
Gleprosy germ 96#
/
9>#
#
"J
.HIV
# " 0 *)
? " if 3<6 % .&
#
0
5
/, ? " ejf u M
/1 0&
ebbl
Commonwealth Scientific and Industrial
/1 &.
)
O&
P A
J
/,
% . )/
5:, 6 6
>
5)
5& E>& #,
GResearch Organization (CSIRO)
.recombinant DNA biopesticides E>
) (& 9/
5,
/, 0
Y"$ 2" 6$
# 6 [
A $
9 :
$ ! $1
:;
?
? d 3 M G%
6< .34 8+ , 0
;( # 7 $"
.7
6< M&
&
DNA
" ( > K
G &
A Q#
>
5)
O&, < ,/1 "0
.
&$) B7 $
$) 6:
A " j
)$ " A Science News 6)3 ebbl
+ <( # .
)3 G $ "
0
:T$ 39
.,
:!
"+
9 ,
$)
.=$1! $! 6
" 1 %\O " $
6
$
(1
2$1 "
.Population control and disease production). Science News 7/2 & 7/15 :=#
A :& " 9L
A " ^ Septrin + Bactrim + ", ) FDA +
+6;
J ebbl
>0, 3/ 0 30 A "+
"6< I& .+
)
%. ? L 0 0
? g " >0, $ E%/ G2
)
=
" %ef 5>
&
0
( 7
, "
A
J 9
#
)
% &
?
", Greenpeace 1 9./
)#
06 ebbl
. % L 50( "
. 3# +#n 9 "
ebbl
M* " "*/
/
(&
9/ P& P
** " :
& :< , ebbl
/ 0 id 9/ P& ", )
H6
"0 .K/
& P = / L %
9
0
", < < 9
1 .
!
/
5. )
H6< 9 ",
" ."
.Delaney Clause "
" " ."
" # A
+
J 9 @ , ebbl G5, Ged The Associated Press &
@, 06 ebbl
", 0F 9. 5:/ '
5, 6< "0 .
*J A
J &
?
" "00
"
5 0
)
.7
M/ # /
< &
?
US Congress )$! r
$7 J 0
4/
# Clinton Administration
$) = D ebbl
% r
$7 J
$! 6$ 1 1" 6) %
.Health Bill
% [
7 %+
)$! '7 <$ 2($
7 $F $" Hillary Clinton
$) , $9 6
&7) #4 $"
. 1!
# W#
7 -$ A '$ .
0
&%
# 39
/
$F
$
% $F &)S $" $ H39 $ 2r
$7 J % ,A 0
6$
% J 7$ -$)
.$
7
9
)
I#
//
F
A
J %.1 L (
L 51 H6< 50 ", 806 :;
/
$&
#
5% " @ %
E % @)( 5. " G"$) :6L - , + M/
;
3;
)
5)
@
J $
^ @ , A ) (O
>
9
)
5)
J V 7/ G( // M*)
G&
.Q, # I, 5% "&
+*, 9< &
#
H6< M/ ( "<// "6
.$*
."& "#
) 0 ", 5% ("# "%$/) 5$1 9
+*1 P < H6<
70 V( 70 O&
3*
Y 5& 0 @( 0 "$0 % G
6< A Y.*? 5. " Gp
"V
I6
$
A
J P
< @) 50 "0
G
6<
5:/
9P) (% 0 ? .@/0 9
A
J 3/ I6
:6;
9P
6< ." *
$&
$)
&
=
;
5
/
:6;
9P
@)
A& # "0 9
, " " ) !
" ".
a"n 9
, .!/ # 50(
&
."()
"
P $ ?& < 5>
5/ A 3
, $I0/
./
"
50(
" )
>, % ."
+ " " ) E.> ";
";
"0$/
" %mf H6< , ", 5
%)
"
9/? , 3)
% .9)
:6;
9P
I<#
;
# 0 0 50( >&
&
.K
6 E/: E &8
Y 6< "0
.-.)
9 I6
(
-.)
* " *
S/
0&
51 " "0/
$
(
A
J 0 n 5> ) 5) " 9# , < 9 3. " I#
)
O0 9 "J
G" /1 "#)
L A
J :
9P) A
J 9
J 6< O& GE.> .:6;
:
9
"0
.)
" ( >
" "6
" 0(
)
0
=
F/
5#, " G1 9 !
9 &
+0
+0
.3(
H
#
) 5. " * , "0/
) 90&
0 **
" .
, &
A */
A
% A
J "
IF/ ;
0
" 0 # 5 "J
"6
K:
, E)
" 5)#/ 6< +* t
" & M* 9/ M* " K
6 @/
K
6 3&
+ #/
A*)
3(
+ A
J 9
n "
1 !
" 50 9%
.@
"
." A& +L, 9)# */ 9J 5#, "
I(
":0
A F 0, G
0(
" )
+*L & # " P 0
I.G. Farben $ ,A 0( K0 9 3&
+ )
0(
H6< GProcter and Gamble 5# 0 0( +( J A %? K ( 0& % ) )%
D Crest "6"D$)" %J 5. " K
6 9
A 0&
)#( % "6
V $
0 " )#
01 0&
(/ "n K
6 A . .ebgc 9)
&
&
H6< $
( G
# "!
'
, % GDr. George Estabrooks !0/J -# 0
G/
0/
A */
/* ;
9
5#
/& >01 =v $
U
5 #
0 0( 0 .Colgate #
0 )# !
9 : !: )
0 G9/#
0
)
5) .
)
Q/
A " /1 "#) A
J
J <, "
( 30
9
)
S
Gebgl 9)
.$
) G1 % 5 )
IF G;
@/
:E.:% Charles Elliot Perkins 0
J
J 90&
)
<#
J 5> +
A
J
J )
&
7
"J"
&
" "
! O&, E "(
& A% 9
)0 K
6 G> # 50 5
=*/,."&
& /
E
"
@
J 7
+
3(
( I, :"V G#
>
!
9 :0
G:0
."/
&
" , )
&
" +/ GE, @6
(
A "
>0, ,
=(
..." /1 "#) 9/ 5% E# 80
A J G
3)
"0
/
&1 9 M/ "N :0
5# Q
'
,
.
/ */
"0 ) E)( 9
)
"0&
Q
'
, GK
6
c# J
$ & $+
AIDS & HIV
!
"$ 9/#, # 9"
& 58>
"( /
1 &, @ V 7a)
"/ 0
G(9/, )# +0
/) "
K < 0
Gebbi 9 +0
5 :# :
Mullis
! @/ !
a"V "N 9 % " , 9)# G(K )# :%
3*
/) !
"
! "
L 9 0
!
# =
P
Q
90
# , G96U#
G5/
G$)
#/ 1 38
G) > Q G6;
+/ 5>
& 3
(
.
&
A& ,
(
9#/ %
P 9 @
Q# G
Q
#J @8 , A
#
" )* #/?0 T .
9 .9/#
T . /
9/#
T . / ) .Q1 $
9/#1 , /
, 9>#
L 9/#
* $) G&
"0
.
&
#
)
5)
+
5 +
3# @ , A 8(F *
)
" )
" S E&
9/
(
T .
) a", O& G# L * " T .
)" A ?
(
British /
P
& 9P I6
Ian Weller "J /
M .I)
w9
jfff A
J jff
7 ", "0 O& / ; < $", < (T Cell) CD4 T . ) " H806 ", 3# I6
+(
"
A (
5> )
+(1 8>V ", "0 +/
) S
"0 G9
%, Q A
."H^ A
J .. "
!(
$)(, K
60 8>V # 30 !0
(
" >0
# A
J G@ )
&
G1 5# %
L ? H6< =# &,
" @ , O& , 5&
< 0 GK
6 L 1 ", 9L
(
+/ /: 5
." "
(1 P I6
9P 3/
HIV
!
"0 ?"
0
< w / ">.> ! " >01 9
)
+& , 0 3*
5# & / "6
+*1 &, "a
"& M* " K
6 >, GE 3/ ? HIV
( 9
K
6 = G$)( >01 /1
(( A K
6 9% G
3/ ?
< HIV
! ! #
a", >J 'Deadly Deception"
Y
" ) @0 Wilner 0
',
! a", A E,
`
$/:
3/1 &, < AZT
", ( E,
!
! #
M* " 5 ? a", /#, #
Q1 /
5> !
$ L W/ )*%
.50(1 " 50( IV I)
:E.:% G9
)
5$1 "0 9
"J G!
+
&, @8 V 7)
Dr. Duesberg t/ 0
So
DNA
(
)
@/ )
L 7?N
AZT
//
$ <
AZT
a"J ..
50 +&
.
" 5F/
"0/ " .
A
J
IF
G/#
+1 =# A
J IF $ G)
Q
(
M1 50 a", <
"N "#
) E
, "( a"J ) "
"
( v50
/
<
0
a"J .
A !
.&&
L <
HIV
AZT
#
)
3/
:E.:% K
6 A 7
3/ ?
! "
(1
Gallo
! a"J "
L 0
$
1
. 0(
$ % 5:/ $, " "
F/ +?F< ", O& $
//F &
, "N) Wellcome Trust / 90 & oT( Gebid 9 Henry Wellcome 90 I < )
, 0 = *? $) , *
O&
oU
//F
9, Q&J &
, (Wellcome 90
( A
J G"
)#
A(/
3*
$0 0 "F( J 90 A8 /
0( / G&.
)
Q A .:/? &
o3*
"
/ M* "
O&, K(
&
$&
/
-. 9)
-.)
< = $:
$&
<P a 90
)#
7 $*
$01 9. 5:/ 0&
= %. .$&
#
0
$>
/
5. " K
6 ) 9)
$*
$)
O&1 <P 50 % 9P )#
//,
& :
G#
0
9)
$
//F
G9)
9o
*
& 5> 8P
H6< " )
< 9
" ? 7
, "), =, :
$%
) `
*
& //F #
0
9)
30
$/
"0 G5>
5/ A . =% : $)
>&, = M* " K
60 (ebbj ebcc
0( O& "0 O& #
0
9)
//F !: 3:
Q&J Alastair Pilkington ""; 0 /?,"
.90
0( EJ EP :/? &
3*
"
$0 C. Gordon Smith O/ "L .! /
"0
(
$/
.90 0( E, E
>
BBC 6J Lord Swan "/
"0 .90
90 //F 90 0(
!: "0 ACST #
0
9)
I(/? !#
Alfred Shepperd
9)
$* $0
$*
+&1 !: Roy Anderson "/
I /
.ebcg 9 A&
.90 0( EP "0 #
0
9)
I(/? !#
"
#
0
$:
90 0( 9/, = % 68 a9 Gebcd 9 .$ .)
01 ) 0(
)8 G >
&
$&
?# $ E, G&.
/
/
./ 90 $0
0
, - J a9 .&
- n < G9 L1 " I / - ICI 0( = K( Y(
#
0
>
5> E& >0, ?# >/ v0 , )
" %el A
J 90
5)/
.$/
$&
+0 /
I0
30
6< * a9 @ , 9)
= G? !
0 AZT )
90 0( $&
% ./
$ */
.
"
A @% 9 P O& 5$) L $/
@8 , > @8 0
"*/
-.)
58> A
1 &
:"& M I# GE)* &
A # ) G(
A %)
:0 # ,
"0 "&
0 .Q
$)
A Q
*
$ #
>V
A v0 >
&
.$/
Q 5&
(, ), ) % % 0, >
&
3# 0 AZT +
& . / "%;/ ",
0 +
# 5. 9 , A
J G %
+
' GK
6 9L G+
6< / " &
(1 A
J 9P 50( 9
5 "#
.$)
7P
v5P G#
W: %
5* 0
I,)
/ @ # " eeij A
J 7 90 0( S, (5
) AZT +
_#
=/
1 &?
5)#
<) *, G0 ? 6< "V0 .* / =, 5. (E # ">.> " > :
.@) 7
", 3# * < AZT + 5 > < a9 ", 3# @8 , < /: *(
) 0 `
), 5% K
6 G$/ $, " UK &
0
E
*, % AZT + ", < 1 3#)
$)# +, " E "( ! " " a", &
3/
) $ .&
?
@
" =/,
&, .90 0(
'
9 / Q
G1
"
"(/0 ")
1
&
1 ./ #
E "( &
' GE#
% 5.
"
G9
"%
I,
3&
, "# & O& >0 K
6 " ), <6 5 G* $
9>&, W: W
, $ *
M/
E, 90 0( 0& .>0, # "0 ",
"0
#.)
# A
J
G"*/
O&, ) " Angus Dalgleish B;
!# , Robin Weiss ! " 0
/ .
Y
a &" / / )# @%, O& A + K
6 ? , " >
5#
M/ 9
/ /
< (Healthwatch "$&
%
" "N / '
,) Campaign Against Health Fraud "&
! 3 oI, @# a9 a", " 5#, " .ebcg 9 6 90 0( " @ # "
?
8
5:/
A 7$)
E# E& E. ")
+*1 *, GAZT + I
+*, A
J E
&
90 0( >V & )
$)
(/
9< 5/J Q/ 9
"0 9
.
6<
UK &
0
$
? $) = = 9& 9 I6
%
K
6 G"
STD
/
.M*
HIV
$*
:
" E
& "#
+*1 " # 5
@ # egf,fff = 90 0( $ K
6
G
", " E? .
9*
6< 5
A )
$ "6
GBritish Medical Association *
< 3#
+#J + /:
3/
.50 50( 90 0( >V & 0 G8/ / 0 0
3# "0
.HIV
! "
A
$* = AZT
) >J
$:
0(
9 M* " 9
0
G3#
H6< 5> $
./ " $& I6
9:
9P
90 0( " K(? 0 0
# +#J 9 G(0(
5 ") 3#
9
(/
=
+
$&
9/% , G? #.)
7
0 MRC *
O&
!# = .$&
9/% MRC *
O&
!#
5& @8 , ? > G
O.> 5
@
" 9 0
G #. 9 , (% " #
A
J 9 ? A G
!
#J
= 9
>0, #
51
9
? '
" >0
9
"6
MRC *
%
! G*
O&
!# #
!: GLord Jellicoe K#
"0 .$0&
, $*
//F
GTate and Lyle 5? 0/
0( A
J GMorgan Crucible 5/0 "L G0 0( E
.&
0( !: ) '
,
3*
0 $0 5)
ebbe 9 @0 @8 0
$&
9/
Donald Acheson "/(,
$/
5
"0 (90 = 0(
"N) Glaxo /0.;
/:
68
Austin Bide "/, $/
"0 .$&
9 :/?
&
0(
E David Crouch B0 "0 . )/
J. Lyons CO &
0(
E
A 5
&
J. W. Hodge -<..- 5% " @ $9 % "*
:
" 0&? *? " ^
:
8
8
6< +# .K
L " 3*
H0
EF
0&? >0, /
< GAMA 01 *
&? / /
G*
0&? * $"J .."
#.)
5:/
$"J .
)
"
I, &1 " 3)( "F( ", "0 E* E#) <>0, 5 *
01 *
& ";
5% " 7 ) #U "0 7/ )* */ ^ 3
/, 9/
7/ *
& = 7
& ? 3* 50 $"J .9s A
J 5
5&? Y
7
A
J "F# "6
AMA
( ", I6
$&
9
50 $"J .!
& 6< +*, 5% " $U * 5$# @ 0 98U
E % @&. A
J 3*
)/ 9/ "<( G" S# 50( @ O& "
)
+*1 +?F<
"..E
L ">
= O&
>V $%
) 5& I$# 50( 5F/
, G=
* Q E, K 9)
'
, G5& \50 A
A &
"0
G#
6< A 5* % 9L ./
>V
)
1 H6<
.5& I,
) 9)
5/0 A(/ )U
1 & A -. 9
)
a"J . :
)
K < O& 9
)
5& * *
&
H6<
&
&
H6< $"V aK(1 3/ I
!
E# /
$
)
:Walter
$
$%
)
)
# < .Q, >0 &
3# G(/
)
*
I0
!#
5% " @ A
9P
K/
"
E .."
38 #
& 9
9
w> 6 "0 ", @
9
$F
$
$
"0 ",
"..@
& +( I, 5)
I6
2
$&
)*
E 5<# +
7
I6
3*
, .? 9, 8 +
>V " )
E
L . /
2
$ #
>V
>V
" "
:< 9.J A % L K
6
@
" E? 7&, , 9%, // A$/ E
L 1 ": I 50(
)
" )
P
, % 9(/ a"V "# E G)
L 0
H6< 5>
9
3/ " +*1 5V/U .+/,
.K
6 A M)
5#, " "# L E "(/
.:*n
0/ GE>0 /
1 &, 5>
5/ A) .E# Ea < 1 H6
$ #
>V
a", P&
>V
.K0&? Q
@6 $
+ A */ G
" , 3% E( A*)U I6
Foscarnet
" 5> : V 9/
A
J A
" )
5 ." #
A)
Y
5( +
6
):(
$ #
U9o/, 8 J :Walter
5 .+
6< 9/ 5. " "
"
% &
, "
HL ^
( "# 7/ @P //
< 0 1 *) ", 6J @8 0
GB)
5#, " !
A I6
O&
# $
M, = =*
6< $% ", ) A& "N A& w& I, I# 9
."<
=
I&
. A
J IF HIV
! a", */,
+
9
&
a", 9 )
9.J 9 !
"
98 , A A
( 9
&
.9
$
1 / $", < &
% A 5*,
.
#/? #.)
9P
= ")
" E# ": G% , 9
"6
A
L a", '
"
.#.)
9P
6< = 9 ) # @) ( E:* E " =P w50(
" ) 9 0
9 , = .@, :
9P Q# >J *
M
$% GWalter
$
5% " $&
" )
A w0
" )
3* G? H6< A E$ .&
A
+*J 3L ? O& G 9:( @ V H
9<&, "0 9
.@& a/& , " H#
( I, " * & 5> A& H*) ", +*1 " /
.K
6 A E& E?> *) ",
6J &
" $J / " ;
. $/& ? 9&
38;
M* K < $ # >V P 6J .E0 AZT + "6V $ # >V " " ) ? !
9P)
5< G5+/, @ +(
"0 ? 5. "
@# $ K8 , 0 6J .#
)
" 7%
J "0
X&
*n 5, *) @8 , A E J '
, I6
+
6, " 78% ", K
8/
.X+
%? *1
.9&
A I& I6
7)
" (
9)*J 9& a9 ebcb 9 K
60 jmcfff A
J
9?^ 3/ # + * 50( A t
'
O& ) CJD A/ (
3
A
J
?&
U
.3
U 9&
A I&
#
" 0
)
A
J (
A
J IF 3* A
J $* 9>
BSE
3
, % 0(
H6< v5&
ebbd 9 *
")*
( J #, w5& oI, A
9&
" 9)*T
"&
M:& #
&
K
60 &#
*
1 **
5> &
" )
.3
U
"/ 3
T
?&
$"n GE# 5% A
J % BSE ?& $", A
J " :*? " 9L
A
.ebbg 9
& gg A
J 9> ebbl 9 lj A
J ebcg 9
& jm " * CJD $/U
5> $//, 1 <
= >
5$1 "
@( CJD " ) Y , >.> K <
M/
J " 7
# O
> Y @
'
, ebcg 9 6 CJD $"0
G06
" )
3*?
."
.)
9&
# " # F "6
"0/
" 6 $/ 9. 5:/ */ $)
#,
$
< H6<
!: /\, "0
, = ( $# 3& ) 8 , A &
3/& 8 , A& .$ *
.#6 , ! ! John Major # "# *
+
, 9&
0^ " "0, +/
$", G$)
A ?
W < GMark Purdy A Y 7(0 % .+/ w& A "
"
1 "& "6
+)
</, Q)
# 50( 3/ "0 9
CJD " O
>
Y
K
60 BSE
organo-phosphate
@8 , " 9L
BSE "
&
$) (
0 $0
9/ ? ) I Y I, # ? e
./:
3/
@ , " I6
7)
! 9/
" K
6
$
BSE " ?& P K
6 = 7)
! 9/ , 50 a"n K
6
j
XK
60 !
, GScrapie B
O$ 7 < 3/
"0 ", 3)
=
"
F/ 0
$0
$ 0( <) I, G, Farben 0( % >
$
)
3&
5.
":0 5$)0
Auschwitz 9$ + #/ / O& G;
+ #/
5
/
Zyclon B
GW
3& E, M)
@/ I6
Sarin 7) "
" Y
3
, L * ($0 3#
(
")*% 5
&
B
5% 0 "
@/
( < OP $/ $ " W <
.$
6
S# " ")*
#
)
E.% A, 0 9/ 8 0
S# =
"
A $
6
a 3& MAFF 6L1 K/1
, ebcf 9
A 30/T 80 OP $/ $ " &/ < E / " K
6 "0 #
)
3/, " *
.=*
P
6< " ) L $0
6
OP +
6< 5 G
)
9P
0 I, 0(
Y
<
H6 >V >01 *
&/
.
6
# M* BSE
?& # " u, %
)
#
# M* "
A
J
5$& t
#
"
" 9 BSE
& @8 , & A
J 5
9
)
+? " 9L
A ( E/ 7) ;
) 1 H6< < & $/
#
=*/ 9
0
6< =
1 , .@/ 9 I6
OP &/
1 H6< "
# 0F
$
)
*? " )
"/ 0
A
5
& I6
@( 7# K
60
9
, M<J
F $&
$) 9
( )
A ") ) $:0
"/ ? "6
"
a"n w5& oI, A .Q1
/ A I&) 0 J
0 #
Op &/ " 0 / #J a9 .;
1 H6
#
" %c a", MAFF 6L1 K/1
& $* % .(@ S/
" jg A,
7) t
Ops &/U 9# .MRL $
)
$/
'/
&
" A, $0 A I&
)U
1 )
%
&
5> "()
"
, $* //, 5 K( . ) G
#
. 5>
#
,
=
MRC $*
O&1 !# <#,
Purdey O&V $P
H6< 9/ $<, ? >0, #,
@ V 7 MRC $*
O&1 !# a"n w5& I
o , A .) U L 8 , O&1 H6< P, "0
* 0&
&
M& % $# 0 " 0, J
.50
I(
! #
A " &
3#" " #
:/
>V
M)
9
< Y
6< S* "
I, +% , F E# "&
" "# ) "*) &
"
? .'(
" &
(
A/, E
, 3/ 5 I, # ? ! &
'( " ,/, , K < !
9
)
" "0 I, $)
$
//F
E
& / $%., 5%, $ 5%, O& * $, #
.'(
0
G+
E > )
V 5
& K
6 50 .$
0( 0
O&
)#
!
" E "<# A ", A
&
50
&
0(
H6< .<6 SV %.)
+
0(
.2
&
-.)
G3/ G)*
8
O& 9
8 , 9L ecff "
6 #
*
O&
$//1
&
A 3#
/ )
@ G<
9$ @ & 3* 3
* 50 # 0
K
6 = .$*
9)
5# E0 E& E
7*)
" &
&
9% / !L "0 70 . &
Q&J A <#, # W: " 9 ",
$)
&
< 0 G
3
)
9
1 5<# 98&
/
5. " F*, "#
3#
X9 " +#0 &
% A "0
&
9P "&( "6
&
?
+*1 $
.!WA L3 )$ :E# */
" J .E/ E?.;/ >01 $:
@ /
#& " &
A 3#
" 5# )
3# 9
M* " 9
!, A ")
"#
</1 5
" :< u
=# 60 $ P
.I(
9/.
/ / ^ < 9, $"V 9+ 9
/ 5#, " * $ ($&
A ) ? F
<# /
H6< % $"J .$ 3/1 !
$ % 3/1 &
" / #, .."
"..A ) I,
!
O&1 H6< $", ) G"/ /
"0
. &
A ", 3# $#
$:0
0
1 a"V , , * " % I, 06 9
+*1 , @ S$
6< ."/ 0 < "/ 6 "0 ", "0 "& A # 61 0 "J"
0 " E 7 &
/
#
/
I
30
$"J ":5% O& G3*
E>V 9<>0,
$
&
H6< ' "0 .
) &
?
& M
6< M* (0
: ) < GM*
"/0
$0 > /
9/
$) " < G( %gf
#
I, ) "LD50" A/
?
5/ A G&
50 E * "0
&
H6< 9 . &
, 7
5
*
Toxin
A
"/0
# "0 G0
@(
6< 9L "0
."
G9#&
G> GE/# ( 5>
9> . # "0
#
" ) %
7
K G( *
5 GI/
&
ej K < .(
$
N /
"
*)
(L
&
3/&) :( 50( W:
H6< 9#
" '
, % .E: #: $;
G &
3# A )
(
$:0
./ E:
&J & *
W: ", ) 6< .?&
" %im "*/
/
5)
& &# % &
a", 5
A F
$ )*% A " ,/, E:
&J < .&&
"0
K " >0, $ :* "0 ?
$*
" , ")
*" (
@0 Hans Ruesch B < 0
S$
0 .$/ @# I,
:"Q0
scopolamine
"?0/
" 9Lj 0 "J .."
&
&, G3 2
&
9)* @8 0
0 : A ", 9/ *
"0 .! $
: A, #
0
5) ", 0 3) " 9 ", (
" K:( "&) 9(
=*/ .!
$
...B#
" 50 - 9/ 0 K/
& J 0 E/ @) G"/J "
oU po I6
"
.(
9/
5)/
H6< G
" $0 = ", 9 L1 =*/ ...
=:(
!
!3)>
5 ",
&
"0 Q, & " .":
**
Q
$ # >/ 3/ G"/
I
<
5$ ^ "& 5 G:1 " ( I6
"/
G+;$
*
9/ )
"..guineapig
&
$#
6;
$", G(.
5% !
"
)
H6< P
# " Galen "
L = .-.)
K
60 $#
$&
$
5)
< (E: ( )*
a", <
/
.$&#
+# ?
=
Q)
`
E?& 9// 9
&
(9
) 86(
)
G$&#
)
(@ ,) 9>#
" 9)
+/ G*, p 9
E &
A Galen "
L 3#
", 9)
P
"0 70 0
7(0 ) ( =/
"
@ P
, GI6
9)
9a
5< 6<
? $ A I(
K./.
M/1 &*
1 +/V :% .0
=
:E&? /
1 &
A
" @ 0 (3
1) Eraldin "
,
.ebme 9 * A(/
A
J
( 7
, :/ " 5 (9
1 5%) Paracetamol 5/
.% W: = $0
E, 3a/ Orabilex !0,
(")
/ 9J) 5 #
3a/ (9
*; Y?
) MEL/ 29 jb / 5
, 5
5. " G
& idd " 5 ? A
J % * * 3/ (9o ) Methaqualone "
0>
./: 50( & ?
.5* 7?^ ( @( 3/ ("v0/U poU) Thalidomide
. /
& :/ 7?^ >.> 3/ (
+) Isoproterenol 5 /
."/
;
+/
Q
"*/ 3/ (/
"*/) Stilboestrol 5/ 5/
./ 0 3
3/ ($//&
) Trilergan "L
.HF;
J a9 A& / 50
& 7
, 3/ (I0/
) Flamamil 5.
.+)1
0
, "*/
3/ 3/ (5/
0
) Atromids !,
.*$/ # " 3/ (poU) Valium 9
.
)
#
3
A * E, / (&
.;
5*1 " >0
% (:$) Pronap & Plaxin "/0. 3
.+&
9
0 A0
* E, 3/ (9
1 5%) Phenacetin "/
.9
, 3/ (9
1 5%) Amydopyrine ",
.5*2
E 3/ (">L) Marzine "
#
"
&
!0
t
"*/
* " (9
*; Y? ) Reserpine " /
.,
+>1
. -< 0
3/ Phenolphthalein (po) "
>
. 5( A 3/ (5/`
) Clioquinol 5 00
.( 9 +)1 7 3/ (0
9
) Mehtotrexate /0>
.9P)
((< ":
0
"*/ 3/ (9
) Urethane ">
.0
E, 3/ (9
) Mitotane "
.0
0
E, 3/ ("*/
) Cyclophosphamide /0/
.0
E 3/ (5/
) Isoniazid /,
.0
9
3/ (5/
) Kanamycin "/ 0
.
$
1 9
3/ (:
) Chloromycetin "/0
."*/ ?
<$( 3/ (# =
) DES
.?
<$( 3/ (">;
) Debendox !0
.0
9
3/ (3(
o3&
) Accutane "0
M* " &
>&
G*
$*
" )
5
9
a"V &
'( A ":
a .."
! P,
&
'( /
3#
/ "(/ 7/ . &
'( "
5:/
.'
V/ < K
6 A >1 Q&J . &
'( 5 "
% %$/
3#
P,
W:
5/
0
5)/
GI#
5*1 5( 5> * "
I(
! #
0<,
1 " )
$", '&
The
""&
&
" 5 > $% K < .."
"//
" :(
&
G$(
M1 9 6/,
50 ( 7
0
) Q
5% . &
" = @8 V @+ 50 Schenkel 50 ( */ GM:&
H6< CIVIS 8P (0
:SPCAs $//
"&
& #
F
"..+( 0 ) 5) ", 0 / '
5 - <
& $", .."
P 0& =# =/ 50( ( 5 G3/&
? AV P A
J 3/
//
/
H6<
"/ RSPCA "&
,
0
)#
+1 " 0 ", & (/? "0 ."&
M&
.( * E# ) ) 3.0
)/? "?;
3
)>
5% &. A
J G
< " &
A 1 51 "" @8 , < &
'( A ":
)
>
#&
,
9)
9
8
) >01 *
J ." &
, 90
*, J": & )
) E (
A 1 50 9 @ , & < @ S
" ") I6
1 , .>
:
9
.@ ,
) " "0 E
L &
A #
E. /
I
)
9$
" I +# 8 V 5
")/ $)
G &
'( % $
" 6
9 E# 9 _ 50( % "#$#D" I, 5
M*
", < =
6
3/1 &, .M.* AE(
GE# > # y M( ^ Y
# '(
)
8P
A "n GK
6
.
/ 3)
I6
"?.
" 5 A
J G+( 0 ".
5) 90&
0 O& (9. 5:/)# Y %J 5:/ K
. / A "s
"0
>F M,
? 0 5)
H6< =# G(
@
*
" G &
A 3#
W:
A ) ($&
L 8% >0, )) $&
9P #n
M .2
&
#.)
$&
3/1 E, 7(0 "
O
9P
6< M @8 J "
6< 0& ;/
A 5
& ", "0 G, 1 /# */
/ #
) 0(
& :
H 6<
:7(0 #&
:
. &
A 3#
/
"
) H 6< G@&* I6
+
5
&
5
3/ ,
Q, 3
/, " <L G*
H6 .M/
&*
1 +*, W: #
)
1 "
3
"0 G5& #J A $&
#&
G
G=#, 9
)
&
A "s
";/
+?F< G//
.
& & =# $*
9P 58 9, < 5&
D$
38
< =:(
/ GCannabis (B(&
) 38
$
K < M:&
7& + F 0, Q&J
"
L "/:
"(8(&
Q
5$
"8
, < 9
H6< " @) 50 .MARIJUANA #
6<
9
/0 9
H6< .
> (
& "
H6< " 9% " "6
B&,
@ 0 G)*
% @:V G@: 0 (& , I0 / I, 38* ?
H6<
.!*
:
O& " M*
. =V 6
" Y/, G1 '*/ A E
Y/, )
.1 @# A ^
I, " 50
"
A, 8
" #/
6
: ) G//1 &
"<
A, ) 38
6 ", < G> 7(0 A
J EF 5$
9%
50( 5/0
" "(
7P A 5) , O& G
/
E# &
"<
) .&
'
G!(
)(1 $) 0/. , "$ 1 :/ ) #
)
=# .)*
0/
3/
G9/#
5/
0
90 A
J IF saturated fats )(
"<
" ,/,
&
.) ?& " <L
9&(
/ "0 O& G0 0
0&
0 9/ ", 38
6 " W
"0
.*
" #/
38
7
, E/ Model-T " 5" (
/
A G(/
0( !/F) I <
/ % 6< .3
&
" () >0,
% 5$& 0 ./
50< # A $
"0 I6
38
% A 5) 0
% <
/
H6<.9
O&
" #
J GPopular Mechanics "!0 0 ?" # )# G&
H6< %
0
.@ )/ Y K
.9ebic 9)
" *( (
"!..
$
.." V 38
!X5&1 $; 70
/
M
u
38
# 5)/ ", 9L .E / ?
"
>
.:)
#
H6< =#
"&. 6
"N 5< ."<
=
A */
" 9, " / 1 ", < M
"0
G>0,
.>0 K
6 " 0, 5 G " :/
B(&
A +% $# /
V/
.X38
7
, ?J G&
?
:6;
0
9L
A
J O&, *
..
:6;
9 % 9
6L1 ", 9< " ; "01 "1
H6< 3/, A
J @) 5
?& &
50( @
" = B% , 0 .
&
)* 9 " !
*; , G>
, G
A
J J ) 3/
.3/, " @
A * ^ 3(
9)*
"0 G50(
.3(
9)*
@ J ... G9% $ "0
.9)*
+( IV W$#& @ J ...#
, G#
, G5)
G9 50 (&
" 5* 9/ 01
", Gebcg 9 .> " .6;
>^
A
J :0
H6< IF ."0/
" (.* , , , .# "0, +/)
( 50
I0 J 5* l,g 5) I,
$$"
, $) #
0 Q
&
B1, Vit.. C, K+
A& G9
,
"/1
!/& G3
"0
(
*JADD
"
*
5
Q
"0/
)D"
A
J I(
:6;
9P
A 0/
5 Q, 70 30
6< ,
.
A
J */ 0/
IF
G
(
0 " G
/ " :
3*
30 Gebge 9 .K
6 ) :, P O&
<
"V % A
J
3 1 A @# )
/ . 5
.5*1 5( " :6;
&
: " ) 0
G eblbzlc " 5*1 5( + ( 5. .5*1 5(
>0, ":0
5)# 9)*
0/
" >0
@ &
)*1 , 0
0/
9
*, 9)*J = A +N & 5(, *& A 0
P
9 .&
7&
@6& ( 0 .(?000
) ;
(
, G00/
, (90 !,)P
0
G "
/ &" ) eblb 9 G
& jlfj
(
0 5(
J "0 Geblc
.1 Q/ A 5*1 5(
0 Y (
K ", = .
& jel A
J 5)
Y IF 5< X?
K 0/
K./ 5) = 5(
5) M ",
# 0 5<
3/, K < "0
G
K# / A
J 5
K 0 X5*1 5(
"/& A
J :6;
P 1 " 0/
American ""( 50 0 7, 5 # "0, "# @( .
0/
K./ "V )
G5
5/)
0/
0
0;
" W
0/
" 9L : ", Journal of Clinical Nutrition
P
6< / % .0
Y.? +
0
. )/ P& /
.0/
5 ) / !
<, K
6
) ? % .0/
5 #
P
"
Q1 /
" )
K <
9P
3 3/ G 91 Q A K
6 / 6J G "0
. / A 0/
5
0/
"1 .K
6 I ", "
L G )* Y , 0 A
J zs , 50( 5/ 0/
", < 0(
.K/#
/
0/
" 5* egf A */ u
01 K/ . M/1 @) 9 9)* 50 A
J 7
>0, < .A 9 eff 6 K/ "0 ( =V >0, < !(5* jff A
J M<
K./ 5
% )
.@& /#, =*/ >0
):(
3&
# >0, I& .3&
A I& *J 5>
5/ A 6V / G0/
>N Q "
K./? A
J +6;
0/
" 0 / # IF .0/ 50( A &
" %gf A 5*2
G1 6< = ., "M6
!/&" M6
K
5) = .9/#
K
#
" .0/
"
n K
6 9 ."( >0," @)#
9)*
0 A
J >0, #&
P
0 !0 A
J 5*
5
O& .0, 50( M6
H 6< G9/#
@/ K
K./
.5
6< A
&
/ .@
3&
M* M 0/
" 0
",
!
@ J :( 5 &
+0
9
5 Fighting the Food Giants "+6;
Y
" @0
0/
K./ ", 7(0 " 5, 9< 6L1 # "J .0/
" 0 0 A 5*2
3&
I&
G0/
;
3&
M/ G+?F< "0
.M6
A
J H IF I6
GK
#
A
J IF
H*n
* #
'
;
@*
=/ 9
+N " " .9# A " " Y M "
X5$
? .E& #*
5 G#
? G8)
!
.#*
@0
" 5
& ", 5 G&
5 L 6J
0/
" 5, < M)
*% 5/)
0 0/
" )*
50(1 "V 9< ? "0
GK < < 5/)
" 5
!V
"1 P .fructose 0
A/ 50( @0
0/
# .H
"0 0/ < 0/
"J .0
(0/
) 9)*
0/ " 7 50( 9/#
@) 5) Gmonosaccharide "0/
& )* 0/ < 0
@
0/
" ) ? " '
, I6
:# 50( 0
0/
" 50( K < ."0/
" H# 9 I6
" #
:6;
"J .(E.> 3 )
!) I)
!
<
./ ) 0 "0
50(
.0/
A :& / 5 /& M G!
(
)
" HL))*
0
&
! 6
( 50 ", " .(9/
50) "
> +6L" @ , A
L
. 1 3& M/ 9
GK
6 = .+*1 ) A& " )
@
% 9 < "..9P)
(( 3
/ G3&
3( 9
"J.." .@#&
< 1 3& 5 " >0 "J .1 3& 5 A
J Q) =#
):(
&
50(
" >0
", "
.1 " Q)
?& 3/
/:
5)
, &,
50(
V/ 5&
*/ z "
1 # )/ A0 G"5*1 Q
"61
" @0 ( . @
# &
"61 7 1
"
. Q
Q
+N H6
"0 .5*1 "61 3
0
"0
.&# 50( "61 +(L 3 , Y < & ;
"
. "
A
0 "0 . z
" 5*1 +?F< Y, >.> "0" :#
0 ."
1 )/ & A
J =#
YJ 9 G&#
Y
5%
." 3 1 " + ;/?
30
&, .Y
6< 5& )
" 0 0 # 7(0 7/ O&1 ) &, 9% 6J
.ebej 9 6 K 0 ".0 "
G"# " @
F
"6;
p"
6
."3&
## A ") 0 "6
5*2
7
A
J /
0/, K . (
/
Q, >0
G+)1 7 G
G
!/
G"61 "
G//& " < 5*1 Q
50(
"
."5*1 I0/ G
;
GA0
$ $
6;
9P A
J 5&
" G1 '*/ A 5*, &
"/ &
: >0, K < !
.."
$7$A 6A
"..
9
*; 5%, 3/ ") "
", " G
"
" ()
A
J )
/
" (< "J
50( / @
9
*; Q/ =
# A
J 9&
J ", A
J /
) ( G=%
.9<L "
">0
G & YJ .#
9)*
' 0 M) : A
J
&
>^ 5
.P&
.+
#&
" "& 9
*; Y A "
:7) ", K % ."#
"
$1 )
" " 6 <
.%e :3&
" 0, # /
(&
>N :
/
.%l :
" 0, # /
(&
>N :
/
.%ji : "
1 # " 0, # /
(&
>N :
/
.%gg :9&
" 0, # /
(&
>N :
/
?
3& O " ig 9&
"
.
1 3& 3/
(&
O
.9&
"
.
&
) % 9&
: ", 5 U.S.D.A. 01
: @ "J
: . . .
"/0
/
:0
" < " 0V
9
':6
:
/
.(0.00004%) ". ( 50
), " 5%,
D
G 0/ " < 1 "J ."/ 9/# +
I&
"/ ? 9
3*
")
5?"
) G:/
3*
")
."B*)
" |
9/#
" " )
@0 5
Y
6< S( I6
G-; .7 0
< G"
6<
:
#
+
<, " 7(0
G06
30
* ) 06
? ", "0
."/ 9/#
"" +
", 9) =#
. '"$ A )$ c# A 9 $" #$# .."
"..9)*
"
@#& 9/#
M 9
6J O& 6 7) &, ? .1 " 9/#
+. @<, Q K &,
)
(
"V 7
V
? < G*
)#
0
A 6&/ >0 0 V* K < .."
G+
A I& (
K ", '&
.
)*
+
" 3)
9/#
5, < 5&0
I(
"0 I6
+
" 9/#
+
*& " Q, 0 "
A
J J G@ 6
",
?& 5. 9/#
+
5) !%
3*
"
" = 3/ .I/
3*
/ A >, I6
//1 V*
5> 6< "J .) L "0
"..I(
9/#
/:
1 " )
*/ : -. 9 , :% +#J +*J "
", ?J ."
" 9/#
&
= P , "0 O& +
9/#
3# G.)
H6< P .."
V*
6 M) 9 I, 9
!
=*
.:0 0 9/ .)
H6< 0/J 9 ", ") 3*
*
+#, ) B* A (F " < +
= P " #
.)
H6< "J .0
=:(
_* 50( 9 #. / G@/ +
.)
H6<
J "0 G
.9/#
( 7# 9/#
"..1 P 1 5& 9 #
& A
J P A& # :0 # 9/
. " 0( 0 6J K
6 " >0, G +
" 30, efzc 3( -; 0
'
-$!
" )
) ", " )
5& "& .F 9. 5:/ =:( 50( G (
, G7
1 P
"
.# &
A P&
< < 7
1 ;
3&
", "
)
" /& G#& ?
+(1
0 ! . "0
.Q1 ?&
" 3
, G"
0
, 50( A >V 7
1
",
. P&? .J 5:% A <#, O&, A ) H "0 .#
&
9</ 7
1 ", 0 S* " 5,
.3
, "
0
"*/0 3;
(
>&
1 9P) ") ? 5:
, ", 0
):(
1 ! /
, G;
9)*
3;
A
J %1 5 G5
@ , =
.3;
)
G
L V 7
1 ;
)*1 7
.0
" 5 ? 5*2
7
1 "J
&
//1 6;
0 =# G5>
5/ A '
6V
.//1 <
&1 )
"&* 9 (6;
L V 9
6 )
)'
& , A 5
50( &
Y .endosperm
" A
J IF 0
"&*
- <0 9> 0
&
"&* "J ."&*
A 5
&
Q, &
" lc G
0
" cb GK
" mc G90
" lf G ;
" cd G9 ;
" cg :
:
3/
//1 3/
"0 < .6;
#
A
J 0
6L1 " @
G0/
.0 &
P&
#
9/
.7
1 "
A I&
IF ", "0 :
"1 G, 50( 3/ ", "0
"n G0
;
7
1 ", 0
. !
G7
1
< !
3L, 0(
GK
6 " 9L
"0
.
- :6;
'(
@0
06 7
1 ;
6L1 " .()
&
>
"
6 .5* " 6 9
)
":
)
A ) :6L W " " #
:
)
7
9/ 6J
)
>^ ) A
J G"/ # . G0
G" 5>, " ">&
" 5
G
G"/ 6; //, 0 9 ",
)
"0 @ , +?F< / . :6L 9P " +#0
. )
)
"<
0
:6;
9 GK
6 A
J .
#
5%
9
0
.
" 7?N : M.*J < 1 . 1 L "0 #*
@0
", 0
A %*
- G9/#
#/ , & :6;
5&
G+6;
9
)
//, J 9/#
"
."*/
*> 5 A I& G-*
S
( 0 G"
(% & # / +
Limonene ""
"
", >
.
&
) , 0 G"*/
" # A
J GC " ellagic acid #. &
= GS
"6
7
1
.@ A P& 9/#
$* ", "0 G?0
)
)
A I&
!0
G
0 G(:&
#(
M, A (&
< ) "
$"
" #
. & %* 9/#
A
J 3
?
J 9</ ! 1 0
" > "0 .K/ @)
I6
)
& 7) K V , I#
)
A -*
)
G5*
"
:
/ 9 #
:
)
" >0
", 0 . " <L 8&
0/
" H
.:6;
% ", "0
" G:
)
9/ ( / " " %
J 5#, " K
6 G
, &
)
A "0 "J
" &
, =
E
(
...
G
#.)
9P
& 9 G0.."# 0
I
%? B&
5% " E80 "0 " /0 9<"
3&
//F
01 W<
) 9
-.)
5:/
) >V Q / A
J G
K :/
. #. " =
G5
: # 5& &
M/1 =# A @*/ */ 5 / !
0 7< "0
.9
*
"
/
*
"*
" M( 0
*
1 G0
/0 9<,
:
" (jj) &
5 G" 0 &
?
*
9)
" " ) "0 /0 @% I6
,
".5L1 " "N "6)(
, Y(
" "
")0/
<h+*J "0 ? *
!
? "J"
#.)
9:/ 0
A& G#
)
3<6
" "#
"#
)
A (
+J 9 K
6
)
.(#
A
J "
%
<, Q M%
< @ !& , 3 ") 3# GE
"N "" :5
/0 50
."(
H6<
A
J 9 0 7
G /0 )
H6 5) ", !; 0
% .5)
5
& 6<
J < 9 .(5
5#
9
Y
? ... $&
*
9P
"//
5) 70 9) )#)." *
& 5#, "" , ")
&
5#, "": 5> 0 " )
0
G<#
&
/0)
"
..""*
6< *, % .01 *
&? > G
H6< A
J "
<, M% 3*
!& I6
3
,
..
#. 3/, , * 5 I, = ,
9<
# G9eclm 9)
V( , / L
//F " &
G06
*
&? 6< ,
M/
< +*1 +?F< 5 "0 G
0(
5% "
(
) %)
-. * ") +*,
#.)
3
/1 5
:/ 5. +?F< 5 70
", 90 0 .0(
K #
W
.9*
0 ."(
"#
)
" >0
" 5)
&/ #
"
*
!
" >0
L,
.!K ? # " E>0 7 ? & #
9)
cg < '
,
) .(9ebfd 9) 0, 0 edf *
!
"0 G /0 5% )
" E?F/ 3)>
'
, ", ) 5
& ", )% 6 .(9ebll) 9)
/ dg A
J )
9> .(9ebjf)
.!X##
G % L * 6)( ) A
#
) )
1 9/ ? #. 9P I, '
, G!; 0
% )"
."> !/, I, A / ? 1 Ga
) " P,
, :0
#.)
,
*
9)
) )
# 5
*
!
=# u 9 %
E?& 7% ", !
H6< " 3* G L Q, #. " <L , 3(1 -.)
, Homeopathy >
Y
9
"0
G
!
) .E % /& 9 ?J
L
H6< ! "
.(L, !
" >0
) #
=
6
./
9. = ")
$9 K
6 50 ....<L Sience
M&
!"/ &
E.) "
"
1 "#
)
" :
&. 9 G
*
)
5. G
K 6
#/ +?F< M&
...+)# / 9<? " >0, 5
"V ? "6
..."&
3&
,
# +# I6
"
6< ..E %
8 L 5:/ A
-. < &
9# "& "#0
..."#
< "
"0& 5# 5% " 9 9< a ..F
..5
5# 5% " "
"a
5#
G& 50 G
9. 5:/ A P S G@/ %
:#
':
+ >
9 5 XX! "/ < &
9< 1 9 V <#
") ..9.P
5#
...<#
9
M
..."(
9<
" ...s0
A 5
&
J. W. Hodge -< .. 5% " @ $9 % "*
:
" 0&? * " ^
:
8
8
6< +# .K G
L " 3*
H0
EF
0&? >0, /
< GAMA 01 *
&? / /
G*
0&? * $"J.."
#.)
5:/
$"J .
)
"
I, &1 " 3)( "F( ", "0 E* E#) <>0, 5 *
01 *
& ";
5% " 7 ) #U "0 7/ )* */ ^ 3
/, 9/
7/ *
& = 7
& ? 3* 50 $"J .9s A
J 5
5&? Y
7
A
J "F# "6
AMA
( ", I6
$&
9
50 $"J .!
& 6< +*, 5% " $U * 5$# @ 0 98U
E % @&. A
J 3*
)/ 9/ "<( G" S# 50( @ O& "
)
+*1 +?F<
"..E
L ">
= O&
>V $%
) 5& I$# 50( 5F/
, G=
* Q E, K 9)
'
, G5& \50 A
A &
"0
G#
6< 5% 5* % 9L G/
>V
)
1 H6<
.5& I,
&
<
GPasteur / 9
)
)
"9>#
P " A (I)
) I
+
5#
*
A
@8 , O& G"
+*2
/
5/ O& "
& ) .
% 9 "
GP
H6< & .(
... #
"*/ G:
"*/ G>8
3
? G")
3
G"61 3
) :5> G P
G(&# ) )*% 3# O&
9/# $ L 50( 91 , 9>#
G) L 3/1
*/ 5&
!
$9 GI
*
-6
6< .
"
8
K
6 (+) / , ()(1) %&
50( K
6 5) 9 9 GE//, Q)
$/# 6
6
/:
3/
9$
& , .:0 0 0 3
/,
"0
.1 J 9 1 )
)/
< G9
=
G?&
H6
&
#6
5&
.I#
5& E E, S% O& Antoine Beauchamp 3( " AU I6
Pasteur / 9
)
) 9
K <
.? 9, P 7/
"0 "J %J E//, E 3) @: 9
)* $", )(
5&/ 0
/ !
5)
G:0
5)
GI&
, #
5)
G:
)
& <
5)
7(0 5
3*
,
P '/ H I6
GH/# "$) %* 5# 7)J A
J IF
(7*)
!/&1 G?) ? G/
#
%*
P , =# A 3# G# &
& A P&
5#, " .)
*
K
&
&
9
& A
J H6< %*
5& "
9 ", O& G"? "
"
& "0 ", 9/#
7?^ 6 9
6< A
"
+*1 5
. J $9 9
6J
50(
6 7/
.@ ? )# #. 5:/ 0 &# O& G" /
, 0 A 5) 0
( L) % # 50( A (%)
) $/ 9/ I
3*
$"J
5 .
+( " 5F/
0 A
J ( ? 8 , 0
3/, A
J ( ? *
H6< $"J .
*
!0 A 5) @/ %
G%F 50( G5
, +
#
<P
+n 9
+
6< 9/ 9
& 58> '
% * >0,
& & "0 "0
G# " P
K
6 9/#
E
.
&
3*
.
A 0
" E? 6 &
&
A 0 8 , < I
3*
* ;> Q&J
&
/
G:
%*
"
( I, Gholistic (80) 50(
/
P
# 7. " * < 5
3*
I
3*
" &
M
"V $"P %
@0 G
6 @
** $ 98P W K < # &
"0
.)*
, 1 V( 5
L 5 -. 50 " &
=% 7 K
6 GI
*
9P
A ":
= ")
)
1
0(
X3 .. < 0
5F/
.!
$) " HP, I)
Q/ !
< E A( I6
!1 -.)
"
E* 9
J / ) ", !
" 98 1
", O& E
% I# G* &*/ (< 50( @
& "/& $9 I6
, .9
/
? E)* .!:* E?, /
3*
*, A $ (+
+( O&) *
# )
@
O& GY
B;
M&/ 1 E& @ J .!A
" ".
: )
H6< 5( ", ) ?J
3)/ 90 0
.!
M < /
3*
//F #
S1 ",
.
&
3/, E 5<# G* %F $&
-
$ A
J I
3*
5 W 7
H6< $"J .
" :(
*
# 3*
)
$0
" 0
W
6< 9$
..
)
..!9 9
9,
.. 9, < 0 , "J ..*/ & )
K/J +
H#? 5. " +( I, =/ , Q "
K8 n GQ, : > I, , (E.> L
0) "#)
1" !0 A
H6< * ", =*/ K8 , 8?J GK
6 A "
& 0
O.>
", O& G < 06
#.)
L " 9.`
:/
#.)
H6< ) G A
)% 30
A
J 5
3*
5
8#
" )
, O
> 7* #
#&
" 5
* "0 L, $", 8?J G9 9
J
#, 3*
50( &
1 K
A&)
$)
#.)
" )
.&
@8 0
5<6 +(
@8 J ./ * %
.K$&
F/ 5$& K/ 7> * K 3# G5
* "0 */ Q/ /
< ((
+ 5> "*/
-. # >,
9
/
#.)
" >0
# < *
s8
A ^ 5>
.) $/0 $ # >V @
!
5%1 A ebjj 9 6 E/ "0 Essiac K/J
5
&
/
$) #. 8 , A / $%
#.)
)
)# < $"J
7
J $9 7/ M$
%
3/ K
6 50? " ) :
H6< $"J . 0
)/1 */V E
L
.5$
50( #.)
H6<
$DD")! 6D D
4/
$")! 8
Hyperbaric Oxyhen Therapy (HBOT)
H6< .&
"#/01 " & 6
'/ O& / @( 9P , 3 "#/01 6 30 50( "0
" O1 "#/01 " 6 M.*J "0 #. L1 .O1 () &, 6 9/ M* 6
" 6 H2O +
*)
K0 I6
H2O2 ("#/01 +) hydrogen peroxide I/0
"#
.O1
"#/01 A
J GO2 I
"#/01 *)
O3 "1 K0 E, K
6 "0 0 G O1 "#/01
30
(5*) , 5) /01 ) 9
w5 50( 5 8 n 9/#
O1 & "#/0, 6 M.*J $9
.) :E.>
.
A
J (
...L G0
) 5> 3L ;
:0
:#
#
%*
" >0 >0, #. % K O1
"#/01 #
)
%*
$"J ("*/
. O2 I
"#/01
,$")
$
$&
Hydrogen Peroxide ("#/01 +)
(1 "0
I/0
"#
9<$ ", "0
" O&
9 3# G(> )*, )
5&
>
$9 6J (< W: 9 ", I/0
"#
" %ig
"0 G0 50( E0 "0 6J @ , O& G)*
, (E.> */
91 () ;
"& 50( E @
"0 @8 , 0 .0& 06 * /
.:. * @ $9 6J 9
M* " @
E, "0 .9
Q# A
J (
*/
? ":
A U
3#
$"V ")
O&1 3*
5# E# ")*
">&
9P) $"n =*
&
( Q
= &
":
A
3#
$"J ."/ A U
3#
= "0
5% " $9 3#
=# $"n K
6 5#1 ."/ M8) & W: , $* - /? * $9
@#
" )
50 ) 5 W "0
9< GE &, 0& ?0 = ")
0&? *
//F
.( * # < 9<, ) M
)
) M%
O&
("./ "
( <) Linus Pauling u
!
Ralph Moss ! 7
9%
0&? //F
H6< $", ' 50( >, $ % 0&? *
//F
5% "
O&1 /
5% "
$
O&
# )
<
%
$"J .H H# I, O&1 W: 7& A %
$&
8P
G$*
)#
G3*
! =# $"J . */, Q/ /
< 0&? //F
*/
)
G*
0&? //F
5% " 0
9.
8P & 5) 0&
.(
!
O3 Ozone
5
",
/ =*/ 6
H6< Q&J G) = 8 * "#/01 " 6 O.> " 380 "1 $"J
) 9
"#/01 6 =*/ /01 5. " .O1 "#/0, 6 O2 I)
"#/01 50(
I6
"#/01 0
< 3/
G@
" A
1 $
) * 6< O& %F !/&J @8 J G 1 +
;
E/0F 9/#
. M, A
J G50 50( G"1 5/ 7/ E 1 +
5 "J .t
5
.9/#
%
V$
1 / $
# 5 ? E( E( 0 +
, E.* 0 I#
K
, I6
!
$"V
V# %
H6< $* %
K# $"J .(I
)
% E.>
)
)
) 9/#
M, V$
" $0 )
O3
! .$ .
9/ M* G / df " >01
, / GM*
9%, Q&J .E$* M* "1 M* "0
9/# A
J @J 9> "1 H 9
"
e/j 3&/ A
H6< ) G(Autohemotherapy 6
9
#
))
= # 5
5)# < $: #$ ."1 $
*
A
8 0
$) * 8 J G
Y6
A
J 3 1 9
) 9> "1 H $9
#
Y6 " 9
- O&
3/,
E 3/ % *
H6 9
$", 8?J G"1 " 0, $0 A
5
& *
H6 .
Q1
$", 06 ."( 6& +* "1 "& $9 O& G 1 "&
< :: #$ .+&
9
. (L1
+
!0 A 9
Q# =% 50( ? 9
36 "#/01 $"J ."#/0, 6 O.> " "$0 "1
M*
" 50 "0
.*
H6< " "1 -.)
9P) ."#
" %cf "#/0, " "$0
.<L A "6
F
/
? "
, K < "0
.E:* >01 ) 66
&1 "
."
1 " Y/1 ) 66
#/
"
E
, ) :
Y)( M 66
", G+&
& #/
M $)(1 < G$#
")
Q
.6 &
" /0)
, >)
:
#
H6< A 7$)
A
", +)
5
5& I6
+
3/ 1 ")
+
E.> +
", 5 Q, * . *&
+(1
7)
6< "0
. @0 G
1 +
6<
J $ 9> " G@/0) G
1 "
"
1 =#
.1 /
# M:& " P
/
E&*/ E*/ ) @ , ?J GE> @ , 9L G"
2
,
.t
$/# < 5 ")
* !
# "
1 ", P
@ 38;
*(
), 3* E# E/( "0 G("K.
L" PCP) * $ " # 5 % "
A 7
# 98*& "0 G"P
9# S A& K < 9, " , ", O
@ 0
G0
A
J H%
H6< 5)# I6
"0
. H #/ ( 9jj ) &/ ;
L A
J H% @ */
" 0 9<&, !,
) "0
G7 ) "#
A 3 "
,
.=%
<
" * 0 # ", < <L "
"..9: @( 1 A E/ "0 % ( / 5. G+ E/
# "0 M:% /
W:
>, GI< "
6 9<) G(
7 )
"
+ #/ A 3#
" >0
I#, %
A "
1 >V u ", "0 5< !9 +<
& )
? 5/ "0/
A # % @
"
6< ",
; O&J A
"
1 ", A
J 5
9 !>0 K
6 " >0, K < @ , .!X #
H6< A
J
(
.E, 9/#
#
)%
"
1 6 :/? K/1 ", E.> P&. .&
:0
"
#6 "
2
;
:0
.!/1 6< A ) = 5) G)
) 9/#, A "
1 K M/ = *
E# //& <
5:/ 5& (n0 /#, A #
"
1 -6 )/ 70 IL 50( 7) &
=# K
60
50( ) 3# 5
5:/
K 5&
9/ ? Q1 &
K GQ, &
? $&T ", "0 . G>V
H6< A ") / , ) ", 5$ "% (0 "& , .IL 00,
L 0, = K& A 5) O& "
1 " "$) W F ) $) +(, 5) A E)(
.XIJ ? 50( "
2
>V
= ", "0 5< XK
60 "& 5< , ... /#,
3/ I6
!X( & P&? ", $# $) , A
J 36# ? , *. A EJ? 5#
$& ", "0 5<
+
./, ", 5) 5< .X-
E)/ * W#V 3/ *;
Y " W
9
"# < &? 6<
%
" 6 +/
" H(
&, 9/? =/
( ? !X
<P
H6< P&?
(0 % GEF ?J <P
H6< ">&
P&. 9
!EJ? 5#
;
K K& "
.& "
V ( %.
"/ L 5), " >0
% G9/#
. & 7)
& 3/ % <
"
$)
" )/ # ", A #: 8
3#
5 GM, "
(
) " < G
&
H6
+ # O&
6< "0
./ 7
9
", < <
Y 3;
1 "0
.<
"
<6 /
%*
<) )/ +?
&
!E//, <
"
KJ ")*/ ? 9 , I, !"
1 A " " ) "6
+ #/
A "80/
>V
!
"
, / % G "
, 6 +, & (
":
" E?#, ">&
V( , 3#
":
G*(
7. A
J Q, "
1 7. ", 0 . # /#, $) +, &
" .& >01 0 &1 +
& (
K .& E*( \5% 0 1 +
& (
&, +
5*,
$)
.< $ >F 3
&*
5> % :0 A &, +
E* E*/ ", E,
!":
Q/ = *
-
= K$&
" "N " Y/, 9) "0 &, + */ & ") "6
"
!
+)
=#, % .0 50( 5
9 9
, +, 9+0 "0
5)
*(
( / ; A
@
&1 "
", A G.
H6< #,
? 5. " "01
", & A
J ' 50( ( :0
A
:
>10 G / &
5# 5$) -.)0 "
1 9/ 0J
M1 &1
9/ G * G )# ;
9
/ " ">& 9% G9ebbm 9)
", (0 .58
" #)
(
A
9
&
G&
@
& -#
*( A <>V )
."
A Q6;
(&
A 5) M1 -#
" 9
+
<8
+0
"
'
3> + " < I#
-. / G )
K
6
3)(
O 7) "0
$* #. W " E;
~+# 5> -.)
/
H6< ", . & E?) E#. )U "0 G"
I<
"
1 9/ "0 G / jgff 5% B I6
OL> "V 06 .
5&
Q&J E:/ "0
O& G $
?
/ V G"
5>
&
" E) "0 .-.)
.%
" &
G@ , @ 3/& 50 G=#
H6< ") A
"0
#
1 0 >V
"1 ", & O&
3*
5# E 7
V '
V G
)
6< G9
,
bilirubin "
Q/ Y ) "
"
& -. @
) M1 "
>, % .9 50(
.(?
>& 5*1
F </ 0J O&
$*
5#
"
1
) Q A #,
O&1 " >0
K <
+&J J 5 G# /
< (0? /
H6< ", < Y
9
F
1 "0
)
#.)
5:/
.E 0
G>& G% 9
M %*
>V G9ecmm 9)
7(0 ", ) .K
" "$ $ 9
)
"0 "
1 -.)
5# :
9:
=/ +
>V 9/ 0J ""/ " ! G0
*( A !(
)(, "
/
#/
H/ !/, G9ecbd 9)
GI#
" #
3
580( " &
&1 +
9/ .S#
."
1 */ \5/
+ -.)
("L 0 "/ ) "N @/) "+
)"
9)
9
)
- I6
6$ $
A 01 9
)
0 #.)
% "
1
>&
/
(,
9< O& "
2
E# E/& ", "0 .""
1 +
p" " ) I6
=:
@0 9ecmc
G
$/#
"
1 / 9% . :0
#
+# >V -.)
#)
.
9
I
I0
"
1 >V 5 (0 A
J 5
G@0
"0 G5
1 I
G5#
6< .$F.'
7$ "0 #.)
% "
1 5# ": >/? ">&
,
5#
6< "0 .Y @ 0 A G GE# 78> G$* G$& G# '
G! GE
GE*
.(
P <,
# W: - G<L # ?# O& G&
50 " E: >/
" 0 # M* # < Spectro-Chrome "90 0/" 7) "0 0 " @
J 5
9<,
01 9
)
O&V 9< @ , ?J GE* "0 @ , 9L .1 " >0 Y , -. 5) 50( 9/
"
1
#.)
5:/
Q&J M* A @% < 5#
6< >0, E @)# I6
."
1
6$ $
A
51
& O& #. " I
3*
#
A
+/
Q&J A @0 <06
I ! "
+ +% ## " ) </# A "
1 Q&J */ 5. " & 6 , .
7D$ , G
-. * "
1 9/ ?. " @& I6
: >/? # 6< ) .("/0
A 5)
P </
>
@P <) - .#.)
"
1 >V
. ! 9 ji O& &
9<? K
60 E< " F "6
"
+*1 " # 9, 3#
9 &
S . / `
.
A& , +1 G#/ 1
& , P 5
:0 5& 9/
#1 " )
K <
@ 3L L ":0 I, '0 , /
.
+( )
# "0 :0
5&
H6< .9/#
/
" 5
$"J .^ A
J & " # bf 50 $;U /* ; 5& E, # :0 5& # >& .()
/? G#
50( G
$", 8?J -.)
" Y
6< E E 3) /* ;
5&
:0
5&
9<? )
A E) -.)
5( , S# " M
&
E0 E 3) )# 80 G
....
*%
.&
)
H6< %
" )
Y + 5#/ Nicola Tesla ./ ?0 9% G( =/
"
G# /
H6<
9/ A ) ) .+(
A /U (<
P,
:0
0?
%*
9/ M*,
>1 " )(
%*
" E W
A 5)
(*
) #
.9ecbi 9 K
6 "1 W I6
.
8
Y + 5#/ }E, ./ 9%
.$)(
./ ?0
-$ $
)
Dr. Royal Rife
) 2
/
9/#1 Y , 50 " "0 G8
=
.
3 , Y)(J
8
" M*
5&
M* 3*
6 '&
"
A 5
&
8
* $# K
6 ( */
.
K
6
..
)(, & */ 66
:0
M
7 #
@8 n )
,
A E& "
6< n % 6J .
@ @
( , &) "0
+( \50
5
& E
L O& ) 1 ; 6
!V0 E)# K
6 , % .( K0 98*& A& <? 9 7/
/
@6 1 @8 J ( 98*&
#
!F0
Q&J = ;
Q/ M ",
9
, O&
)
6< A& &/ )
? %
" E
# $ df,fff E0 $"J .0
.*
+1 3% ", =*/ @8 , 8?J #
E0 9$ ", 0
#
=*/ 9
.E, =/
$ * H6< $"J. -.)
O&
(
L1
0 <, 6 $& 0 +, F 0J )
.)/ 3# E#
& *
0
/ $/ % " "80
.9/#1 K A *8/
)(1 & 3 , 5. " >
.)(1 & 3 , */ 8
/* ;0
5&
" >V
/* ;0
"
*/ /
5
7 #
#
?0 )# $ Gebil 9)
.9.
> :
Rife 7 # J 0
G(:
&
) "
"*/
3
ed A 7 0
/ W: %
* O& #
A M8/
"# Q/
)
, +*1 5% " 7( 70 @/ $ @( A ?&? %,
"0
."*/
A +
E, Y*/ I6
5#
(# ") 9 0 /1 3
1 A 5
&
#
*/
3&
, A
J (, < G0&? *
//F
"> "6
"0
O.>
" 5% " @&. $ "/
Rife 7 0
, ( , $# G5
" A ; .
:
98P
3*
6
:% 90&) !
? " >0 @ ) *&J @)/ @( % 98P
3*
5% "
A @& $ A&
"0 H* @ $/ " >0, $"J .(
...E0 < H M& GE
H @J G5&? J G L
Journal of the American " AMA 01 *
& 8# & !: E, < I6
01 *
&? !:
0(
" 0 G#
% !. S I6
5#
& "6
"
+)
+*1 =# G9ebib 9)
*;
# "0 50
3. ? 6< .7 0
") 9 V "0
& G#
6< @0( E
: >/? /
W: ". &
F %J " * & 9 5% .E, 9 / O& GE
/ 06
9> G"/ # K 9P)
0
9/ 9 G9ebil 9)
G"*/
A -. 5. 7 / A %,
7 9 G@
H# M& "
A 7 Y %J "( ! 5( ) .!@%, =#
@ $3( I6
H 5% G7 #
@( # A I6
" " 0
, .3
>)
M&
*/
0
.7 -. / / / "0 I6
" " $ ^ M& .@, @%, @
, M&
", ) .9
" : # @:*J ) G /L A(/ H# 5. G9ebme 9)
5L @/ 7 5
"0 9P)
@ .. E?# "0 1 .. &, @ K ", " + E, .
3( + @& ^ A,
.)
0 &# .. K
6 A 0 //F
&
... E?#
A p% 50
@)% Gary Wade IL < Rife 7
:
K < P&
"/&
7 M* 9) ", =*/ 70 5$
M% 50( <6
@#: 7 M& 70 S( 9 @8 J .
A * E# / 9% 5 G7 5& ):
@)%
$& , %
=$ ? ", 3# GK/
(5$)
"*/
-.) :E.> Barry Lyener
I 0 @ 7 0
30
5, ).
( % New Mexico 0/0 " Dr. James Bare I !# 0
(
The Cancer Cure that Worked
.K/ 7 $ + $0 5& *( MU ) 3$0
)"
) 8
Georges Lakhovsky
5 P 0/0
9$%
.Gorge Lakhovsky 0/0
-# 5
1 /
!
< ^ =? 80 O& K <
50 I O& ()(
) 7
5 5)
$&
" # #
*
$"V
(
)
+1 K
6 $&
.
=# $"V E?# 0/0
.(
G)/
G&
)
.
<? 5/U ( 0 5) ", =*/
A % <
L .
"
<? "0 A $&
,
& ) G@P
E)
"0 @8 , # .("? 9)
/
.
< "? K
6 # 9 , "? 6< A P&
*/ ()() 7 50( A !# 5
K
6
A 3;
)
.
< Q/ B) J )
5% "
)/ $9 % <
" @ 0 !#
6< A
J 0/0
(,
.
*
.9
)
5& /, 50( A A& , G
5& &, , M*, % 50( A :J M* " A
9L
*
A ( 0 -,) <0 9 ."0
<
/ # -, * !#
6< $"V A$,
.)
$
//1
= <
0 G(.
) < = @6
( 0
-1 ") J < %* 5J $9 80
$"n 0/0
E) .Resonanse ""
" A : <P 5. " Q%, .
K <? &
,
#
) " * 8
*
5
A& @>&, E&? =$/
."&
"/ A (06
/
.Oscillator
#
) 0/0? #
-6 5$,
A
J @* M( % "0 G9eble 9)
.
)
Q/
A )/ @& 3#)
H# # J & G% )
#
" " ) I6
@0 " 0 K" 06 ./
I
5.&? " E< G&
?
GK
L
P
(
5% " 0/0? A )
5 0 70 The Waves that Heal "(
(5# 3* A)
K :> 9 - J 9 % .#
5 M* " #
@#. >/
" )
" >0 H+# % .)$#(
)
@#. W: 0/0? # # J " >0
@
.3#)
H# " ", "^ K (/
I6
GN =8
, .("; 0/ ," @/) #
)
&, K
60 G1 *J Q/ E./ K 0
# 9
.X!
" Y
6
5 :# "
? 6
:E &,
(
&)
Blood-Electrification
", % G #. 9/
:0 #, " * .# 06 G
91 5.
9
0 # < >J <>0, &, .30
" )
( A
J G &
& .
# " &
A
J G
" >0
K < ."K 3" 0
blood electrifier
"
" 7?N +( / , /
H6<
) 5& "K" 0
+ %
9
) G
/
H6< 0
7(0 % .!
)/ , " <L "
M< K
60 G"*/
G1
.9ebbe 9)
K
6 GScience News )
.#
Q&J E? @+%
-7)
0 5. E> E(0 G"
0 "/" 0
""
9
" 0
:">&
M& G9ebbf 9 7
@$) ) ( @0& 5( @*) "0 1 ! ", & A
J .
.K *
""(
,"
) ", ) # 6< & % . ? ( "# = low voltage direct current #
/ :0
:0
6 H$ 9> GHIV-1 ! O 9 A I& 3 , G".
") " G:0 3*%,
, .E#
) W: M& @ 0 50-100 microamperes (uA) , 0 eff A
J gf 6
", # G
G( "0 9 G/
, !/ >V I, "
& A GE.
, 9/#
)
)*
9
.
Greverse transcriptase / /
2
@# J 8*)
!
7.;
7.J # 0 5
.9/#
. A ;
, <
I
&
s 0&
< CEM-SS A T cell line () 0 A 5
A !
/
G
( -6 " 7?N |/ /
!
9/ ) .DNA reproduction machinery #
" $# 6J "0
.!
( 60< .
I#
#
/
M* G9$ ", )
#
G() . L " # 7) !
'
G( / /
1 I, ) |/ /? H/
N
.9/#
)*
# A < 5/
" '
-7)
+
Science News # GThe Houston Post (Mar 20, 1991) # " 50
50( 7(0? 6< " ". 9
:
0
"0 "0
G5
E.* E% ", 0 .American Diet
9, (<
& '
K Q/ " 5 50
K$&
$ ", 0 G)8
#
)
0
6L1"
."/
0
9>#
L
6L, 5 " E?& 7% ", I
"
@ J G
"
Q/ = &
AP& ", 5#, ""
5
G& > GE # #
) L 5 3& G#* G)* 6L, 5 , G#
) )8
$0
."7P
+
" >0
G &
"
$
, 6J K/
"
W$$ $$4
.E E ;
9% K
6
G#
9P
9
? 5( 7/ <&
" 50
:6;
KP ;
& 6J
.N
)
A
J 5 ? 5% ;
= 9%V
5& W
H
50 L
*
&
,% 6J .&
$ J .K&
)
58> (
H6< =# .;
(
,
" ;
M. ef A
J d 5) 6< .80/
" 9L jl em " A I& , P&. 7/ )
3 # A
>0, 3( 0 6J ./ l
@ Q/ " 5
A 5) K/# A
J 3$/ )# . 50 80/
9 0
6
) ;
(
5 " ">0 "6
H6< .PHOSPHOROUS /
" )
0
G;
(
0
Q1 0(
,
A& %
5* <#& ( 9/
0
0 ) 9/#
#
")
= & , O& G9/#
Q0 )
" <
9/#
GI ") < 9/
0
.
")
K " /? " 9/#
9& G9/#
" .
-J
.9/
0
A 5
&/ E6J ", " G")
6< A ;
(
0 6J .E 0 0 @
J -&
, .3*)
% 8(< '
E L 7/ 9/#
.!" /1 9P)
@ J ..X9/
0
5
7) 5<
"
" ) 0 A
J ) ;
(
3 # 3# G9P)
5
& A "%
+/
.
Y
)8
9/
0
3& A 51 7
" E? G( &
)
:% , .* +
)
6< 5/ K 0 GE
/ K 3#
)
& A 5> 6<
("6;
" Y P ,) .E# *
/ 3#
Q1
8
The Water of Life, A " 5
-.)
5& &*, G&
+" :" ) 30 "u /,.."#" ( G9eblg 9
@
" 3( I6
Your "
(
", & 58> &/ L L 0 30
O& .Treatise on Urine Therapy
50
K:":" ) E.> E0 "/0 >" ( % .!
&
) +(
/ "
8
9/#
&* . " "
" 0 < "5
" "V ) E)* "&
G)*
9&
9L E 5
"
!
" >0
.K " 8* '8( 5:/ @ 806 .E 98) @ 1 G"
"
GI " G/
H6< >0, M)
5& .P
/#
9<<P K
60 H6< &
9
& A P&
K
6
.K& 6 J E/ /
H6< "0
G / *(
Y, =# I#
>/? @) I6
3/ ":5 @0 "u /," 30
K0( "
+/ )#
50
3&
, " *
1 '
, G#.)
1 5# < E& <>0,
9 9
G(9 gf ) " /
H6< 50 ) 6
":5+/
= ."
-.)
3
/, %
Q 5& 3
G%
6< 50 9L !X+
6< #
/
)(1 9
&#
*( Q/ "*/
-. " ">&
5:/
K 50 9L G6
:30
5+/ 9> ..X@#. 9> " @/ 7(0 5/ 56 I6
#
G5
*/1 ) 9
5 ? K
6 = G9
-.)
Q# 9 " G9
)
5& +*1 " 0 %
-. O&, A "/
":
5) 6
:5+/ G
.!X&
5 9
"J E/: E?) E#. /
*
)
-.)
3
/, 5<# )/ A ") G51 " :< 0
*/ ")# "6
G"*/
.!X/
-.)
3
/, A / ? , #&
0( O& .E+/ %
&
", A& .+( $; 9 G"u /," 30
" 9 df ) I, G9
,
1 3;
.A % I, " (
A E* >0, 0,
&
V G//
5# A
J %.)
1
G " * +L1 .S # 7) &
, , < M
"0
.!S*
%
? "u /," :/, ", <
" 9
98P
3*
1
0( @/ I6
Y
3601 "%
? I6
9< G";
K
60
)
H6< "*
=# ", 06 "0
.1 !
* 51 " <#
# < &
7
.%
E&, # "
7/ ... 9<L G")
G
)# G">&
G"/
G"P
G"**
G*
.I>1 5#
&
H6< % ", ) G1 )
" 9
& % (/
.30
6< " "0, ,
G#
>
01 (0 "
" G9
A& :%
? G
)
<& 3& K <
/ 5#
>/ ? 3&
H6< .E# E// GE
@ ")
E
G:/
I0
W
A ":
G / &
" +( 5# 5 !
!/V I6
G9
:/
$*
W
.&
3*
5>
5
)
*/
=# A 7 5:< >V 9
"6
"#
+?F< .P
#
)
5# 5 5
!
G
9P !0 9</ 6< .(
Q/ A 9
&
,
) 1 :
//
.9P
6< <P
%
#
#
" GK ? 0?< " B)
? , ?J G
)
9
)
I&
P
6< 9L
&
, 5
^ .// E% >0, !/, 3/1 5#, &
, 9
", < M
"0
.*
(&
& =%
Q
9 **
GI 6& + 9 J .(X% "0, "0
P&
!
0 G<
# 1 ! ( @ , 5 $ @
, I6
"
J
" 0
, .#
)
@, I6
")"$
"$"" 0
.:/
$*
W
-. / @J < &
@#
9 <
H ) G#/ 1 9$
W * " E 7% "V 01 +
+6;
J
#
#
9
.9
A& )/ " "0 9
@.#/ )
@%, =#
E, E % M&
% G/ " H* 9 E % M&
G714X @/ "*/
-. $* I6
2"J"
-"
F"
*
O&
" H M&J 9 G6$
.J.8 0
, .0/
A #V $F
"#/
H 9 0
@>&, ( S/
9 H 9 $
,9 .9)
K
6 %, )/ & 5. 9ebib 9)
" 0
"#
)
" Y )"
) 8
. / %*
5& 9</ 0
1 "V >
0
.@/.J A
J , :% 0&
)
$ 8
.9ebli 9)
/
#
%* 7(0 ED$ $D&
.0 <J ) & ? % G) "
(
#
8
9 G/ 50 G 9 50 .=%
&
P 0 #
)
.9.
" >0, 9) '
, @ , .)
>&, # ")
5& I
O&
0 A
J G
.)
!/F
"0 . 0
1 M // :* */ O& 5% G / ge H G" "> # G9ebbc
=/, )
G1 :
"/" W !/F @ , A
J .`
)
&
P W
G&
91 P G
)
&
P " 50 ) 0 A
. Y / O& 5(
*
&
<) 9, O& GE)/ E?# 9ebbc 9 9. 5:/ @&
/
.0 " <L
.
.
&
#J / 7
" /$) 5. " "/ M& K 01
Q&J " 6V $
#
#
& " 9, ) GL 3/, " G / ig H G"!> 50" 0
G9jfff
"0 .#.
& ) E ( % G / ej < G&/
3
n A
.5/ &
/0 0
" 6, " 9, >.> ) GL 7P G#
#
G"
" 0
G9jfff
.9, )/ 0
5%
*
." /" / G&/
3
J
G";( )#
*
E "0 .) L 3/, # GJanusz Jeljaszewicz "0(# ! #" /
G9jffe
" Y
6
1 5
^ / 5# < : >/? @# J 0 . )
0
0
Q
.9 # J ".J K( A G@ "
3/& G"0 .0
) GM.L 0& L E # G / ll H (5
1 ) G""; " /" 0
G9jffe
"0 % , G#
&/2
S
A 5) "0 .
/ G0 ? G@ 5) "0 I6
.E#
E&./
5# @
A
J .< )# G:#
#
G" "" 0
G9jffe
A 7* @># # ./ G! - /# A # @/ E0 GL 50( A .0
/
.5 iff @/ "0 " ) G/
Q&J H '*/
Q
Q&J G@%J "0 " 3
E? # G9 dl G"K (/ ." /
0
G9jffe
&
/ E?;( "0 .FSU #
&/1 W & 9% 9
)
"0 ./ "
J
G0 J
.:/
&
5 5$) -. A
J 5$
I "0 GI
. )# *
/
@ "0 " 3
G3/ # E? # G"I0 " 0
G9jffe
G@0 6< 9L .5/ 3 5& "0 9<&, G5# ), 5% " S
3
$) @ ", ( 06
5 E# O&, A 5) G
#
.9)
/
01 + G9
)
#
+ =# " E# E) "0 .Y(
@ 7 .%* 3 @ V0 E*& @/, G@
5 E? # G"7 (0 ." 0
G9jffj
.#
S./ I, $
S
0 A
J 5
@ V
+ , "0 .&
?
G /
Y% %;
@/ E # G"B 50" 0
G9jffi
5)
K
6 G+
6< >0 & , % "0 G5 @ 5% . West Nile virus "5 /" ! & .
.
< H( ? /:
3/
" &
A
GE? # G@ O&
* & *, % .5)
A
J @<6 5. E A G" / (" 0
G9jffl
.
E
"0 .& @ V E/ ",
A
J / @># # .#
#
5# 9
)
+ , " ) G";0. 9
" 0
G9jffl
./# K/( W H '*/ A 7* O.>
3:&
G& 5 )*% 50 G=*% >.>
5, 5
& @
, </ G#
&
9
G"K.0 "#" /
G9jffl
.0 J @
E% ( # .(
)
|/ /
)* # Q& = /
7% 0
@/ # >& 5% G""/
, >" 0
G9jffl
.#
#
0
G:#
#
5# E "0 . G?0/,
/ 0 O& E& E "0 .& , :, " "
/1 & 9% I6
"
8
"
.2
/
1 9/
E/: "0 .@/# )* # @
E? # G"5
" 0
G9jffg
5 .0// "/ *
=#
01 )#
"
":
E/: "0 .9)
0// "/ A(/
.5 @ 5% E>0 H0 ;( / ) A 7) @ V @#
M
Q&J L G ( ## */ @/, A # 5% G"0/ (/
" 0
G9jffg
.#
&/2
0 +( J E
"0 .0/
H6< 5)# E& E "0 @ , 9L .t
*#
@) ) G" u #
" 0
G9jffd
P "0 .* ) , " <L G G*
, 0 & "0 .)/
&
.9jffi 9
)
6
)
&
"
+*1
)
O&
" 0 )
E#
>, " < :
H6< ", 06
" / ( 6 9
)
5& #
O&
" : " " )
H6< + % G&
.&
5#
" <+J , O&
H6< " 1 >) <
V/
H6
< 9 0(
.9
A& I#
? G*
I6
*
K ", " / 0
G+)
, +
&, " 9 50 =/ "& .9. 5:/
:E# 9< 5F/ GE# * & A
J 5
7/ ) )# 6J "0
.5
50(
&
O&
H6< =#
D
D $
9 Q #" ;$ ,3 .!Q1 T9 % 1 HT(1
B% $ ,3
.!Q
)7 ,7 >)
2(A
.M:& ) A
& G=
& 5#
? "& :E E, 06 ", 3# G@0 6< 9L
"H
B) $:) :)A
9 ; $ !"
(
0
.#
Q&J ", #
1 )
E# ( "#
+
?L 0
:5 / " )
L W/
)$ % $
$
)$
A Career In Microbiology Can Be Harmful
To Your Health!!
K < 50
", I, .)
1 " $) -6 "
F/ $) 9># K < a"V 5 9
:/
0
Bechamp 3( @/ U 5% " ) 9 "0
Pasteur / /
9
)
$P
H6< $* .
@>#
>#
"0
$/#
?& 50(1 ) " O&
Gmutation (*
) 5$&
$P $F "0 I6
&, 5%, 3/& G@/ Pasteur / a"V /
30
5. " % .Pleomorphism
. " P
P $P
% Q, $P '
$>#
@$P A;
, @, $L % (Duclaux !00 0
) @ )
A ) G/
$
1 $>#
$P
5? G5&1 =# "0
.Pleomorphism ) 50(V >#
.9/#
0
5 9
//1 -6
G1 "
Q
9/#
, Q/ , P ? %
50 (0 %.)) /#, = B)
0
Y , " )
K <
M* .H^ A
J..*)
I )
/
*;
M< A
J $&
L &
$ 3/ G!0 ?
, #/ 1 I, GI/#
"<
"
&
H6< " #
>/ $& 50 0
Q6;
/
( * G0
@ B) I6
366
Q/ ! A
J 5.& ?
$
H6< 0
S* K
6 ) .( I
!
Wilner 7) 06) 0
H6<
0
H6< @ >0 ", "0 I6
a"J .*
0 Q, ,
, 9
M8 0
9
G) 9)
)# I6
9/#
L A % "0 ? % G Q6;/
A
.0
H6
E0 E)* K < "0
Q, 50(, A
J 0
H6< 5$& ", "0
" G7 5 0
5 P 0 GK
6 A .
"0 I6
0 # H$&U 6< G:
*(
E K
6 G"*/
$/
A
J A&
, E.> # &
3
50( A "0 G0
5% " &*
$/
.
H6
&.
/#
5)
$ .@
E: E< A
, 9 50( < H6< G(0
J )*
9/#
*)
)
&
#
.//1 3/
A +
!
1 H6< =
1 "*) G
&
$*
/
$)*
+(
$ + >, 9/#
'
5
0
5 E
L 9 G$&
+*n
$*
Q)
5>
" Q, 50(1 /#, ) 9, )/ 31 ' 5)
6 .9/#
9
.0
)*
#
9/#
A
fungal infections
"6
"N ">&
" )
) L @#. "*/
%
3/1 $", ">&
80F 9
6< A&
.
//F
$0&
:
5% " =% F & E: 9< 3/
") 98 , "80F
9/ ", 9
" .@
:/ "
$) "0 ", "0 6J
$&
)*
9 ", I
"
", 3# .* &
$
) # !
G98P =#0 $/ 5)
9
) " 50
O& ", $# !
XA "& 6
5F/
A 80 ", 3# .51 +
" O& M:&
A '
!
@8 J G$)*
& " E+# !
.@ ? 98& +( 8 , A <
1 , O># "
$
F/ .@, " >0 $<, >0, @/ "0 I6
G@ 5
&
3/ # I/# @8 J .&
.0&
+*1 $
F/ * !
G 80 = $&
3/
" L 9 1 9
2
E#. ")8% E +*1 A
J "/ (
" ".
>
< H6< GE, $: F & 9 X7$
6< 9 " X* 9& " ">& 5 I<#
9)# >J , 8
, # ? G*
9P
6< " E. "# "6
+*1 +)
@
E . F(
.9<J J 9 60< .(I0
+
) 9% " 7
+
L : 50( I, A "%
"00( "0 ", &
" .9* " 7 Q, M* #
"6
(
+;
"L L 98 ,
6< $
K0 )
@ S " = % 3* aI, "J .@ K0( K(
'
", " * K < "0
"
5#
!0
F # @8 , aK( ? .
& W
)0 H 9
@& I6
30
+*1 9P) 5% " % $$:! % $#.)
$
5<# 9 @8 , ?J E >J 9L .;
3*
"#)U
; .
)
3<6
, @& I6
)(
6< ", O& G#J * )
H6< A
...J
,
A
J $
70 :< 5F/
"0
.E, K(
"0 ? %
9 . P "P 9)# I
X1 6< " E# " " 6
X&
H6<
9 , A
1
J =8*
P)
@
( H @
GH^ A
J...E// GE GE "0 "J G3<6 50
#
H6< ?
G!/1
9< E, :* ?
+?F< "V :
" $ 6< A1 5>
./ P " @ 9< &
,
)
)#
)
//F
0 A
3<6
)U G9
9
)
+& , 0 / I6
)
3<6
,
,D '93D @
J (U G/ 01 //F
K T
?J @ 5)
3# O& 0
!
30 9<L " 9<<( "6
96 9< H )
3<6
6< 5*, =# .MATERIALISM
" / 9 E)* G@/ 3<6
6< !0 A / "$/
+P)
+?F< ./
)#
3&
G
./, A
J
, , I6
$
$/
.9
:
9)
A */
0 0
W
E) 3<6 I6
$
4$" /
...&
$ 5)
# I1 )/
G=#
Q
)
$*
P
0
.
8&
* 0 58> & - / Q/
- 9
@ 0
:
3;
& !.
A
J E
9) 9 "0 + " 9<L ...E/ # E66( H "0 Q) ? 5) ""*
5)
" H/
..."
+ 1 3
" 90 .@)* : A& . L )U G"/
+?F< @) I6
)
M*
6< " - 50 "J
M) $6#
>
/
Q&J " &
, A& ...0
*
H6< A V(
5#, 5#,
8/
H6< 5$ &
, )# X
/
/
J 5&/
" '
,
"01 ")
"#
!
, ../
%
Q B% ", 9& .%
$&
Q 7(0/ , (%
& I, " E:
.&
0(
"0 *
< G&
..XK
60
K
6 "0 5 G@%
3/ 01 &/
H
"0 ? % :/
)
M*
", 70 $
06
&
06, 7/ .1 # A */
) / L > 5:/ $U F #
06 A V &, ? .)#
!
)
>
" E =* " E#
U
K
60 G &
)
P
) GK
6 5. " .& ) //F I, E, &
H6<
. 0 * A */
)
8/
9
@) "
.I(
0
* I6#
I6
*
!
? Q 0
K
6 .&
K
.9
H
0 , '93 " 0 9
/ 0
A $ "6
5:1 +)
.9
@) " )
M:&
* 5
& 0
"s
5% " @/0 9 0 !
K < .E.
, , '93 K < "0 9
G&
K
6 " * ) +# 9
)
M*
90& I6
, 3<6
.&
Y 5# "
9/ ) @
J (U '
, I6
<
Y
6< I6
)
3<6
./ 0
=
Y
2, 3<6
A K
6 G1 A
J H> &/
" H)/ A
J Q, ^ 3. 5
& A& / )
&/
&
F
<
//F
:3/
0
!
//F
" / 9 "0 @ , < 3#)
1
"1 G5#
6< / G0 , / , G# I, A Y G
:
3 #
A
&
!<#
E< E 580(/ 6<
VITALISM
)
K
/
=# A
J <) 5/ G( =/
"
01 &/
A
/
P 5%
3<6
6< .(I&
3<6
,) &
/
J "( GE 7 Q, / / 0 G+/
A 0
"/
"< / GI
3<6
+( ) .(1
) ( !
"
6 E:/ "0
.( 9 %
" )
9#/
"&
"F .&
< & %* A : ) &
:0
", 0F ,
$ '93
&
$ 5 # " ? G :0
+
^ # / 0 ? :0
:
"
"V
.P
0&
GY
6< .E " > 9 5* Y
.9 0 Y
V( A& "<6
5# " 9#/ ? 6< A % 9
//F
K " I, I; % I, P 9 GI&
3<6
, .....(/?
#
1) //
G
...((
& " :
3 #
A 50
*/
//F
E* E/ 0 A
J )
3<L A
J <6 GI&
3<6
5# , ...
...I
3<6
5# A
J
9
5
3<6
."/
//F
A <#
$ # (5:< I) & t 5
&) &
01 @( I6
0
=#
)
">& ("
) I
3<6
Y, S G01 Y
&/ " E& ,
$ '93 - K
60 &
, 0 , G/
,
% " >0, "0
/
% @
!
G$>
:0
&, Q/ !
< "/ G / J
"...1 G&
G :O.>
p
$&
< :()
0
%*
+ "J .....30
G5% 58 " :( 50( G1 V( ", 6 G6%
1 <$ $ ,A [ < &
.'"h #
...!(
36 G:( 50( 1 A& 5&
H6< A //
,
$ '93
VITALISM
< .Prana
A 9 A 0
H6< 0 ..
5% gfff 9 E
&
A
J =#
" " "0 Prana
", 06 .#
50 5
&
# '/
%*
0
H6< 06 0
.Sushumna A O
> P "&/ "
Pingala ?;
Ida N < "/0) "*% ,
.%*
, 0(
A & , * =/ 5. " 9/#
M* Y O.>
%*
H6< "V 5
A/ ;
, * )
H6< = M
9/#
" & M* A
J =/
0(
H6< %* = )
.H 9/#
* '/ I6
< ;
)
H6< %* Y# .Nadis
9
& ("
) A*/
0
%*
H6 M) / I&
*
>
*
#
06 .+(1 =# # < Qi ( A 0 %* " O&
A >)
9 G.
5% ifff
(
", 06
*/
.)
L =/
3/ K
6 L &
&
;
*
O " 5
Q/ W
GI.
( >
"
G5& , A ./$
9
)
> @ 50 $
G
//F
/
5& Paracelsus H/ 9/ 7)
:
30 . > <? 9)
" 50(, ,
P A
J IF
< &
"V 06 .Vital Matter &
Vital Force &
GIlliaster
.Y W
) # #. 7<1 &
9/ "0 .&
=% " G/ 0
" / G 80 GE// )
"
'
, G, "
" A/
G) )/( 0 0
^ " V 0
7
K 9)
S .I&
3<6
Y,
# &
A
J ( 9
.)
" >0
K < "0
G
&
A& #
H6< "J .&
(1 "J .7) ", " 50
< E:
;
< &
.
( >0, P A
J
P
K "
.
& " #
& " 7(0
9 0 "6
* 9< :/
)
)
" "&
/
, .( =/
( !/
"
O&
9)
P A& '&
50( I&
3<6
9 9 9
0 (=#
@
V 9 M* " 5 E0 E '
, O&) I&
3<6
* 9 .* <) #
3<6
% .&
*
K 0&
/
"0 ? @ , O& G+&1 9 A 0
0 0
.@ ")
" >0
# " 9L
A "()
"
@ 0 I&
G:
9)
A */ % emjm edlj Isaac Newton " M&/J H* I6
I
0 0
W
", =
U
9 , = .&
" w5 "0
9 @ V H
> % ")*
+)
" )
", ?J
."* + " ">& 0 +&1 9 I&
3<6
> 9P, ", ?J (")% L) "V "00
(emil eddf) George Ernst Stahl 5/ / J -# < " I
) &, * G5>
5/ A
/
< ( ">
"
+)
9P, &, ", 0 .I&
3<6
!/, A E.( E* EP E* E#
, " "0 G#/ 1 9 !/F ecfj emme Marie Franois Xavier Bichat ( @ / I
=/
"
I&
3<6
(
8P
Karl Ernst von Baer " / J 50 A
J J .I&
3<6
.>
@(0? ecjm 9
5 I6
(
3<6
A ;* )/ ( 2
/
9>#
P /0 G( !/
"
#
Y )
&
A P&
< '(
9
+1 7:P A
J H ?
9 K
60 .;
3*
I&
&
Q
//1
, G7 5 0
O&V0 G8% >0, # (0 "0
) .&
Q
50
.(
& GDr. Franz Antone Mesmer $
A 3*
< G& 5# 5 58> G( ">
"
5.
/# 5. @ " M> /* ; M @
5& Mesmer 30 .
%*
5# "
6< 50
"
."^
(, -.)
@/ '/ M
6 &
L &
9/#1 ""&(" ", Y*/
.-.)
.
%*
5#
0
Carl von Reichenbach r7$
) "
5, 0( G( =/
H6< 7
% .Odic force 1
@ M*, E "()
! % H
=:6 E
"0 %
( W 0 G&
:0
" * W )
0
", ) "0 ./*0
%*
M* "
) # J "0 G5
5> G0
H6< " )
", # :0
9 = "0
.&
Q
#
/ B A
J &.
&(
:0
(0? , .)
L 0
W
K0 :0
0
'
, G
&
<P /
&
)
&*
9/ I
" '
, O& G&
.9/#
)
)
) 5( :P +, +1 )
% 3/ 1 3/ ) A
6< .@>J " 0 9
9 1 G L E( @
I&
3<6
" P
"()
"
+ 7
# !
GI0 @$# < I&
3<6
"J .I&
3<6
M)
9
+/ P # >J A
>& 0
#, ,
:E# */ < "
" "5)
" < 7(0 " ;
9)
"80 9
I6
3/
.
? 5)
# ? "0,
)*
#
0(, %*
* , =# ", A ")# G*
9>&, / ) G+
+ ,
, "0
.....)*
+ Q% " < (<L ..: G0 0 G0 G/* ; G:0 G&)
.
)*
3/ $& -6 + M A +)
Q
H6< 5) G
<<P =# G&
#
.E & , E "0 "J G&
50(, " 50( v50 E: O .)*
"0 v50 # $#
%*
H6<
$& $% # " $? XM.
5)
6 9
5#, " +)
Q
H6< @# 9 I6
5#
6< <
@ , " $ ? GE6J .
* 7
G0 "n K
6 5)
"0
6< a", .&
J A 5)
50 M> ...#
2 G< ? GP $% 3& B) V G* 6 9)
5# 7 .5%
.#
@<
I6
#
9)
a, ...9P 5 5% "
%*
I1 M> ? 6< ", A
J $ /.
7? "
!
.
I6
< G"0
#
I<#
6< a"J 5 # 9 A
J GO&
)
@$#
)
%* */ G06 * :#
0
#
9/ M* " K
6 9 ."N :/ < 0 !0)
.#
<
<<P
0(, 7
"0
GE:
+&J , G(&
5$& 5& 5> )*
<
&/
<P
) 0
E 90&, 5& 5<
X # 5& 5. "
6
,
I0
3
)
E %
G(( '
", 5% %
@ = I6
A/0
7.;
)
/
(
6 M.L 90& 7#
6< 5 ."
, 3&/ A
J 50
5$&
G
3 1
!
"0
."*
/ # 7*, # +, / $/# G#
:
= 5
I, " E
)
%
://
B
O& G"/ % M Yn /
G):
"
1 " # 5 G3/& 6<
.
!
( 50 @6 0 -6
6< . !
7*
E#
"0
3&/
K
6 */ $/#
7*1 +1 +# ", " :< 5F/
.. <6, *
!X# >V I, " E 5)
" E 5) 5:/ A Q/ I& ?
@:, " #
$/# 70 :5+/ G
5&
0(
+# ", " G
M>
6
= 5&
K
60 .!XB
+# ", " X#
:
!X"
L1 M1
5#, B
" +*L 8) P , " 78
F $& ":0 A
J
5 5:/
5$& ", "0 70
!
5 580(
* &/ " # (/
A
) !!XH^ A
J....t "
M; .+
" 0 G"*
* A ) GE.>
& G 6 V ."*
" * 5
!
, GE)* E, 6< % .;
'
6
P&. / G9, ) . A& 9, 6
K G"*
:< 5F/
"0
.XK
60
!X:
"
6< +# ", " ."
5
& P&. / G6
) 5% "*
" % 6J
& 34
E. 580(U 9/#
&
%*
5 ", & 0F %
, # A )
5<#
K
60 . 9)
9L
5 I6
( 0
>1) 0
%*
0 A *( &
$( ) G@ $&
":0
&
E//,
"6
"/
"
" >0
" )/
.(
(
>1) "/ *&
%*
5& @ 5. " 9/#
.3(
A& 9)*
" ":
*
%*
"
6< A ? 5. " 9&
A P&
>" /
% "J ." L / <" 30
""L
&1 6
/
" " ) 30 >0 >, 0T6
H6< .5#
6< A ")*
=# Q
E# ) ebdj 9)
A& ecbc 9)
"
, (
""
9/%, % !) A
J E:( 5 ", " !* /
9)*
" 9
A % 5. " !
(<,
!+
Q/ </# A
J E:( 5 9
H6< "V
& ( 5. <% <
& "6
+*1
"0 9
5#
6< G9eccj/l/e
J 6$) # @
%
"I( (
" AU I6
I
5#
(
9% G/
Q&J .)* 50(
@& B) "0 @ 0
. ", A
J ! / "(
3( , 50V
I, " <% "0 "(
) #& I( (
#& G &
A G/)
!$&
@
& $; 9
>V 9 !3( , 9)*
Prahlad Jani
!!9 dg
3( , 9)* "
"V $*
M
80, G
+ ) ./
A $/ %
@ A
J .## 3 " Q/
l 5. +
5 " E& +
=*/ ? I)
"/ "V 9)
=) $
H6< 5* 3( 9
50V 9
" #" /
!!9 dg 6 3( 9
50V 9
" #" /
", 7)
" .(9,
lee ? $ $
H6< ."K " <" AU ^ 7$
A Q, E>&, "H(" 0
Q#, %
9)
#)
>0
;
<P
Q&J H6< !* E; ~+ "K " $/
5 G*
H6< 5. !!E
.</ I
30 K < .5#
6<
>0, A
J / "0
G<P
H6< 9
<06 "0
>1 " >0
K <
JC(D
" :@ G"/ " I
7
V " < G"
/>
=#
5% " G9ecbf 9)
(T 9%
.The Science of Breath & the Philosophy of the Tatwas" ("
A$ 7 @ )
H G@ "& < "J . ; 5
& # < G /#, O& G & O& 50
01 H6
G@ )( G80 $ , .Q, E0, G $) 0, " @$ , .&
I6
S? , # Q &
< (
01 H6< "J .:
K/# A 0 >V (
3/& I, G@# # 6< Y 3/& /# , P
IF 7/ G# , .K/# A& , )
6V / G# !
@/ &
& 3
", A
J (
0
H6< 3)/ 5#, " .
&
: *&
=%
" >,
">V ?
( " -.)
A " # G 1
$; #
", X9, g 50 $; K
"
", X( l 5. 50
$; K/# P)
50
", 9) 5<
5. 50
5$ K/# +, " 50 X=/, d 5. "# ": K
'
X" 5. 50
8) 1 A 6
GQ, " E# E/#
'
O& / $; /# ",
* ...X $)
& ", I, . < 0 $; ? I6
&
+(
"J X0
H6 5$V
90&, 5& 5< !X/#
:V
50
9L ":
E) "*/
5)# I6
3/
.< 0 A / , "
) /
)
.:
/# A
J
. " P
*
< =/, d 50 5.
& I, /# 0 # %* .6 & %* < ..@ "& " .. / , H#
P <
50
%*
H6< . /# +& , =# ( J .t
* "0 ? %*
H6< ..
" ~+ 9/#
5% . /#, # #/ )*% 50 50 = 5
0 G(%*
)
6< M* " . . "
:/#
5)
"
%.)
K >
<P
) 06 7/ G E% / ",
$"
(
Placebo Effect
% +(
", < 5$1 5&? G?& O.> # V % S#
6< G-.)
"0 GS# $) 8 W
)
% +(
", < >
5&? .I& 5. " 0
5%
&0 G9/ I6
-.)
" ( # "0
^ 5. " @ ", )*
9/#
"0
90
& 5> G&
)* 3/ $/#
#.)
"J "0
G#. %
!
+*J GO
>
, .9/#
)*
.placebo effect /. 5) @/ "0 6< .@/ +( 5) 50( 9</
9)
& (/V/ "0
.7)
/
7. 9L =# 06 ;
5)
6<
* '
+
A I& n & "0 I6
*
, " O& * # O& G9ecbf
.S
9
1 " E A( ,
0 G+
@/ 9L "0
."
" & & @ , @ ) I6
%
1 ", 5% E0 E?#
H6< >,
.+(
0n "0 9
Q& " 3*
'
, 6J "0
.#
< 9
/& 0 @ "V H0V 9L 3*
90&
( A
J "$)
.E//, @
) ? 5&
# ", = G
6< V E.) 3
(
6< "0
G(V*
K
6
.60
&#
I, /.
&# A/ P % .<P
H6< >V " ? &#
)
,
9 GI0/)
&
"/< 0 S$# 9%
#
K
6 A E?> 6V !&
&#
> W:
H6< =# G5
3
3/ 0
& 9?^ " " ) 5# ( A G"/ !" A G9ebbl
& &# ) S#
6< 9% GN & G)
L A
J 9
J ) "0
.&# 38* ?&
)
) , )#
O.> *(
90 S# 9% G"%
, .5#
+?F< " * " >?
#
(%1 9#, 0 A " / E)# 9<
9
()
5#
- .5)
&#
.E 5 % 9
1 "V 5#
+?F< =# S$
G( / ) .*
6
#
$&
M&/ K V , 6J K , I, .X(" %)
& 5. " /#
A 5)
>V Q 6< !0) ?,
E6J 70 G&&
L 0
H6< 0 6J .9< !
& =%0 $/# ..E.) 5
&/ @ n K
6 5
& )8%
X"0 50 (
"/." 5) <P $/
GM&
9
, G)
* GP
=# G!,
=# 5> , " " ) "6
3*
I 9P)
3*
6< 9 J 3/ 5 G-. " 3*
3/ !
1 H6< " "( % G<L 3) A& ,
A Y 3/
6
.E: <>/ 9 O& :< -. %
3*
"
(
%.)
H6< .@0&
? GK
6 .Y @ V H)(
3; 6 GS
5
A
J 3<6 L @ V
5 ", 3*
50( A !
"0
G/
3*
5# # (<
) /.
V G3/
6
.+ @
7
", 3*
I,
!
" <L , E.> *(
5>
.-.)
A #)
1 H6< +& 9 . H6< 5. " G9. 5:/ . >0 "
.0 >V
E# &# /
H6< ", 0(
=
%
Imaging
5
@# M* " -.)
G / , " 0 <# 50( G5* % 0
9/ 9 $0 98) ", 5% 50( G(.$
) $)
a"J
% ) >V . / V 9<.
)
$0
" @8&/ 8 V )( G9
)
@ 5$ I6
50(
"
. Q1 #.)
1 >V Q & G"$/& )# G
& A
A #,
O&1 a"J .9/#
)*
+(
9P ( 5
/ A I% >V E, 5$
5 G+(
* ")( ? !
.-.)
A %
$ M) > 8
V # % placebo/. 5)
.-.)
, +
9< Q A * ) K
6 50 .=%
A $/# 9<0, ", I, .E, E/# "(
5< G(/. 5) = 5&
< 0) IJ? 50( P @ , 9L G# /#
&
A I0
>V
",
*
5) = 5&
< 0 Y
&
+#
" IJ 50( 0
H6< 9/ "
(
"0 / "
.X/.
01 9
)
9
G!# , !
*/
92
)( -.)
G" / 50 0
9
!
+(
% L */0
9V "
A A @* G@>& Q# GE# 9% -. 9/
.A
51 , E0 E&# A%? #
-.)
"0
.* & 9 " >0, B)
5,
lf ", O& G-.)
A
"0
1 F $
-.)
" / 0
9/
eb GE/ E /& P, :
jj G#
H6< p " / =, ) &
% A P A
" :
"0 (5$
) $
"J" :" / 0
5% G:
@# W: A @) .0 50( 9, )# :
"*/
. % + 9 0
G$/ 50( G@ <6
5$ ", $#
# I ",
.")
/
3*
6/, ""/# ! " 0
5> G#
-.)
6< 5#1 9<# 3;
+ " )
!$0 %
E 5 "& G !/1 ;
< $
" :5 G-.)
6
* ( I6
G"; "/"
=
5)
1 < G
A
J <6 5$& /
01 "J G
+( 50 =
, Y
50( A &
<
H# 9/#
#
" $; ", "0 /
" #
G /#,
# ", I, G'&
< !0)
G3
, A& G
#
)
S% , 5
.")
=0 5) #
)# 3*
0 /
&#
6/, "5#/ " 0
06 #.)
$
< "6
+*1 " "
>, .I0
-.)
A "*/
A
E# EJ 8 $
", O&1 >, "<," )# ."5"
. G)
/
.
< G
#
.
= $
",
, /
.9/#
;
;
9/#1 0
G91
; S
H6< $
+# " ) % 9
S "
A
", "$ G .0 3*
0 O&
-.)
"/ " V +/
" # A O& >, G"*/ 9)
!/(/ A(/ .
% .
)(
3
? A " # ", 3 # )# ">& >, .(
" P $
)(
3:0?
?) I6
G$
-.)
M* " )
9
& $/& :
| "
", "0 $
-.)
", >, G"0" )# *
!
9 6/, G( ! , 0
, .*
K
.
7
G /
GM1 '0 G3
Y/ _* G=
9
*; "
O& @>, 6<\ .+*1 +?F< @
J 5$
6< "
= 5 0 )%
= 5
"
.0 0 & A
J @(
*( ", " 6J G(..I.)
O) # )*
)(1 9/
% .& )% 50( /#
$/# 7/ $) &
& $
6J , I, .()%
) "
&
@%/ . "n GE.> 0 @ V @
80 "/ ", " 3# 5. GK
6 " >0, A
J
.J? ;
;
9/#
# 980& (
%* 0) 5$V
"
8 % GE, K
6 ) G!
0 " ", ,
" * G>
>
&
."! =% @ 0
!M$
? ," :E(< <P
H6< A O/ 0
M8 .Q6V 3
", " 9, ) !
.<P
H6< 5&
3#
" 7?N %, ", ) ">&
+*1 " :
@ S$
6<
9#, 7:P 90&
A 9 ") G<06 /,
,
0 "
G9
*; Q/ G9/#
& # G3
/0 G( L )
/#
.0
K
6 50 GQ, /# 7:P " <L G!
<V*, !%
elf A
J
@ / = Y*/ I6
(9ebji) E.> $ <* I
" >& %
.!E 7% E &, !%
lf / A
J
@ 980&
=*/ G" ": >.> 5% " 8>0
/
= I6
G$ & I
K
60
*) /1 @
) 5)# 9% ? Q&J .!@% " 7 / 5)# * @
)
0 GE, %
! G%
cl / "1 @
) 5$#/ G%
! G%
efj /
.!%
mj @% /
I, P 0& ", $) V " / 5. ")*/ "6
G"
"L
9
51 K ,
" +
, G)/ , 3
+*J , G) J # A
J !8
+*J 9 0 .9</# +, "
/
(
" &
# "0) #
*/ E +
=*/ " 9 G*
3( 9)*
.91 H6< &, A ) 9
M:& H6< .0
K
6 50 G7
V
M*
" # ) 5, " <L G
5% " @<# 9 9
)
6< "0
.: >/? /#
<P
+ =/ 0 9
" * % H6< "V 806
.K < <
5
& <P # @ V0 1 )# O& )
//F
9. 5:/
"$4 $
0
% 5. " /#
&
#
9, E.>
( 06 . +/, 9< E.0(, 6 @ , 9L ) " 6 /* ;
9
x7U
9 5. A
"& 0
"0 .Aesculapius !?0/ L +
@
J ) 0 O& ML
@
"V E ") !) &
")( 9< E&
"P/ G&
9 ) " = +&n E.
)
.9, " 9#
9 + >, 9*
<L K 90&
G"806
A :
" 5> E/* ; 9:
<P
:
0
A
J
:5> >0 /#
9:
PJ )
H6< >, G"N <
/
% "
:Anesthesia )(
!&
3L
.K
6 A @>&
$) +( )( ? Q ? =/ ?
:Hyperesthesia )(
!&
$&
(
@0J " #) #
E;
"0 @ I1 3# @ , O& !
/& =/
F
P& a&
.I)
:Hypnotic Analgesia 9
1 5<# A
.&
9?N
J A
@% 3/ ( =/
"
E# E):( /* ;
9
"0
9
( =/
"
+*1 " >0
")/ .@$( 0 9
1 5<# A E/* ; 9:
% <
*
H6< / % .A
&# %J 5#, " ) , 9
& / 5/ /* ;
G */
G9?N "0/ 5#, " E, /* ;
9
9/ ."
7(0 9 ", 5% %
"
K
6 5
& G+( )( ? @ V
+& M* " K
6 50 .& 9?^ " <L GM&
" #
K
.E.)
.E/* ; 9:
Q
/# ; /# & P
( =/
"
#,
3#
Q&J
3*
, ./
A :
@, G
*
"1 3 #
A /* ;
9$
P A1
9)
= !* 3/ I, " &$ S% < A P % !:
&
A 9
1 $/# Gn
!&
!
$)
<
",
:Self Healing 6
+(
A
.a)
/#
&
<#
@%. 9/#
5)
9v0& % (/
<P
A
J ) <P
H6< >,
3
"+
Possession
L *
( ", @
.+
0 * E/ possession 6&/? 9 "0
I6
P
"0
G>0 <P @
6&/? 6< .
1 @
( " E 7 GL Q,
( 0 6V
7
Q, L :0 " <L , 1 , 0:.
,
N , "#
,) S2
< GH
"&
" !* " <L
%
%J ) IJ 50( 9/#, A
J 5 ", (>
7. 3/&
# J : >/ 5V & " (L , "&
& " ", ) .;
:0
H6< &/ 5#,
.#) " <L ,
A (
, 9</#, 7/
!;0 %
)
(
0, &
5:% ) /^ M( 3 # , E
& B)
5:
" # K <
H6< " =# G
/, "5 #1" 3)( " # #
0, "1 & " *
5:
L @( , (L
. " G
!* 50
G / " 0(
#
(
0 G</ "0 ? % 5, 6 " 9> G( :0 " HL , "#
, S
9 6&/ O&)
=*% V0 -#
=*% 50V " 9 !&
-#
/0 " =*% A "( , !
5 , 3
#
A
!06 Q6, IV
", " G
#
" =*% ") G0/
"
H&/ 5#, " $) E/* "/ G!
S 5% " 6&/? <P ) &/ 7:* K <
3)
% .Q, : >/ # J A
J 1 5)
" "/
" >0
+( A 5) 9 6&/
G
G*/1 M(
G"01 G0
# "0/ )
!*
E/: E 6&/? 9
.&
9% 5. *
H6< / (
, * /
/
0) "
, .,
./a
%*
9< 9 6&/ 0
GAIA 91
N &/ 5#, " /
< @/
3*
(
:)
< 9#
)
0 ( #
?
S1 (,
!"*/
" A& GE.) "( +?F< ", < 1 >
GJOSE HERNANDEZ
#
0, &
"
.-.)
*
H6< A
J (
**
IF %
I
$
", A )#, 3)(
H6< =# ., "
1
/, "0/ ML "
G9)
5# */, A
J "
#
" 0, 5/ ", 5% G
A
J ? 6< $ .E) @, P A
J
W ", "0 G3*
E E 3) ", $
"0" :5 "!/" (
I//
3*
30 O&
."@#
) ", "0
1 H6< a", 7(0 7/ G+
./, )
#.)
3
/1
& 3*
A )/ P
, 6J
58> #. &
@ ) E A(
"0 .5%, ? >0, ? /. 5) Q/ "0 9
:
-.)
M*
) 5/) H/# M* Q&J S# , G& < 9) H& , :( * $& , 5
5 5 +
5 !
+(
> % !
+?F< ", < &
.' "$/& <) )( @)#
0 (9
"
7( I6
3*
, -.)
6< " F 0 "J
."$/&
9<)(
w70 6< !#.
9
(
"
E
L GA
-. 8&# >01 ")(
+*1 ", 9P&? 5<) .-.)
6< A
!
&
5)
9 I6
+
6 & < 9
(
H6< X"/
%.* &
.(A
K 58> G "% A
J )
K (/ ", "0 G&
(
% " O&
I, G9( A 9# 9 < G* & 9 K
6 " 0 .!!
M* " A
+( A ,
.( & ) "0 6<) ! " /$
*1 K
A8 ", )
;
&$ " < G8/
)
3
"
+( A "0 E.> / K "0
+?F< $ ", *( G@# 9 @
" "6
A
" :
5 ! K
"0 .\5/
+ /
9 jlff !
@ , ( !/
!
K
" 06 ."K( GK/ K
": +/F
A
0 J K G6&/? "6< " "( 0 /, K G"%
"
"( 0 G#
K , !@#
5 G) *
9% K
!
A
+?F< +( + "0 I6
3/
... Y
+ " "( 0
+(
A @ M*
9 J A
J GK
& "0/
+?F< 3 "0 I6
<
)(
.E.)
" 6 I, G( =/
"
A& G
)
9/ 0
1 ", < ^ E, P&. %
&
/ L * 9
+*, 5% " ) &
, G"& " +*, 5% " 7
0
G3%
.*
)/ , " 9<6 !
( & 0 K
6 = G"/
* &*
+/, =/ &
, G*
5#
H( I6
5:
9
O& G
)
6< G9
,
% E , >0, V )( 6< )# G&*
" <L "I
&
" "|/ /?" "I(
9 #
" 5> G#
6< & Y 80F
+
& <(
? "0
.1 A
J P
)
K @: K % 3*
", "P
./ 50( *
9P
7/ &
1 " 90 X#.)
9
5:/ " +*1 5/ 6 G9jefl 9)
I, G"N " 9 : )
X
E: 5
& 6< !
, X"
K
6 9/
Q
)
#
>N G0 5
#
>
#
3.
" #
&
"J
&
@&, I6
9
# A 7$) A& 9 : P 6
.E%.*J K0( L & &
, G/
X
&
$
V )
"J ."
= / $; $&
)
M:&
"J
H6< .9
A 5$ )
H6< "J .$&
* V "&$
") O& .EL $; % G9
0
*
9> ") )
0 .(
" 5#, 5#, @ $ I6
=%
< 6< .&
<
G
)
1 0(
> A*) J G
)
6< G"N , ."$&
0 K
6 9L G"6)(
A& " (
.&
% A : $&
&
) & A
J @( , M/ * .3*
%. I,
!
5# 0
%.)
//F
K
//F
H6< A ":
.3)(
A E>V E)% >0, 9, =/, M* A "0
G"6)(
0
3
/,
5, <
"
G
9. 5:/ 5. " "* "6
"&
+
+*1 " E(# " #
((< Q
P G(1 0( " 5) <%, / A )* GK
6 !0 < &
...!
?&
K " 6
J $
# , 5 &
G1 H# &
/ $# $&
) G1 H6< A 3)(
"n G@0 K
6 = .E, $; +( ? ..E: 0
* & E:( "0
.1 5 M*
@/* -.)
3
/, 5$ 9L G*
/ )
G"^
= = "/ S .0 , " )* G ) % @ " & G9<L 0 "6)(
0, A G0 5#, V( .@&
M8) E
G: &
A
J -& 7) M @ V %
)
< &
, A& &
& 980& G:* "0 E
L G>0 % G5# A
J 5# " > )
.
&
=
H6< "0
..""*
9?^ K
3// 6< G"
&
- ?" :5> 0, A V( J
."60 60 5 " , ";
= )
5 G"*
9
V )( 5& " :(
+
" < Q, %
9?^ 3// 1 G
!(
)(, & - ?" :1 0( <(
/
5 G5&
K
60
H6< Q&J V )( 5& " " L # */0 >0 1 , P G#
!,
06 P& G<L 7?N
H6< O J .."+(
5#, " G # " 60 60 5 G1
I, .IJ? 50( K
6 5
& G<6&
H6< 6 /#, 9 .E%.*J K
6 ) ", " G :/V P& 0
@ = , 7/ G* M:% )
Gp* 3/
'*/ A "
& &, A( 7
6J
@ J G, "
@ ;
+(
K
6 "0
!"*
9?^ " E.) ) 7/ GK
6 )( ", " G5
5)
+(
K
6 870 G@ = ^ + I, , G;
= )
" E.%
5 G
A
J / ", &/
50 <6 3#/ G& # " J .
'/ "*
=# G, 5
" ;
:@ +(
K
6 5 G"
" *
% !( & &, 7
6J .0 , J "
.60< ....!,
=# 8.)
(
)( G"!,
9
, % "& G!(
& I#
5* %
"
< G
$)
?&
H6< " Q%, , G>0 @ "& " Q%, J
5 " # I, " =/ 9
"&
O&
G+) E.) , A
J ) 3/
5< . / 5#, V( 0 V(
/# Q/ /
X+ )
M&/ ? Y
6<
O& .A
1 >.>
(
G
& G0/)
% "6
"0 3#
$ % *
G @( 5 G"
& * !
G
( !* 7%
A " #
"#
"6 1 ."$
*
+& G1 90&
" Y
K
6 S P&. !/
9P
6< */ "0
.................................
)
>0, J . 0 ,
J @ ", " * ) 5) n K
6 = 2/F =
.0 ? 7)
6< "0
H2O < +
:0
;
.1 @# A )
+/ K
60 9
+/
E)
"J .( K/ 00 "n G+
6J .
&
%* +
.1 "( J .&
+
580( 9> +
5&
" <L 0/
")
=# . /#, " %mfzdf 50( +
=# :0 & %
=*/ +
K
6
. :0 &( 5& <
Gcolloids L
P& G&
:&
H6< 5& A % A n G3 , &/ A
J +
5& A& .&
:0
#& G&
) +
", . *% ^ A& # 5>
5 0 E J .%* A
) A
H
0 >0 "0, 0&
H6< F 0 G & 50( 0&
5. " /
J A
J :
.E.> !*;
" -
# " &
& .)# %*
G"/ +
, "0
G: l " % +
& # "0 G#
5#
, ;
Q
%
GE > G &
0& & I# "V E?,
'/ ", 3# G& +
A 0
.%* . /^ '
.: l u
>
& # A
J 5
0
1 A
J ( 5. " K
6 A 5> 3 .9/ )*
#
0& 5)# < +
@
&
, G8&
A
J Q, 6< .Y/, 50( M )# 9/ 50( / +
5)# I6
/
:
#J 9 .5
&
/ "0 ) 9
/ >& / &
, 8&
# #
O& "3
" / "9P " A
J E, "L(" (, .
, +
"n 9/ 50( /
A 1
GK
6
.$& +
A % +
}5h)h# 6< "/ =
" % M ", A #,
.# 50(
Q/
.
7 A
7 A
J <+( J Q$,
G9 L( /
*
?
Q&J
.E, )*
/
&
=
9 . A
J / 3 , 8 < +
( >01 M*
Q&J
0/
<F0 %* / +
"n G+
*; I0
*
% A )
9/
5> /
0
M* "
3# 0
0
E
E) '
/ 60< ./
% A
J IF 5
&
A &
%
+
H6< "
&
0&
- J A / 0 3 1 5 A
J
( ( 3 1 L(
# 50( A )*
* M
+
'/
3 1 %1 */ 5&
A
J +
# 9
vortex a
"#
,
E *
H6
+
"J .%lfzif / 5&
# " K
6 "n G &
H6< " / 9
6J .&
L # w, A
J &
/
&
) /
5& A
J Q, % flow
/ ", &
"0 ? . / , A % % "0 +
A % 6J .+
A 7/ O
"n )
"n K
6 = .&
+ A + E# I
" 6
.P &
H K < "0 9
1 H6< A
)*
A
J IF
0
6
Q
, A I
& 50( )
&
.1 A
J
:/
:)(
E//, +
"0 G
"%*
" !$/& A @% I
)
6< ", 5%
!
+
3( GM
"*
5& */1 G3&
&
&
QF
G!
G"&/
Q
)
0
K " M G3
= < J
"/
^ Q
# .)
, /
Knossos !/ Minos ! K
& 0 I
)
.I L 3# + <
9 0
&
! 1 A
J ) ", 3# +
", , A E 0 B) 0 #
H
5) ..$&
..
&
, ./ H , A H
Y , =# % G )/
.3(
H
" @ ) I6
%
6< .6
I#
u
M* , A *&
G+
" 0 0
& 0
G
1 /
" E# ;
0
+*n 58> -.
O&
& G(5) >V - 0 ? 8&
0 "1 )
+
06 A ? "0
7#
5% G?) ? .
t
" %.)
@/ ) .9/#
5:/ /
, # 01 >V
5/J 5#, " */ 0 )
)
#& # ) A
J
" :0 " Joseph Duggan "#
0
/ .)
5 A % L <& ")
G"@ Q, * A
J t
" * " )
Jacques / K# /
9
)
"0 .@/ +
< 5%
"0 6J )
3#
+#n (
)
K# ', % .homeopathy >
#
)
<, +
06 A E/ +
A
, % Bienveniste
.@
./ 9 ", 5% M/ % @ # 0
:#
Y 06 ", =*/ +
"V +)
" HL
@&( 9 6J G
9/#1 A I& I6
+
"V P
9# ebcc 9)
Nature # (
@ V0 +
6
#/?
. // G 9/# I, " E E
'
", A
J
@
+)(
&
H6< "0
."#
6/1 +)
+ */ 5
K
6 >, % . 9/#, A I& 5?
, 0 06
.# > * 0
" ( 0
> ", =*/ 9
#
9
6<
P/ S
6 P/ .) A
J 5
9
M* 7
":
9/#1" "V 5
"( ^
.& + % *) + # A 5)
( , 6
GF
% 9/#1 H6< 5)# 0 5& 0 H*
" <L 01 = # H
#
somatids %
.
9/#1 ;
Q ", ,
%*
, 01 A )" & .0( h"0 Q, G#
':
A +
8 ", 5% E .>V
"
"a %" .<& #
3/& E, H; "0 0(
9P
6< "V P&? % "*&
&
) 01 0 6J M
V =*/ .#J 0, # +
#
:
9/#1 "V 5)
Jacques Bienveniste / K# # % ."/ 9, #J ?) 0
0 50( 7 G?) ?
&
/* ;
)( "V G+
)
" =*/ 0
"V
@( I6
0
+
5& E6& M*, ( 0
", A
J .>
#
)
A %
M( 7# <( "n G/ * +
6< 3( 9 .=*/
+
@) 9 I6
( 0/.
(L1 7#
IF * +
30 ; =*/
+
"0
G9
7# ? +
3( "n G" .3(
."*
0
A G
, 0, ", "J /"
O&
%,
: >/? 3#
0,
H
:)
#
:
O&
! !+
:# A >V
0 G0&
+
G>
/
H G)*
=
H GE0 #
)
+
:E.> ! . ?& 7P
$)
/
Q#, .<
H
Y 3/& G<P 0 7 #
", 7(0 ... <L
=
+
#
<) 9 GI#
, 0
9> " #
* E) +
A @>&, "J"
A 5
&
Y*/ $*
s $#
# & <0 9>G & + * # M* ") ..
$) I6
7P
&
3/& +
*
#
@P, I6
50(
5. " E# )
1 &
" G>
&
" G)*
=
" : >0
" H 0 "J" =# .@
"
GI/
"
Y A
J ##
H6< " & 50 $ .## $
:W:
" -6
) 90
J .#
A/
$) H
$) H
(0
A/
"E0("
.. $ ,"
& ) G
"K%, 7/
A =D) D) 2=D$ &A
$ 2 $"" G $ $> $$ 6
=3
1S
H39
.!&$ &
(
I6
+
"/& ", @/ =*/
5)
) )
K6 " 3* K0 & " @0/ +
" E/V0 6V O& B< 1 @ J" .@/
...3(
5#, " *
, 9/ ? .&
" +
6< I( ? !! H$# 9/#
E.
,
0
.!K6&
#
O
"V 06 .@
)
5& 0 E?# K
< "n 6
1 !. +
6< :$" H$
" #& G(
!(
)(1 9 50( ) &*/
+
. #
+
+/ ) *
)(1 3(
+ ) 9 3# :P&. .+
&
>V 3/ +
%* % "n G(0 /
!!...E, (
!(
.@ &
")
" >0
K < "1 # "0 n G(
) 1 " -/ H
H6< "0
:$
H$
^ 50( A , G;
= 50( A #
S/
P ", 0 G#
*
M
@&
.&
)
G")
L < .&
A O)
3(
H
//1
H
H6< ) :<$$ H$
G=*/
M
"
V 5. " <( "0 7
)
&
#
"J . 5&
"0
50(
5#
"J .: l # " @& 3 B) @ J .P
6< ! ^ + I, P ? O&
6< "n G(
"*/ ,
# 5#
O 9 9
6J G3(
+ =#
/ M* ) =
H6< "
...@ O&
3<6
E M&/ GE 3(
&
A +
( I, #
) A E% 0 "0 .#
)
0
5&? @
*/
9*
"/ @ 0
G"*/
!*& @
^ A #&
9 .#
)
/
5<F L @ 0
I
50(
6 L( 0 A
, % .
50( 6 8
" +
@ 5. +
& A P&
3/ @ 1
..!5
" 3L, &
"0 E
L
? GK < < 5
& E>&, (/
3*
) #
9)
<) 5? E/ 06
<P
H6< =#
L
? Q, 5 A
J G)
5 " 0 / 5 3/ # <6, "0
!/, A ? &( <P
H6< / =*/ W K .E%.*J '&
L + 6< "0
.E
50
&/
" A ", A
J G"
" * 5* +
% =
$) % )
W
6< .>
)
9<
) A "$)/ G
&
.I&
3<6
@ J ..I/ 9) .
"
.9 50( )*
$&
:0
$/#
<P
/ I&
3<6
5#
:DD$!
AETHER
%.)
58> , A
J Gsuperfluidic %
/ 6 */ " V >1 7
"0
.6#
+0
/* ;
0 : <P $/#
0
<P
=# "
<#
-
G9
) ")
G":0
":
"/
"
" >0
'#
G(>0 +
" Y/,) P&
50( ^ A
J "0 " %*
)
5 # J 9 % GE 0 $&
%*
&*
<# "N &
, )# G?
? G.
G%*
5# )
0? " K <
.M/1
.
6 @
% 3# >0
K G#
&
" ,
"()
"
"0
." /
7?s 30
5% <
=
&
O& >0 K
6
"I
3<6
" Y, 9% <V K0( 3# 5. " # L @ V >, O& 9 9
6< A 90U&
5%1 A 6< G&&
L : "I? "/0" # 5)#
3/1 " >0
K .E K
6 !0 "0
7P
6
K 5
5
M:>
K
G9 ) E ")
M:&
@
J (
#
M:&
= 3/ I6
&
)
-6
< :$!
", 9
9) &
, .#
#
I
", & = M )
#
H6< =# GUnified Field Theories "$&
5#
" P " 0
K/
0 G
.33 5 5. " @0 H 50 M
G
%*
H6< " E> $/# !
6< ", A
J ( #
*)
=# .<& , <# P& ? , ?J G *& %*
H6< "J G&
50 5. " Q#
G/ 66
%*
" 5:<
58> G>1 A/
/ @(
*/
=(
/ K./
&
)(
)( 0 . > P&
50 ) , G"0
9/#1
M8
" >1 6< 7% ", "0
.9
A # :% A 0
G+
&
M* 9> "#/01
_* G:
%*
" /
@
& A
J ) "0
+( 50 A(. 7/ G0& % * "
.9.P
\5& )(
< G:#
$6
I, G0
580(
+
#&, ", (5
"
+) #
:
3<6
6<
5
I#
I>1
6< 0
% $
) 6
" < K
6 " E? 5 GM.* A /# /
... 0
5)
5
^ S( 7$) $/
E)% )
5:/
>0, < :$! 9 "J ./ M
.
G*
'
0
" "
G0
3)/ "/ @ , , " I, &
3)
"
Q
H6
80(
)
O& 0, #J "0 .t
//1 0
= 5) @6 9:% -6 '
,
</ # 9 6J 6< G
;
%(
&
" 50 > //1 &
%*
:&
.0 =/ 50(
.prana " " 9/ &
Y , \5T0
//1
6< A
J (
h3)( ", U#x G.
5% gfff
&
"u " yin """ :"*% "% " "0 I6
Gchi "(" 9/ @/
6< A
J "
(, .
5% ifff
5% 50
& "0 @ 0
@
50( ? +( @ J ...":@
H6< Lao-tzu " ?" 7/
x7
h % .yang
5, 9/ # 9)
."0
9, J GE, E: # G: ? G$; ? G
Gt
G 0/
J .."0
",
@ 0
7) L
< 0& ..:< L * )*
5
^) Tao "" <, G9/? 6< "
."..(+(1 50 M
/
#.)
$/# "}, U"0U &
%*
"
"0
6< a"}V "!L>" 98 G.
5% gff 9
H6< 7
I.
( >
"
illiaster "/
J" '*
Paracelsus "H
/" # % .2
B)
$&
:0
=# @* 5& $& ":0" @ , A &
8
"0
6< "*., Q, .
."@&
G"0 50 # &
.+/
}, 1 t K < !
@ V ) 9
)
5&
)(
>
=#
+(1 =# "V &
G6< A ~+ .+(1 =# :& %*
!
F "0 .
, :
G0 0
)
=
9$ " ;
9
)
@ $ 50 9L .9&? M&/ n 6
G() P)
S
5
A& G*
:
@
:
(% 7(0 9 G
HP 5. " .&
)*
6 ">1" A/ 9
.I# L E.* ">1" 9
5.
"80
" )
5& G(</ " 0 9
"0
) +0
/* ;
6#
Q% 7
9 ", )
(
@
) "5/0 K.0 !#" t
A& .
&/
9)
%*
" #
50(1 H6< *
%
+(
A
" O&
F % "
"0 Gecdl 9 /* ;0
5&
6< A& $/
?
H6< G" / +0
" }, "
(
/* ;
" 5> &*
"/
">
"0
Q
9% % , .(","
, " / %*
5&" 58>
O&
9
)
.5
" H6 % 6 G
)
3/ 0
M)
9
6< A E: # &*
M.*
)
:
3)/ 9 9 ) "0
./ 9$ /
7)
#&
? G6< " 9L
A
"&
/
" 58>
9
9
3/& A # 7*) 5
& , G0/.0
/* ;0
5#
.">1".. vital fluid
5
" P = 7
) /* ;0
Y)(`
#
)*
>J )/
/ 9 ", 6
.@
. " Y)( ( 5% */ 0 E# h)*
" "0 G(:#
" 9/ * 5 +
"V
L
">1" W 9 60< X+
, +
0 GH 5 .
E E*/
#
3* ?, G
& ( . 58> ">1" # 7? "0 .;
5
&
> :
9)
5%
*/
@ V ">1" " )
9 "0 E
L (:
)
&
" .(9
5
& < !0))
"/ "6
3.*
/
E./ "0 .">1" M *; # 8
E, 6#
% "V V( % .
5# 0( GK/1 & #
)
0 @ , A
", 1870s ( =/
"
)/ +
.K/1 5% " @/$/& , @P&. "0 ? G(+
) : L 5:/ *&U
/ )
"0 G)
I&/
" &
A =%
5#
">&
GK:
, ,
H6< 5. @ J
/* ;
+0
p
)
&*
A ? : >/? / 3<
"&
%*" 9
9
) mesmerism "
" @/ @/ * I6
GFranz Anton Mesmer $
A .3)/? /
5&
, "&
%*
" 9/ ) 7)U/ 5 G . * !/, A ) 3# +#n , G(/* ;
.morphogenic field " #
"
O& GI(
9/#
" M 5& )(J %> A
J Gecec A
J emil " xB I6
I/
G (,
.">.>
>
E* '
, @ , ?J
w9&0 " @ , " 9L
./* ;
" # Y 580(
. 0
Q/
A Q
= 5
A % @& "/ 5 Q
"V )( G"
"6#
" P E>V "0
% G(
%*
5# <P,
;
>V
essential "//1
)
" '*
Wilhelm von Leibnitz "
" 9" = G( =/
"
K
60
0 "n G( =/
"
.0&
<
A I& Q% 0 < " >1"
>
elements
9<
6( 5. " % Guniversal essence " 0
<#
" , Gdynamic life force "
:&
"
0V
3# < .#
*
.&
& 5 , G
P
Theosophists ""/>
" 5>, " 0 #
&/
0&
)#
) 5 7?
DD&
AURA
G)
/ 0 "1" G"/ 9/# *&
< G>01 E
V '
, Y A 7$) "N
O& & ":0 50 5& >0 >0,
& $/# I6
(
>1 @ J .)
&*
" / %*
5&" ,
">&
"80
GE/ /, 0 .+)
#, */ , ("&) "/$/&
) 5% " ( @<( "0
HF. "B 9
" M8& % .&
%*
H6< 5&
9P&. 5#/ " G"| (" "" 5> G$
$/# ", (E&? H06 A V /) ""L,"
"0 70 3% O& P
#&
<(
" >0
H6.
<P $/# ", =*/ G@/ "0 , &
%*
/>1/"L1 ", "$ .$#
")
: *
A :
2
0$&
%
/#
+ # M, A
J -$
M1 "
" S O&
) K
60 &
&1 ">&
%*
"#
)
"n G5&1 =# "0
.1 "
A
J G9
/ %*
5&
:
&
0(
A E)
(
"I>1" 5&
, < )
* 5, X"1" , "
" H6< & < GE6J
&
;
0 ", "&
+*/
, %*
"#
)
"80 (3
) E)*) )
/& */
O& 5#
6< ">&
" )
<0
#, K G%
! .A
( 5.
H6<
(
Y 5& >0 , P
.Q, <P
0(
$( !% " 9 80
50( , * " 8
F
H6< ", A =#, 50
.
P 5& */ /
/#
1
" "0 50 (
0
>1 = W , E A& @ ) 0 E# A(. 9/#
5& 7>0
", A
J E# 7>0 9> +( ? " , $&
":0
*&
"
" ", E&
GE# 0
3/ 0
.
&
.:
/#
I, G!
I
0( $/#
$$) $
#$
$
* 7(0 9 ", )
H6< <P 5& %*
"#
)
"&
+*/
+ $&
" 80V
P&? G/
& /1 &
+A*( A /0 9ebib 9)
.Kirlian photography $$)
: :# , + M G( ?) @# GSEMYON DAVIDOVICH KIRLIAN "
0 "/ :0
,
(L
A +1 H6< P) "/ 9/# A
J G
# 6 :0 3*%, 3% / G
%
P G
# * @# = "
0 Y fE80 <<# 9 0
5% " ! + P&? %
50(1 / *
H6< / % .KIRLIAN PHOTOGRAPHY "
0 * U G' 50(
$$) #$ 0
7*1 &
G %
..Q, %
@
5 I&
6>) $ $
$ & H39 6
6;
697
&
(
5 5. %*
5&
&
;
GS "$ ", " /
H6< 0
.(0 L GL @( G(L G <6 ( " ?&
H6< S)
, I0 5 I, ? GM)
? G#
& %.
!
G9/#
*&
M> ", >J " 0
.#
9)
5# / " <L
.
5: I/ M, " *&
P G/ &
G)*
&
(
"0
"
A
J 50
5 , +& *
5 G
& , GM% , G* "#<
& "0
.("#
# 3/&) &1
&
%*
5 5 5
& # Q&J (0 G"/ .7.I" " .." G"0 ">&
./ jl 6 *% Q, GE>& *% % " (
)
& 5
(
", "$ G(
G
3( * # ) 0/
& 5& >0 O& #,
I, G&1 "
A
J 5$& W<
"0
.0 #
@ *&
#$< G( , 0/
&) / Q,
./
&
9
& = 5
A
A
J E.) %*
5 A GI1 = %*
5 * "#
)
) % >J 9
.#
/
*&
.
5#
& ; %
=
H6< 5>
./* ;
@ 9:
M$) 0 #< @ , (0 GE/* ; ":
*&
9
"
6
W< G(L I,)
& @
) @ , P&? G"&
+*/
&,
9
.
5: M,
/
&
#
3/ G@ *&
%*
5& 0 @
-6 @
"/ J 50 ", (0
.(
" 0
#
K
6 9 ", "0 .30
K
6 5& . W< 50( P&. GE.> 30
0 G"$) +( 0
(
9% 6J
E0 /
9/#1 *&
.
W<
", < 1 >
.0
7?^ @ ) 30
"0
A&
5> GE0 / I6
(
; ! ((
#
5
, G78>0
0
5.
)
.!8
0&
3
.(
" *) (
*&
W$< G 3 # @)
J 9<&, 9% 6J
H "V
^
(
6< 5$ 6J @ , " .
9</#, 7:P 90&
A
9
( G3<
(
6< !
6J .E.) M&
5
& + >, "0
*
!
W$< GM&
.E.) M&
& @ V0 )*
(
5&
W< GM& H ", 5$ G)*
%
50( 6 6
8) &
A G % " +# $ 9
)
9<
" 9< A ) >0 M:& >, 0
G& / <
& "0 ? Q, >0 (0
.
)
$
$1 A
"
"9
9
& (I
)
W
" "#
) "8/
+)
$/ G"()
"
6
life field "&
5&"'*
+#
"
" /
. / /#
= 9.
%*
" 5&
(
(
=
& "0 .1 Q
(%
) &
P&
.H &
%*
$( Y A ? @
&
8)
(0? )
" 5:< # 5
& G
"
" )/
>
)/
,
% .;
+
% GM< , s0
E
;
#
(
"0 "0
G;
*
, */ 0 .' 50( G9/#
*&
G
?^ M* " G*/
.$&
, $/
&
3/& $; , # O& G
acupuncture
* , chi "(" %* !% ""Hiroshi Motoyama $
7
$9 ""80
.M> 50( %*
H6 *
meridians
$
L
/ "6
(1 "
7
+
! GHIROSHI MOTOYAMA (< 9%
(1 "
+
E, $
", Y*/ .P L G : / 0 K
6 9/ .* /
G(5/
< N 9/#
5/J A/ ^ 9/# A
= )
"/
(1 A
J %*
"/
, 0 G.
:0 . +#J 5) 9
A $# .
:#
", "( J 5, P,
G$)*
@
& $/ < I6
.
5&
/
#
:#
" " K < .: 0&
&
P 1 +1
& K
60 $&
& ; A
J K
6 I$F G"
6< 5 O& ", $# "0
.+
& 366 )# 50( .
%*
H6< G$#
& $&
0 6J ."/ 9/#
! t
" /1 "1 9/
5 " )/ " "80 GJohn Zimmerman $
O&
,
=
%*
5& -. /# 5. A
%*
"#
)
" 50 ()*
&
"0 L 6< ", =) %
.
? 9
E# ;
+#, @>&, + >, <( G#
+&1 9
GGUSTAVE NAESSENS! / 7/L /
% 6 G"30//"H$/ E E# Y G
#1 9/ M* " 7$)
"0
@P 5 .0&
:
;
:
$:#
@/ )
@/ G($ if,fff) 0
I6
%*
+I#
6< , &
$
H6< & " 9 ", "0 ?
5
", GSOMATID"/
"
'
%*
80
%
*
K < G&
( < /
", ! / ). /
H/,
. 0
%*
& /# 58> G0&
:
%
*
K G/
", E, 80F ./
EP # G JOHN AND EVA PIERRAKAS!0 J "# GBIO-ENERGETICS :&1 %*
"
)
7$)
"5
"9/ <(
A K
6 ") G$/
* , 2
T# E#. T
(
G/
-.)
# * A
J <(
K "
/
)
, G(
) / %*
5& A
9/# " +
O) ", @>&, 5. !0 0
>,
"&
%*
9" @/ 580(
)# )#
"0 @ , O& O)
+
9#& !
$
% ?^ 9/ 3# Q " 5, < .$&
%. @
"/
$
( G$&
0
=# ?N H6< # ", 3# @ J 5% G"/ $&
# $& ", *
H6
.#.
(
" $% A $) / 9%, G
"< ?")# " GZHENG RONLIANGu u <
0
E )* 7(0 # M* " K
6 G
"/
"$
&, 9/# " >)
"("
%* ! 9 G"u L
(
"! " "("
%* M.* ! G
9#& !
% " < G
"
O&, F A
@
I6
"/ @
) "
/
"" >)
%*
! K
60 G"u L
0 50( 7 "u L (
" ! " >)
%*
66 ", # .(
/
!&
" IV )/?
%* K < ", P&
G SINICA "
I; (
$6
/$/F
0, .
/
" >)
K "
%* ", E &, P&? . $ 6 366 # 7
8 %*
H6< ", Gu L (
! " >) &
9#& :#
H6< "0 G+
'/ MICROPARTICLES # :# " 78
F 9/#0 P 0 "(
"
. >
9/ gf A
J jf / ("0 df)
8>0 3# %, GGORDANA VITALIANO
L GDEJAN RAKOVICB0 "# ">&
. / "
"
&
$:
)*
/ 7 G./L
&
$:
)*
/ 7 G./L 8>0 3# %, G
L GB0 "# " ">&
MIND "7 " /$/F V( , O& G&
?
"*/ "N #
0
. /
GL
#
G
)
0(
/ A
J /: 50(
O&, 7 .(5)
#) I, GWAVE
3
/1 " & GE.S.P "!&
" -
K" <P A
V
L 9>&V 9ebdg 9)
F
", ) "7" 0 + # , .(*
<P A E
) 9# >&
:
)
I&
5&
%*
H6< / . jfff iff " % $ 6 66 M* $&
:0
"/ '# Q%, '
I&
5#
6< ", (0 .BIOPLASMA .
, BIOFIELD
" P
H6< .0/ $*
9)
0, 7(0? 6< " , .9/#
- A
J .
5/J
. * G
< G
G
, <) %, $) O&, W: 5%
:. " # = Valorie Hunt " < I
" 0
<
K < >J O&
?# >0, Q&J
K
)
")
# = M
(
9/# " >)
#
H6< ", "$ G(%*
-. = .)
K
) Rolfing &
.$#
9 V <( 9 V "&
+*/
"
1
*/
"0
& 0 %
! G $) * (*
!T
) #
H6< 5&
9/# " 50 *&
" >)
"
1 9V <(
Rev. Rosalyn Bruyere" "
" <
)/ = #
0 9 % .%
= < % @<( 5#/ % GK
=
(
K
60 K8
U
,
$
Biological Transmutations
(I0
)
, 0
, 50(
GQ, A
J
& " 5$&
< *
)
"
M 5&/
" @ , <
J ) ">(
E( )
>0, Q&J G
+0
< &
P 1
&
.
=# "V E, "$
":0
9P) .I0 5 M* " ^
7(0 5% .&
<P =# $/ G", 3# G=*/ <& +0
"V " F 9 .)* 0
6 G)(J L * # : >/ <( "^ + 7(0 G5* % ("( " A)
?
.")
A& &
" 50 ;
)
G %*
, Gbiological transmutations "I&
*
" 9/ 7) &
, $&
:0
"
&
.
H6<
)
9
/
E# < )
.
" Y
6< .nuclido-biological reactions .
"J .
G6;
G-.)
3*
G:
9 G#
#
G+&1 9 G"0
9 G+
?# " 50 /
"0 ? # I&
*
"0
.</
P S* 9L G
#
? I&
*
6< 5
^
.@ " 5)
=*/ ? <
G&
)*
!/1 <#
580( @ J G@ 0
von Helmont < " # 5. " ( =/
"
, I&
*
/ "V 5
"0
", #
7#
@ V '$# .(:
"
/& 9
" /
*%/
#(
M1 A
J ) 6#
.#(
Q
H
#
")
< #(
H6< //1 5)
"0 %
& "0
G+
#
"0
/0, " carbohydrates 80/
580(
"V 9) &
, 9
"&
6#
+&
3(
" :
"
" 90
6< 50 +# E6J ", " .+
!
G
" V )
)
"
!XM1
5) 9% .E -#
<
&
0 Vauquelin ""0" /
:0
B< G9embb 9)
" 0 # G -
5& ) .* "(
3& " 5* )*, & ##
5
& 70 "0
G * @ 9 % &
", W / .##
0/
0
" $ ! >0, 9/
0
.XK
6
-# & 5 9/
0
0 / Y G A I0 J : ! G9ecjj 9)
.X+# ", " .
( @
%. ? 0
Y? 6< ", "$ G$
5< "
,
1 #
9
)
Q#, G9ecci A
J 9ecmg " G / c
0
" @0 =#
J 9
GE>0 )
=#
#: #&, O& G"
H 3#
% &* "0 ? $&
V/ 9
) 5? H+. */, I6
Y
, .5
" E @>&, )
."X
#
")
V ", "":< 9$&
5F/
6< .86
)
*/1
% & !% A 5 O& $) 5
& K
6 " E? 9/ 5 G
9/ "
5< 9%
I6
#
# 7(0 G
, * / " 50 @% " + = 5
& 0 .0
E* O& ", =*/
", W / .
& 5. $/#
0 ?
)
H6< .@%& 9> H
E "/ ) "0
G1 A
J = ", 5< 0 0 .(^
A
J
5& 0 I,)
)
.# " <( I6
Dr. Hauscka 0/< 0
A "
9/% # GE
iodine
V( O& G!
I&
G
/ I < /
G9ebld 9)
"
) & L H < B)
H
0
A&
=
9 3
&*
", # G&
3(1
* A $& aldosterone "/
1 "< ", # G! )# " G
/
!!(
0 5
% 0/ 5
& .
/
E.% "0 ", "0 6< G9/
A
J 9
(5$&)
.
50 9; igf A
J 9
5
9/
A I& H @) 6J tenches B
K/ ", G"0 / )# " G"
# 0
>, G9ebgb 9
!* / =, 5. %id / 9/
0 " # J G9
0 " %el
"0 !
0
6< @ GI&
*
5# E/& ">&
>0, G! )# " G"0 !
/
O&
)
7
V
:0
M*
@# & )
58> E. "0 ( G /
.5 :# @& 5#
.
)
" *
/ =*/
", 9# 50( >, O& @>&1 >
W:
" "0 7(0 . &
K
6 5) "0 ? "0
G
)
" * O&J K 0 G9)
:/
M*
3/& ", < Y
I>
1
G3/
6
.E/* ;0
5) 0
0
,
!
G%*
" 5:< 90 "
(I&
*
) <P
H6< ", "0 5 .>0, !
9<, < "0 O&, ", &/
/
H6< +)
9P)
G/ 5( G * B) I6
-#
58> E?> 3 .)*
&
P 1 =# #
G)* 50( E
= ##
9 GK
6 9L "0
G9/
0
A E, I& ? *
H6<
I& 0
G
" 0
* ##
"0
.9/
0
" #6
0
A I& 0 50 "0
)
5# & # H) I6
, 9/
0 A
J 9/
5& =*/ ##
", " G9/
A
.#
9
6< & ": A& "00( +)
9P) G@0 6< 9L .0
)
6< 6n !3#)
E> 5? I(
":0
9/# (&
) pH "+< +"
Q/ 980&
9P
A 3)
< G9/
0
A
J "0/
5& 9P K < .!X3<6 ", A
J G
, I, # 9
, ?J
9</
>0, "& ... &/ # :0 " "& ...7) 9
, 9)
7 ... "F &
H6 7)
K
6 "/ G9(J 9# & & &
& /#, ) ", 6 ...
H
#
9)
5&
./ $/# &
50(
, G 0 I#
0&
%)
)*
N E.
"0 9
, .60 3)
" @ , / 5. # 0
GK P
#
0 / ,
:
9)
(0 9
5 , " % A ) &
<P
) ", 0J K G5
9 " Q/
"...)
:#
&
9" :" ) I6
51 @0
G-0 )# " GK( +&1 9
9 0
H6
.ebce 9 ( I6
GA New Science of Life: The Hypothesis of Formative Causation "80(
/
Nature )*
&
@ G"I& &" @
)
@ 3& : 5) 30
@# %
&" :"
@0 @0 K( * % ." / )
M&
'( 5, .. .3;
E> E0" :@
The Presence of the Past: Morphic Resonance and the Habits of ")*
"
:
The Rebirth of Nature: The Greening of " 9)
:)*
#" Gebcc 9 ( I6
GNature
.ebbe 9 ( GScience and God
, 6 0 +/ G)
/ =# A G #
&
, G)*
P 1 ", < //1 @0 0
5&
*/ ") 9P & n G :0
" )# , :0 , +, , . , , :#
" /
+(1 =# " )#
06
H6< )*
P 1 O .> 06 A I&
G #
50( '
K/
*
* , ", #
"0 Gmorphic resonance I
"
A )
5&
G0/
5&
5( G #
5&
" E/ E* K < ", K( Q .0
5. "
.>
#? 5&
G)
)U 6< Gmorph < "50(
" Ggenesis < "$/#
" :", O& G"50(
$/#" E& Morphogenesis 0 )
'
*
& 70 X
, 6
0 */
50(1 K " )
&
:0
V( 70 .E& E;
9:
" Y
G#
A
< &
:0
(<
"J Xu
"/ J A
J & , G#(
"
N" ", E, 06U 9 G) ?^ # /
&
:0
", '
" .Y* 56 , 7* 5/ A
J S#
G?N !0) . 5* O& ) # , machine egg "
^ " " : 50( * % machine
<* @# G 7<
( +( K < 5 G) 80
+#1 " # # /
&
:0
"n
.& 7<, ;
:0
"V 5:
,
$ '93 I$& #
E
V( % O&
0 0
+&1 9 ", " 9L
A
I6
"7
5%)
9P
"
V/
3/
5&
# @ , ?J L & 5 5% " 9P
= &
genetic " #
#
" '*
8> G@
< P p 5V G :0
580( @
",
* :< 5F/
"0
.0
# "&1 ) " #
#
" H6< @( * 9 % .programs
5 # )# % #
#
",
" !
, G% :0 5% "
% 0
#
+)
) S% 1 /
X(I
3<6
3/&) :()
)*
6 &
/ $
5>
" 5> &*
A
%, % #
#
_*
9
", : &
+0
5# "
7
1 , .>
H6< @> .internal description "
7
" , internal representation "
.K
6 " # 9 0
GH/ 3# <
& DNA
:# " >
(
", O& . #
@) I6
<, " 9P)
+&1 + 9% %
" .
G.
"
9P
*
& ? 0
G
1 &
3
:K( 5 .&
":0
" +1 G+1 " #/ 1 G#/ 1
&
":0
9 ", G*/
=
H6< =8
P 1
#
",
.."
@/
", P 9> G3/
%
+
=% A
J +
5
n @(, 6< G: 50( @/ =#
"..: 50(
/
>& I6
;
A E 0 E 0(
/
"V 5 ./* ;0
5&
6#
5&0
"0 K( ", 9)
= .E ) /
%*
L %*
/
" H K( ,
: >
"J .%*
", 0 G(0
: >
) I 9/# A */ I6
I
L 5)
0 5> : >
" Q1 50(1
. L )* " 90& I
9
)
6< ) O& Gmorphogenetic fields " #
5&
" '*
8>
0
H6< S% " 5$, K( "0 9
% .
"
01 )
1 ' 50( $/# @ 0
GE# ) A
J )
9
A E>& # 9 '
E @
<J 9 ", 5% G >.>
()
5#
6< 0 $*
&
5&
" 9 $) 0 G#
5#
6< A
J 9
5
5 .">
#
" @
J ( 01 &/
!
5. " 5
) A 7$) .
)
# " HP J ?
"/
" #
"0
Developmental Biology ": +&1 9" " ) 0, 30 5
Q&J " 6V
5&
9 +
%J 9 70 "0
@ S( .Susan R. Singer "; / .."//" Scott F. Gilbert "L .7.0/"
50 5 O& 01 &/
A
J $ 5, # 9 '
E/ */ @ 1 5 G@$&
9 3/ !
G #
./
0
)#
E E)# 580( O& G@)* E0, ) 30
6< ", 806 .5
9
/ < 9)
6
/:
7
"0 G#
#1 9 E.:< E)/
"
>.> ( (
, Q#
GGestaltungsgesetze 9/
1 ;
@ M* <) " #
9P
50(
&
H6< A*, I6
9
.(
, < &*
=# ", Q 3/
6
G5#
6 ? " Q0
/
M* :
L 5&
6< 7) 9 % .morphogenetic field $
# 9/ @
J (U 0
5&
6
.E ) E: E )$# . 50(
.
" # @ V E 5
0 "0
G
$ 5&
6< " )%
.
.&
H6< " #
.
. # +1 50( & &
= ."$) 50(
=$#
", GE
& 5&
6< " +# V 7) )# * )
-6
@ 0 6, 5 G9)
@) I6
//1 I0
-6
< $
# ) 9
G
"
" /
=#
, % #
5&
P 0 GE& &
?
GK
6 5% A& . #
/
;
G5& , A .'(
9 (+1 7:P 9) #
" E? >
9 A #1 9 #
.:#
Q/
<# A 5:? 7(0? # )/
# " P
#
5&
9
"/< '
GOrganizer ; # 9 Spemann's laboratory "/
)
I&
:0
" #
9 ":(
I6
#1 9 5& 5:
#
O&
, .P
, "0 #
P
!/, ", Gembryology
"
P)
9<
K &, "0
.E/ E% #
5&
9 "0 90 K ", 3)
"
Needham 9<
/
.(ebdd GOppenheimer ,) >J
& %
J # ?
/
O& " 5, .Gestaltungsgesetze
9
"
= E0 E P
H6< 0( (ebgf)
Alexander BL /0
, 9% 9> G(ebef) Boveri I "0 " #
5 #
5&
9 "
GKraftfeld Geschehnsfeld 9/
M*, G' 50( ) (ebjjGebejGebef) Gurwitsch
3# 5. " ):( 0
H6< 0 % .Embryonales Feld ";
5&" 9/ M*, ebjj 9 E,
+
5 / "& " # ", 70 "/< )/ % .ebec 9 <#,
7*1 A "/<
." #
" Q, * E, E* *) ", 0 .
" "
% A I&
+
5 /
% G"
A
J 7*1
$
5&
)*% 6n G/ 9P ", 5&
6< " .
"0 GK
6 A
J J
"P
5&
" 9/ @ M*, 9
6< 0 n G"/< M
GHans Spemann "/ < 9%
5
.60 EP E.& V( , % dorsal blastopore lip P
(
&
"V 5% GOrganisationsfeld
.(5% ) @(% /) E EP E//, 9
6
A*, G( / 9< A
J G(ebji) Paul Weiss ! 5
" 0(
5&
H6< 0 M .:
9
*
G #
)
# M* 58> 5&
H6<
.
G"
5&
" )% 5. " P 50 < &
.
&*/
"
>0 5> ) P A '*
6< M* 9 .@ MU > A ) @
"0 9
A
J ( 5&
6< '*
"n G/* ;0
5&
'*
0 .7*1 & G
)
&
Gplanaria
% G #
50(
<P /
5&
H6< 9/ A (ebgf) 9< M
% .E) )
0
%.)
:
< G& 7) "!" ""; " ""/" " 50
P
" -
* G9P
" +# $; "0 H6V "0 I, ", 5> 3
" 9P " < #
5&
.."
=%
" " 5&
>V V( .9P
6< " Q, +#, $; ^ "0 H6V I6
=%
= & %.)
580( $) +#J //, A V( G ) & , 9 * 5&
"J . 0
H6< <6V
% @#6 A P&
@ 0 G M* @
G3*%1 ) &
) 5&
6< ."0
:
H# "0 ", *( "0
G7 I& 6 @( -6 = - ? @ 0 ./* ;
5&
0 E G , @0
".. #
5&
" &
& < #
>V
-$
& .E:. &
.& #1 "
F/
G6 % " )*%
.
9> " I
$/#
* <
*
P %
.I
$/#
* I6
)
9P
P & 9
G"5&
" 9
Principles of Development "*
p" :" ) ebib 9 ( I6
"! 5" 30 -
:
P,
< <& *
<P
/
G"O&
M&/
=
" A
J 5&
= A
J 6< Q, ."I
=%
" ) @ 0
G S( # !
_* 50( 9U # '*
"0 6J" .7(0? >& )* <P I, / 3# 0 E @/ 3#
@/ "n GI&
9P
V/ M)
# " V( I6
I0
* :
H0 9 G
" Y @ , A
: #1 9 E# ) >, 9/ &( 9> G5&
//,
.I
9
> 50( * 5&
*( "J e
.@0 :// !
@6 9:% "0 " < 5&
"J j
.5&
>V
& K < "0 E
L G)1 >.> 5&
i
% g
.//1 5&
@ _0 50 5& A
J 5& 7
50 5)# G"
A
J 5&
>V 5# 9/ "J d
.& <# A ) W: *) ", "0 "& >V
# - "J m
gradient -$
5&
< @( -6 K < # G
P 1 @(
5
! 5& A
J J
Huxley /0< = ebil 9 H( I6
30
P Gavin de Beer I "L 0 " "0 .field
9 " 5&
6< 5> - .Elements of Experimental Embryology "#
#1 9
" :" )
6
"n (ebbe) @) ")
De Robertis ! I P&? 0 .gradient -$
9 #
5&
<
0
"V 5
GI
"Gefll" -$
< 51 :>J
>.> 9
7*1 50(
0J A
%, ", P,
(ebji) Swett / <#,
3#
< >
.
&
, .5&
A
J # 50(
% G1 7*
5& " P
1 *
# 1
.
" ) # 0, ", P,
planaria &*/
"
A #,
3#
O
>
50(/
* " 1 9/
.
0 6n .
.
A ) 56
, !,
50( A
H6
5&
(
)*
H6< P, % .56
50(/ n
* "
9/
0 6J , G!,
E# E/, 50 50(/ 9&
? J " "/
) 6n G!,
* M( =
M* " <P
.E.0
)*
0( .
* K
60 .9&
? J " "/
= !,
* M( O&J ) # E/F .
"
.
/ A , "$ < 0 56
A &
% /
% .50(
J
E& E#$ K < ", (eblezebeg) Child ( " %
.-$
#
5&
* ! % .1 9/
* " /
# !F 50( J
0
* 9< K < "0 GK
6
.5&
*(
% / H#, A
J (
? # < -$
"V Q
#
5&
<, "0 9
G5& , A .
P
5&
6< < 5& )1 =* /
.<# " E "0 =#
.B =
, 9 9
. #
5&
+( I, 9 9
@ , 5> #1 &, X #
5&
9 I6
6
3/1 " )
K < "0 G*/ @<# H# 9 J .E# "0 9
@ , , :* @0 "V 5 *)
.5<#
*% 0 5&
<P #1 +)
'/ O& w70 50( # &
+0
"0 9
GE?,
6< / 0 5& >0
% G! 5> G #1 + =
.HL
)
/
-6 7*1
" (-$
5& !T 0) 0 / M* " !
0 00 5&
! ", 3# "0 6n .5&
H6< / #1 + A 3)
" @)# 5&
" ! $
"J .5&
6
0 & #J 5&/
>
9 @ "0 % GE% EL E
@)# =% #1 9 = G&
:0
Q/ 5&
.+
@/ *
0
, 5;/ genetics #
I0
0
5> 0
G
, E
G, &
9)
5 0 =# K < "0 GE >
. #1 9)
//F
E& '
, *
", .9<1 < 1 *
H6< .580(
5
@# = >
9 +( GE>
>
"L) #
u
;
! I6
9)
@ V 7) '
, #1 9 "n G #
3 ;
/
H6
#& K < ) 9 G #
u
" Y0 7
&
, #
", .(ebilG Morgan
Sol ";/ 5/ - Geblc 9 5& G.
#
&
, G#
.5&
, :
0,
/ @/ "0 G
- 7 .
", 0 Spiegelman
H# ", ?J G"/ A E* 50( ? @ , = G+)1 B) 0
" Y ) E. Coli
0 (( 0
+1 50( "J . &
#, " E? (0
" * Q, Y , # A E(F ) 3(
H
*
;
90
# ?J < *
;
", 0 G>
u
* ;
# ?J < )
.>
u
(
EF "0 I6
Morgan "L . #
5&
9
E E: +&1 9 >
W
"0
"
E ) )* ,
O ", 36
" ) 5#1 "0 GDrosophila 0
6 ."0
'&
.(.
Q #
)
;
# )# G
:
&J
E G# 1 )
1 " % #
5&
", (ebbe) HF. ! I Q
G #
" E# >0, #
5&
"0 9
G5& , A .E# ?J (0 "0 ? E< 0
9 < #
"V ") Goldschmidt (
L Bateson "/ 5> #
+ ) ", A&
% 5&
9 ", (ebdd) Oppenheimer , Q .5F/ K( =
@)* 5 E,
5&
", / G5& , A .@&
>J
& &, 9 9
/
" , A @&
9 @ 1 =#
/
P
# #U& 1 G) P 9
&
.
"1 )
1 " % #
1 0( %
:
*;
A/ ? ", 3#) .@ 5&
) 9
I6
*
#
, >
( #
5&
3/& A #
9 '
: 0 A
J #
5&
<P
" )
</
K = expression domains </# ?# M* :#
+0
"#
# GE?,
. #
5&
#
'*/ A #
./
A
J P
P&. "0 morphogen 50(
:(
5)
#/? % GE >
G60< . #
5&
0
&
K , A
J P
"0 ./
H6< 5&
.
.
.& 0 < 5&
H6< ", P
7*1 5& 9< GE# 5&
9 Gdevelopmental biology : +&1 9 & )
#
M*
K ", < &
+? "0 G>1 K .)
1 # 3
5&
A
H6< 50(
(
H6
0(
#/ 1 " 9/#
/:
+1 9P) 50() " #
" A*/
, 5&
0 +&n : +&1 9 5# +)
" )
9% G&.
/
.* &
"
" :# 30 (ebbe) H/ ! I 9% % .+(
*
//1 <,
.
0 G%
K
6 ." #
-$
5&
9<
5& : +&1 9) "
+)
+( J >
*
/
#
@) I6
A ! I 0, % G
# 5 5& I, +#, "
9
Hox proteins "!0<" @/ I6
-$
") " " K < "0
.5&
H6< 9P
.7*2
0(
%
H6< G& M* ) - J A $& ", "0
H6< -$ ", < G51
.(B
9 5& , 7*1 &, 5& 5>) 5&
+(
*(
_
L +)
5 "N A& .+1 H6
*
&
_( %
H6< -$ ", G >
9
,
homologous
>
K
/
7(0 "n G5& , A .5&
H6< _(
.
& A "%
./ 5&
H6< +( 0 5& # P & %
pathways
0
A
. Drosophila 0
6 5&
H6< 7(0 :#
+&1 9 ">&
, %
.
" # , G-$ 5& , A *
(&
imaginal discs 50(
: ?
"0 A % A P& G I, 5/
9P , GE.0 E )
) = . 50(
.%
" ^ = 9 &
0
6 " +, +( 9</
G %
$/#
5&
O& % E ) E E<( ", .clinical geneticists *
>
+ 5% " 5&
9 7(0 , K
60
A
# ", A
J 6< % G , " E+# "0 (E.>
!/ =
,) * #
.dys morphogenetically reactive unit " # 66( &" )
) = 50( <(
&(
50(
5&
7) 9 % .)*
7P
E # & 50( &(
A
# ",
9
)
9P
6 #
5&
:0 V G
1 !/, A GE # 6(
#)
" )
<(
! O&J "0 @ , P&. 5. "
)
H6< 0/ % .I
#1
.)*
*
5. " , E# (7*1 =
1 >0 , & "
E/ '
, GK
6 A
J J .?./
* 9 +(
*
9 +#0 #
5&
E6J
< pathways K
/
H6< Gpathways K
/
" +#0 5) #
", .*
H #
.*
#
" */ "0 = 5&
"n G #
5&
:
&
# (1 [
A
K( = =
:K( ( 0 .0 0
&*
M 06
9)
I*
, I;
K/
5> <P / "0 ?
+0
G:#
+&1 9 <$
M:&
" <P
H6< =# " 5
5#
" $< K < .."
#< , 0(
30 )
+ 5> 7< IL K/ / "0 70 "..
)
#
G>
9 G&
!X"
=
DNA
M* " G8%
M @$# /& A ? *
)
*(
O& Gbehavioral fields 0/
5&
@P I;
, )*
K/
", K( Q
> A ) Y 2
0/
)
< :;
"J .mental fields )
5&
5. " .
morphic
"
M* " Y
! "/
1 " )#
06
" 0/
5&
+, 50
"# 06" 580( I6
"
A ) "&
Q
0/ +( "J .resonance
Y
" Q1 &
A
J )
H6< 5 A
J )
)
"&
3/0 _ ", E, "0
" .@
5)# % G "0 # &
"6#
9) ", / 6< .5
5
.
/ I, # 9 = A& G@/
.5/, 50( &
! 9) A % ()/( *& & 5
%) Q, "0, Q1 "6#
.5(
t
06
"0 &
?&
=# + % GI
3<6
Y1 /
0:( 0( 06
50(
", Q GK( , .t
" "0 I, # L %
! "0 50 # 06
", "#
Q
K>& "J" :7 G"E.
, K < # L J" :5 GE# */ t
06
"0 & /
5(
3/
#
7
9 G3/
!
5(
90&
Y/1 <<( 0
W
>, "
# 5
G * 06
E) O&U % t
" ) M*
J ", '&
."@ $ ? @ 0
O
5/?
" +#, 3
I, "n G*
! .#/ 1 K )
06
", > ? 6< "0
.
, +#1 5
", > ? 6< "0
G; ,
H( %
", Q .5&
H6
"
A ) 06
", G #
5&
= M 06
", K( )
"
E, >V 0
G
= % >0, "0 &
:0
" ", & " #
06
)#
.
9
( < G*
, 0(
06
" Y Y
! " "^ , "
."^ ! + Jung u H$* I6
O& 0 3/ ", 3)
" @ , = G%*
!
)
5 " <
"
", K( Q
"n
/
&*
.supraphysical "I M" "0 % )
%*
Y ", GN " <&,
GK A % 5# - %* /# "
F
>1 9
)
/
" # @ I
9
)
50 " 50(
Y* ? .astral light #
+
/ A
J ( .ksha (01 E &, A
K < G> * .)*
06
" E 50( n K
6
G 0
(0, \5#/ A @* 9 O& 5) 0
.
>1 ?&
" "0
%
"9/#1" " # I
9/#
5& "
M* " .#/
H6< A
J 5
Gsupraphysical M
/
>1
A =* 06
"n G"6J
@> 9
"
", 0 K( .#
+
5. " 66
H6< O 9 G366
"
A
J P 6J E %J >0, * Y
9 "0" :5 O& Gmorphogenetic aether " #
>1"
6< "0 ", "0 6
Q ", 3)
" "0
.""0 50 # @ , &
G5
# 6J G" @ , A
.I>, */ 5
L %*
", 0 " E %J >0,
9
5
)# "J .
? 3<6
0 0
3<6
&*
#? P
9 E, 5&/
"
) G5)
E) E/ PT G B(, + 0 G1 " E . 9 ", "0 5&
G5
G1
% .%
:0
G9P
" A, / K
&
:0
)#
H6< 0 ./ - J
+ ) G/
@ 3
I6
S.
J @ 0 G5>
5/ A G1 5
", /
P,
7
(&
O& 8
O& I6
Y
# A "
"# 5) G
5
.+ , " 9L
A K
6 50 GE
5(
Gsocial fields "#? 5&
" @/ "0 */ P )/
H6< 5> ", K( Q
50(
G &
")*% *
3/, K/1 # K/ / A E, 6< / .1 =#
K/
* , =# M/ , A #? #
5&
A
J P
"0 ./ I1 w& * )
G
G=
G#
K/
5> ( +(, A +
*/ 6< .(
)#
G#?
>
90&
Gcultural fields >
5&
M> 50( #? 5&
* .)
G
.>
71 5
< .("
) "0 0
+&1 + A )
)
"
#
5&
5& K( "J
:0
(
:
" <
,
GP
5& P
)
50(1 @; ), A
J 3<6
:
Q,
J Y
6< >0, =$/ /
-$ $ ) A
9
@$# I6
5*
G#
H# GLeeuwenhoek "K
" " ," #
9
T
9 )#
H6< "1 GE 5
& % !0)
", < &
"0
.I&
3<6
@ I6
">1"
.I(
0
# 9/ # 50( $* ">1"
# ! W> ) )
9 7(0 I, A +
7
"%$/ # (0 M:& " @ 0
%
;
( #J 58> ", "0 Q, M:& (0 ") %
! 0 G50 50( I&
3<6
H# GLeeuwenhoek "K
" " ," #
9
", 70 E/ 06
. / )
3( >0
GQ, & " "0
.I&
3<6
@ I6
">1" 9
@$# I6
5*
T G#
9
A
J # " &
P
@6 #
# 9/ G01 9
)
E%.*J 06U 9
^ 5* K <
.-$ $
$ 0
" O$& "& .)
M*
)
-$ &
=/ 9
, O&
)
6< A& &/ )
? %
" E
# $ df,fff E0 $"J
0J ) .*
+1 3% ", =*/ @8 , 8?J #
E0 9$ ", 0
#
=*/ 9
.E,
3# E# $ * H6< $"J. -.)
O&
(
L1
0 <, 6 $& 0 +, F
5&
>V % @
'/ @8 , 8?J
/
9/#2
)
7. E 7 # 3) 9
.)/
0
/ $/ % " "80
.9/#1 K A *8/
)(1 & 3 , 5. " >
:0
.)(1 & 3 , */ 8
/* ; 0
5&
" >V & *
%
"0 ", $&
P 2
? G
)
" * O&J 5#, " .#
*&
-, * ! .
=
5) */
& :0 ", O& G!/1 I < *(
6< "V
"$ .6
A >V
.K
6
0 .
#6 50 8P 80 < /
H6< =# ", A
J .I)
#
*/ /
" M
0 < >
5$1 Q/
" I;
M
", O& ;
^ A
J Q/ "
!!Q/ ed K < ", 806 .I)
#
5. " H I6
I#
, 9
)
)
?
&
= & 5
5)
80 <
& "V - /? E6J *
"
7(0 7/ .)1 )
hyperspace %
+
Q/ 5) (
) , I, G(:#
) 0
+
M,
P
V/
/
"& GE)* .%
? /
H6< A >V
(
) 0
5)
"0 70 E&?
K
60 GP $& A # A
J G$& / # & 7 0
5 >, .)% L
.(=% =#) ? =:%
" /
=# A 5
& 0 *( 5% 90& 5
&
$0
6
"0 G5) G8>F & , &
:0
)
? /
H6<
%*
" P $& E, G/
0 G#
0
B&
, ./#
:0
580(
", (&
%*
)
? =%
"0 G:
&
50(1 H6< ", "$ .? =%
" /
3/ I6
:
50(
$/# ) 9> (E I, ) filter "
" A/ 5. " $ 5
.H) F# "^ + A
J G7 0
Q
"$ 5%1 A 6< .!7
0
QW & T"
>, I,
"0 ", " $) : 9)
" $/# ", Q1 #
:0
/
9>#
"0 70
XK
6 A
J I$F I
:'
8 ", ) 8
J /
& $/# ? 0
GE/ 9/#
# "0
?
&
.K
6 5) " 0
$
7P
&
", ?J G
@
= I6
I0
-.)
# 9/#
%
0
, !
", 9L
./ :
"0 0
, !
/# J "0 O& # A
?
-$
) 67) 1
A :< %
I6
I#
H# 9/ ) E :* < >#
/ P ", -$
) >,
t
) ?
&
" / 3 5
& "0 G :0 # 7(0, G0
.
&
(:
!
I
Q/
0
Q/
" 5 # :0
"
0 .I#
=%
" Q/ ed "
F
"V
H# */ 7 0
7(0
0 .I)
#
5. " H I6
I#
9
)
" M
0 I;
M
^ A
J Q/
"n G
.(0
) :#
+
M, )
?
&
= M>
5
G;
.
I
Q/
; A
J IF 0
Q/
; I, 5
&
:) $ X7 )$ .>%
&; $) 0# -
" 2 $/ 0
/# $
?
&
A I& &
&
H6< G *&
/* ;0
%*
"
<
&
:0
=#
!
/#
&
5
(0)
5:/ #n @< " >0, &
H6 9 ? #
3*
.0
,
.!
/# ) 0
/
&
'
A& P G# ?
&
A G!
A +
)
( #
5&
) &
/* ;0
5 O&J , < !
A +
&
/
.@: H# =# 5&
.( #
5&
) )
I&
@
# 9 ", ) : 50( !
A(.
DF
! %
Orgone
9, 6 (
+? 9P
s
(
E$) <>0, G5#
>
)
5)
>0, &, " O& 7/
<0 J "0 ? " 58> @ , ?J G" & 3; E: @& 9 @ , 9L .Galileo "
L"
GM*
Y, I6
@:
" #
9
)
58> "0 N )
GM 5& @ V )
5% " H 9L .
/
& "% * !
G9$ 1 @ A G01 0
)U
&
M ", ,# E
"0 &
@ 0
.
* " % % K
6 n G"B 9" 9/? 06 $# .@
/ "% ( 5 G91 A
J
.
=
+% 5. " E: '$/ 3/
(
"/ u K
6 = G E 0) @
* 0 .ecbm 9 /
Wilhelm Reich "B 9"
% .(
!
9
G" ;/" 3.* , &, '
, G!
9)
#
p
P
! S 9./
E* '
, ", ) G@
# A Q, ( M8 % "0 6 3*
5# "0
Q, )# ( A 5
&
").
&, @ V 9
)
Q/ A E) "B 9" '
,
"
" >.>
.E/
5
.//
1 I% !& !
9 5# * @ M % ./
-.)
!
9
M& 9 % .(
P&
>
:/
5
/
5
"B"
5)
K&
//1 -6
, G#
, GP
0
, A ")
"6< A
J TPT % GThanatos
K < "V
.)
H6<
Q1 5)
"
K < "0 6J E 0 "B" , G7*)
. $)
/
Q
H6
3#/ GK
6 L "0 % , G":0" %* "0 G8&
%*
" $) ?&
0 %* 7& ? , B0 ? 3/ %
>V
& & "0 ", "/ `
"0 5<
X@
", " E? .*)
)
50(
" ) Y , "P , A
J
(
" Y , / 9%
"B" 9% G@, 01 A @ = /0
A !# I6
/
W
)
.
"3%
" = 6
!% .9) Q 0
9<>/ E &, 9
& 9/ 9
.H
I/#
9
)
9P
/
*
" H) #
P
H6< 6, % .@ )
L ?&
" O& G#
:0
.
< A
J E# /
; G!
9) "
=#
9)
/
A
J # .8&
3&
( " , 3% = >0
# J " "0 "
@ V "B 9" )( ebib 9
& @8
/
0 .(@8 P "0 6<) 9./
&
5P @
EL &
?
:
@) "B" 5& G0, H#
, @(( , 5*) , ; 5
& 6J O& G&
:0
%*
" 50(
I% : /# K < e
./ /# ((< "< A
J G&
":0
: ; 5
& A
J K
6 IF % G
@ W ", "0
" "0
GI
A )
/* ; , :0 !
< G@ " 6< %*
50( "J j
.%*
H6< 7>0
& /* ; :0 E?&
.) M* G9 50( / )*
"/& "0 G%*
H6< = 5)
* 3)/ 9 9 5& i
.H#
/
-.)
*
=#
@ ", 5% G$#
O&1 " / ) "B 9
" A, G0,
9/? M*, % .@& " A 7 //
@>&1
1 !/1 "B" = (K ) " ., u
" H
"
/
GOrgone ""L1" / 9> " <
Y*/
%*
50( A (
.organic "I" 9
$( !
M* 7(0 % .
<<P
& 5& G
H6< 5
^ / "B" ,
+ 9% % .*
G 0/
+0
G&
!
, E/ ( L 50( <& , "L1 %*
=#" 9/ #1 H6< A M* ""L1" %* " 0 , &( " =# A % V G,
.ORACS "K,"
J (, , orgone accumulators ""L1
1 5)
A(. &
%*
K/# "&( M
H6< %
" +% < @) K 50
," +
E $ O& ("L1 %* =#) #
H# 0
>
"B" Q
'
, Geble 9)
H# ""( ," 5) $ 5& &
K < !
.#
6< HP I6
3;
>V
@, )/ ""( ^
I, > 9
, O& "B" 5#U "0 @ , 5% " K < G)/
W:
5<T6 @ V 5% " K < O& G#
6<
)
@%, +/ #
>V
" U
H6< " +( I, 06 9
"( s G5&1 =# "0
.@
Y*
+
6< 5& ) "B 9" 30 % .5%1 A
P
@%, !
G
(
@06 ,
.The Einstein Affair ""( ^
V/" " ) 0 @/ <( > G
0
+& , =# ")
+.
" 0( V( , .7
F0 , 9
)0 +/ "B" 5, < G )1
"/ "
, +*, 0 +.
K:
, " )
.">1" ""L1" %* Y 5& 01 5
1
9% &
?
.""L1" P * M*
5* A H&
G"B"
A
1 A*
)
.""L1" -.)
Q, <P M* " <L ORACs "L1 %* =# #, # +*1 "
) 5> >0 5:? )/ P, .&
L , &
P 1 A +/ 3#
" .:< E "B" Q#,
0 # +
" L 3 , A Q#, .2
I#
7.;
"L1 %* #
.DOR
T
Deadly Orgone "
I#
7.;
" M* ( J ."L1 %*
)*
L 50(1 &, < DOR
)*
@() I6
!F
O& 91 H6<
) "1 )% 0 /
=
H6< G2
B # */ DOR
J 9 ", )
06
/ */ 0
%*
H6<
9 @ V G/
* 5& 0
@>&, @
P,
5& %*
H6< "n G(armouring '
&
H6< ) 50( A E/# A#
G"<6
F
5% @ , I, Gpestilential ":
" 9/ 0 50( "'8
"
(
/#
&
@/ 9% % .DOR A
J
GE.> /
1 , "*/
0 /#
1 ", < 9.0
. .P&
I, 8)
,
`
0 A
J )
%*
H6< 5) J < -.)
G %* A
J 9/#
&
"L1 %* 5$& 5) <
.'&
,
30
5, &, . ;
0
) @& "
H6< 0 .bions "
" 9/ M*V G&
@ / #J "0 5? I6
GCancer Biopathy " */
I)
5.?" " ) 30 <
K "B"
Cosmic
" 0
30
" " ) "B //F"
( > K < E, .Q0
)
0
3<6
% K
6 ) .0
:#
"/
A >1/"L1 5
^ #
GSuperimposition
K
6 / % GMaine """ Rangely "; " " 3
V(
O& 0 A
J H @) E.% "B" 0
.Orgonon "" L," 9/ 0
"0 ."L1 %* G $ * 5$)U G>&) L Y*/ @ V "B" 0
S$
Geblm 9)
<( 9 ;
> A
J G&
&
5% " / O.>
& 5& &
Y
6<
(1 >
K " / # GK6 ""L1 K&" " / "0 ", "0 = *) O&
#
6< =% A
J $,
F
!:/
" >0
( > "L1 K&
% "J .;
</0
.X Files (
5//
" ;
H6< 7
"0 .50
8
9
)
30
9
&
G9 0
G@0& + "
% % 5% Gebgm 9)
> 50( ..."L1 <P @) ...% # "#/
GI&
">1" 7(0? I6
(
5$1 98)
3L 5P '0 / % orgonomy ""L1" 9 ""L1" %* ">&
=# "n G3#)
&
, "L1
:
L "V "P&. 5#
6< "
)
K:
, " )
"n
&
% .H, I6
"0
t
" , Gzero point energy "
*
%*" )
>&
)
(0? = E# # 50( 3/
.( _* "0
G%
A & # " O) "B" 0
/ O&, ,
.quantum vacuum
"" L," G"B 9" 7&
$>:" -$$7) '
&? GK// *
? )
) < Vlail Kaznacheyev 7( 0 5. 0
& ) ? H6< ..
# " -, A / "( " >0, 6 I# .M/
/
#
3*
9 " E 7 O& I<# //, 50( -.)
K
60
5 0 3)/ 9
.:/
, @
"0 "
-6 " A/ , I
", G9# 50( (7?^ <) 7( 0 3# >,
Q&J .
,
& $/# /* ;0
#
/
.
GE/* ;0 @
/J
"0 .7( : #& 5
O& )
) 5 M.L 0& "+ = G%,
?
Q&J $ GE >
.
" # + 50 = .:
#&
# " ?J E "?) "+
.H^ A
J ... 5% #/ M Y)(J , G5% ! , GI Y)(J , G:0 $9/ , G0 Q)
"#
"0 6J @ V ? 5. " "$ .5)
H6< Q& $)
.
# A
J E& $, )
H6<
6J "0
.
5)
$)
.
#
.
; I, ,* 9
GI)
-#
" Y
:
#&
P ", ) G/ ej 5. .E%.*J =% L E, 5
& 0
" Y
:
#&
"0
.0
#& " N 3 #
A
Q1 .
# )
! P GQ)
$)
.
#& 5. " G* E: G
.
= 5
A
L .
6J @ V W / ^ K <
E: 5
)# L Q, . 5
L .
H6< ) 9> G/ jf , ec
0
5
& 9
@ V 9)
= ..
" >
>
#
H6< " P
, G0
#& 5. " *
.0
" #& 5. " G* E: 5
"0 .O.>
#
H6< " : 5
I,
)(J M* .
", P, I6
BL.t., 0
5) @ 7( 0 0
+6& 5. "
" O&
5. " 3# " 7( 0 M O& GQ, . A >V
0 ( ) mitogenetic radiation
#
#
&
.
", # .&
.
# " >
-#
" Y
#&
5. "
" #
H6< .#/
M
" % *,
"0
.8>V 9
)
#
.
K
6
G#/
M )(1 H6<
G
.
! / Q1 .
A
J
" )(1 H6< 0 0
" E#& )
.E/* ;0 >&J
/J "0
,
-6 "V >, % 7( 0
50(
G
.E/# &
,
E/* ;0 Q)
&
, #
.
GE6J
; 5
& " < I, G5$1 9
I
Q/
A I# +#J # " < 9
& )* ", GE/ 06 0 G
)* 5 -6
"J .
)*
+1 :0 G:0 G:
0
+
M, )
?
&
= & M> 5
5)
80 <
A 5
& ; I, G
.)1 )
hyperspace %
+
Q/ 5) (
) , I, G(:#
)
.!
:
Q/
E.) $/# (?
&
I, ) "0
" Q/
6<
.1 0( F
", "P =#
.E,
" * ? !
9P) "J O& ... <06 3# * K < GY
6< x% /
5%
" "#
0
", < 3/
.&
/
H6< "0
.& A "/ " "?# < " #
0
" "9)
"
"/ 9 "
, G3L1 A "P 9< +)
.0
* "( /
" +)
" " "
? * "
& /
)
W
A ? P
") +)
.>0, " 9 , I, G"
" E.% .+(1 H6< @) ", "0 "% +(1 " 9 "
, .#
)
!/1 A
&
H6< G#
0
&
" 5#V +)
A ", "
"0 .! =
/
P
9$
.!+)
5 !
"
5 :< /
H6 G0
S /#
" # A >0 >, K < .
)
/
" ? "6
"
5 H&J 9 #
0
>
9# J 5 )
Q# L 9 0
01 /
x>0 9
" "
.5> 0, < "/, ! ... 3 A x/,
9)
" >0
%
>0 =# 06 G#/
M ($)(1)
*/ -.)
, .. A
J )
"=*
&
" " ) @? Q&J
#.)
H6< A
J E( !.L./ 9
0
5 .0
: (#
0
1 #
@
) Cutting Edge
0 "/
$) O& G1
% //F </, AMA 01 3*
* )%
#.)
"
G9
9$/ # & E " 0" "K0 <" "*
W
G9ebii 9)
.Q1 )#
#.)
%
...-.)
6< # E
A) .#/
M )(1 -. K
6 "/
50( -.)
*
H6< 9/ 9 9
6
.E 9 : 6 #/
M +
*/
1 -.
"..X9
0 91 K :/
1 9P) ",
G=/
+
5% %
"
< % -.)
/
H6< ",
.
"
" ()
) G#/ M /* ;0 # 8
Y +
X#.)
H6< 5
Y? + " ()
K <
-.)
"V 0
S$
.E #
% /
Q
& mb "V I..3.- 0
80, G9eblm 9)
"^ -. @ 1 / Q) 90&
E: @ ? "0 9
A #/
M )(1 */ */
"0/
/
H6< ", 806 ...*
/
K
60 GE, ! < ? G! < 1 .5$)
"
5 A
J 5 I0
I, "1
&
H6< E) I# ", I0
+
"0 ? K
6
..
5
.
!/
" !
5% =*/ #/
M Y)( "0
.E,
5 7/ !
5% 5#,
#/
M /* ;0
#
W
) 3* &
#/
M /* ;0
#
# , A I& Q, &
""!
/
0 =
?
& -6 5& "#/ M" /* ;0 M.*J 0
.
", A
J
5/n % )
/0
6 :
+/ .
3
Q1 .
&
?
&
A 8>F
A 5
& / 5< X
.
A
J )
?
&
-6 5& "#/ M" /* ;0
A
&
9 G: >/? W:
H6< ( " = @ 0
.7( 0 0
H0, 6< ! < 3#
.X# #
@#6 @
50
G1
."
"
+(
-6
&
5
" O& # 9 5. "
9$ "0 .+
-.)
5# # P
'
,
GE6J
.)
#
G&
:0
" /* ;0
< 1 @* 50 .1
&
/#, @ & 9 S
I, , 0
1 " I1 #& ) 9
()
) :/
? -6
= 5 0
/#, A */
/* ;0
#
" # 5
. , Q I1 (%) &
-6
/
7 ,A 0
B#$ )$ $:S
#
H / P, .!M:% 5. ( 5
@ 0 G # GI0 GI G@//, "0 I,
G9
5/
0
Q/ ", Y*/ . <
3/
# "(
/ / !0 =*/ V
sleeping
9
-. '# % .!5/0
0 Y? / )*1
(
5 / 5. A&
L
#6 E,
" 0,
H " ,
^
9/ " 0 6J G(H^ A
J..=
, G5# G) 7*, + J ) ", =*/ &
+1 ", "$
!XE.) )*
H6< 5< .H
^ 5 * "0
)*
6
+(
", ?J G@0 < "/
+)
, M* " 9)
/
01 A
J 9$% % H 5 ", 9L
"#
/* ;0
" 9 5# A 0 "%
+)
+?F< "1 6< .
^ / =*/ 9
01
# " 0 #)
H
^ Gphase conjugation "I*
"%?" Gscalar electromagnetics
.electromagnetic device using phase conjugation G"I*
"%?" , M 5) "# /* ;0"
9/% G
H 9/ G%.)
) A
J G$#
Y(
6< 5 9 +>1 51 5# " >0
5& GE& 5? H "0
H6< "0 E
L) "
)
+)
5 A
J #
9<
H6< 5J
& "6
(+(
) "&
+)
9> " 9< V @/
A
J @
J 9> G#
6 / 7 5
()
*/
%
.E: 1 < 60< ... Q "
& ? "0
GH*
= )# &
?
"&1" +)
" # : 9% "
E& <06 3# &
& K <
" 9
A /
0&
H " / A
J "/ & E, "&1" "
" #
9)
I,
A ") (/
$*
=#
) 9L) M/1 &* 9> #1 H6< =
5
.
0 I6
)(
*;
5 )(
!#
"
" O& G@
:
) I6
:
1 # G9/#
6 50 50 5 A
J 3$/ 0
/* ;
5#
= 30
!0 =*/ (J 60< ", & .E# 9<
9# 70 O& ", )
(
A 3# "0
G9
:/
1
5 9
//1 -6
G1 "
Q A ) GPasteur /
$
1 $>#
$P
5 ?
K < 50
", I, .)
1 " $) -6 "
F/ $) 9># K < a"V 5 .9/#
0
.
@>#
) " O&
GE.> Bechamp 3( P K G
K
&
"0 9
/ P
.Pleomorphism
. " P
>#
"0
$/#
?& 50(1
50(V >#
P $P
% Q, $P A
J 5 S //1 >#
@P " A / ", 9L
P&
//1 @P !0 / 1
0( A ":
5
5# "0
GPleomorphism )
. ? < #
:*
'
A
A
J 50( " 5$&
A 0
% >, "6
+*1 " >0
O&
3*
P
+?F< . "0
:
*( 3/& K
6 G"*/
A& G^
/ A
J "$)
/ " G^
9 GP
+
%J " E? "0
./ P )% 9 9# 50( >, GE.> 7 0
5> G+*1
.&
(0 "6
+*1 +
%J
"0
G) ) L @#. "*/
%
3/1 $", "80F ">&
5? O&
)
" %
6< A&
F & E: 9 0
G-.)
(0 3/
") 98 , "0F "6
"N ">&
" )
K < &
.%.)
1
0( $0&
$&
:
5% " &. =%
#
3*
//1 )
&
,
)
)
/
*
0
)#
0 G)
//F
,
? "6
+*1 Q/ -$ . G
G1
0( 5% " E
G(9
)
5& /
I0
+
) 9% " 7
+
L : 50( I, A "%
9)# >J , 8
, # " F
.(0(
@)
I6
5:/
u
",
"$ G/
*
02
I
&
, 5
)
W
9
980&
5. "
.Q1 #.)
u
" <L 0 )
O&
& " $# E <# a9 % -.)
$)*
3*
/ ) $&
< G9
)
$&
//F 9P) A */
0(
H6<
& & &
, 98 1 GE%> E , >01 #.)
u$
E&, +*1 ) 9
O& $*
5
50
.9>&1
+
0( A 9
9<
-. 5:/ 0 ", 5)
5. " "0 G9
3*
9
90&
K
P
" >0
K <
"0
.<L G"*/
G*
, G/
G 5> G1 A
J +
1 5
:/ E# &#
@ 0 " >0, G#/ G// < 1 .1 # A M* 50( "*/
9
)
90& '
" !
6<
.!>0 >0, @ J ... / J G$*
&
+/ A ) G&/1
)
% 0, > ) E< E
% #,
G$:
0(
H6<
/ 9< 0(
Q
.A
+( 9< $: 0( I, Q
# ? .&,
&
"0/
" (
& &
+/ ( =$#( 7/
$:0
=
# , M &
+/ A P&
=/
.
&
3/
58> E "
, #
)" Y %
F
<$ $ +#J *( "* :6;
1
0( A ":
=#
.E?
", " 9, )
#? H6< .eugenics @ /& 5/
& 7 )
/
) *
( 50 980& G3&
+#
" 0/
" &
$) 5:/ #J < <, Q&J
. )
0
1
6L1 5. " % 9/
H6< "8 !!3# >0
$
G&
" 9& +# <
$", 0 ( G9
)
+& , 9P) G1
0( &#
Q " $&
G5$) 9/& 50( G$*
9P
9% G@>
)
(
5. " .1 )
."<#
0
%)
" :& & 9# 9 G!
" $)
0
$&
-.)
."I(
9/#
)
5) 6 9) "0 9
91 )8*
" ", <
//F /$0
#
1
.9) I6
H& O&
9)
< GE
% GE GE// 7
5:
<6 5. " G3)(
" 0(
H6< ,
<#
&
1 9/" ", ."1 -. +( " &
//1 5F/
< I(
":0
#
" ",
.")*
#
:# K 58> &
$
&(
=$ 67)
)
W<
A
J "N A& * # 9
G
"
&
#
>
(0? )
.# P G# G# * / $&
A
J P
0n '
, G3)(
A
J
I6
)
W
@ !0) .5) 6 E# 9) G9P 5 5% " 0& )*
", < @ 80V
9 5$,
$% 3& B) V E, 9)
5# 7 G>&
(0? H6< ) .1
0( @/0
!#
50 M> ... #
2 G< ? GP
M* " K
6 9 ."N :/ < 0 !0)
!
!
I6
< G"0
#
I<#
6<
<<P
0(, 7
"0
GE:
%* */ G06 * :#
0
#
9/
.!#
<
+ 9$ G%
! P G :0 " )*
$)
& $*
)
"/ !
G/ = G # A
J GK/
+06
8 # " 5
/
.E, :0
% 5 G*
G($0
) :#
, Q/
E: #
A
J P 6J .!/1 < ."0
<# < %)
.
H6<
@0V "0
K& 9 G
)
#
5 ! .
H6< 5) .#
&
<
H6< ", Q
o0
o
=#
.M. ) "0 $/# ", "0 .6 " > : %* M* "
.90& "00 )*
$*
)#
" 0 0 "$ O& G) I& 5& < G&
":0
*&
/* ;0
5#
6< ", "
Q& A 50 A
J @# & , @* E, 5& G
#
-6
. " 90&
)
7%
=
3/& * 7
G#6
P 9 G)% 3/& (
50(
A
J 5&
.p*
0
.
50( A & I& /* ; 5& # " "#
0V 70 ,
.@* I&
/* ;0
5&
6< & >
9 #
) A ? G" #
. + #
1
G I6
*&
:
= 9 9#/ ..50
"
& )*
H6< &
:0
=# .
>
& M +( 50
P
9/# j ...&
/* ;0
e
.()*
"0 ", 3# 70)
>
&
#6
? )
G)*
&
G5&
H6<
.E
/#
H6< ; I, 5
& $# "0
# 5>) 0
A :< %
# #, 9/ ) E :* < >#
/ P ", >,
t
) ?
&
" / 3 5
& "0 G :0 # 7(0, G(7 0
.
&
(:
"V
H# */ 7 0
7(0
0 .I#
=%
" Q/ ed "
F
M
0 I;
M
^ A
J Q/ "
#
5. " H I6
I#
9
)
"
= M>
5
G;
0 .I)
(0
) :#
+
M, )
?
&
A
J IF 0
Q/
; I, 5
& "n G
.
I
Q/
;
9/#
%
0
, !
", 9L
&
", ?J G
@
= I6
I0
-.)
#
/# J "0 O& # A
?
./ :
"0 0
, !
:) $ X7 )$ .>%
&; $) 0# -
" 2 $/ 0
/# $ 2W3
?
&
A I& G *&
/* ;0
%*
"
<
&
:0
=# ", 06 DM
#n @< " >0, &
H6 9 ? #
3*
DZ .=%
1 A :0
</# ", 3#
#6
.0
, !
/#
&
5
5:/
.!
/# ) 0
/
&
'
A& P G# ?
&
A G!
A +
) D`
.! I 50( !
/# / :
'
", ) DP
, !
P
/
:
'
.>V
3/& E#J , E/ J
& ;
>
?
/ >V G()*
? -6
A I& I6
) I&
/* ;0
5#
>V
0
:
5. "
&
H6< " )
"0 .0
P
3/ I, G/ -6 A
J 5$& @)#
)
", I, . *&
/* ;0
& ; 5. "
&
&
90&
"0 DM
H6< $) 6J G
DZ .P K
60 &
<
& &
<
"
H6< &
?
"
H6< &
? )
5 5
& 7/ / >V I, A
J /* ;0
(I
I/
A) I/# 5
& $/# ", " $ ? G
D` .P K
60 &
<
& &
<
$/
" , +( 50
&
$) *(
.
*&
/* ;0
5#
"0 G*(
"0 @ , 7(0
.50
> 50( /#
% $) *(
", :5 Q, 0 .&
#6
?
" 5 7)
.
*&
/* ;0
5#
"0 G < )
"0 "0
I, .=
A
?
&
*/
A
J IF 6< G&
#6
?
&
>V %
.) /# A
J IF )
<
",
=
)
0
&
< .
*(
6< 3/
//1 <#
3/1 Q&J
.
!0 A
J 5 (*) # ) A I& GI&
%*
5&
J (
G
H6< ", 06
5&
6< , G
H6< $( 7) , 5 5
& "0
.@. I6
(
#6
&
&
(
*)
)
&
e
.9/#
)8
:6L 5 , G
:6;
)
J :" W
6;
+/ l
50( =$# %
/
%*
9/#
5)# (..GQ GS#) 9)
, P
9 " W
O$
g
.&
>
?
&
A 38;
#
( Q/ 7
? <
)
6< (
" Q)
1 5
& /:
3/
:6;
9P
A
J G>0, >0, @/ 9
#
3*
, ", 6 $/# ,
&
H6< .&
.3)(
A I6
& H# / +#J 6 "0 K
6 A + G&
Q/ & 9> " %*
( Q/
,
: >/? #1 H6< Q&J ."/ 9/# 50( A $/# ", 5% &
%*
7)
.9
)
5& E)/ E( (
;J -# 0
/? ", .&
@
& >F
(
"& %*
" Q/ "V E# 7) '
, ", )
(
.
0
A +
" 0 G#/ M /* ;0 # M* 0
J #,
&
A 8>F
/* ;0
#
H6<
=*/ * 0
#1 ", '&
5< :< 5F/
X.
(E#J , E/) ?
90&
"/ =*/ 5< .XA1 06
0
#1 5 ! 5) ", )
#
H6
"0 5<
.X0
*/ .
?
&
/ @ 0
"/ )* % J ...!>0 0, +0 ..!9) < 3#
. V(
)
<, >0 3/1 K
6 G/ 70
(
#6
&
&
!0 A
J 5
(*
) #
)
A I& 1
@%
7) GI&
/* ;0
5&
6< , G
H6< $( 7) , 5 5
& $# .@.
,
0
$/#
'
9/#
7) GE0/ 9/#
+
.
)
1 8O A
./
" O&
& 9)
@# "0 ? E6J 6 GM.* A K
6 K( I, "0 ", " G&
H6< A
J 9)
5
", )
"
=
5:/ " O&
" E? "/ /* ;0
)
5&
6< *( A / 5:/
? E/# :
9>#
5% ", & >, ", )
.X9/#
E//, $
0
9>#
5% 5.
= GK
6
& / ", $# 9>#
H6< /# A
J E: 5
)
? ?&
A +
0
."
)
(
E: & / <
", 9)
:
A P&
< @) K 50 .<L , )(J ? 0 ? +*, A
J #& /
(
)*
#
&
A P&
) 580 7/ 5&
6< .E*( K I&
5&
+ 3/
:6;
9P
%
)
)
"I&
*
" 5>
#
Q ")// G:
)*
-.)
K
60
? G<&
5) )*
Y . ) 5# " # 0
)*
# % " <L , GE.> 9/#
) 9) ", 3# G@0// I6
#
M*
A A
1 *
, 0
"0
.&, " @# I, , &, (
.
$1 1
. I1 ) 5& K/ $
?&
=# #
) $0 98) G
3 # $0 K/# 5) 70 98)
.. E# :*
)/ ?&
I, .* }E# & 7P "0
G(/
+*1 A
J #& K , '&
$, .$
1 )/ , p*
L A
J 5
#& , =*
< G:#
$
$/
O&0
98) K/ 7> ", 51 " G" .
" 1 A/ A& ,
1 , $
2
/
>0 0, "0 * $
E& +
K
a"n 9)
A .I
?
9
" E)
&
#
) $0
IF K/# 9/ K " 7) 7/ "
" *
1 5 a"J .
)*
M*
) K8 ,
.K&
E * >0, +( A
J
IF G0 I& I **& A
J
.2
#& K , 5
0
*
6 KL 5/L A 5 % 9P
$3*
.+*2
#& /
,
*
* H6< A ":
3# A
J 51 M /? < K
6 5) " /:
9L $", < &
.#
% GK
& " )*
$/#
5)
G=#
M
a", KJ 5. " G6
7>
98)
5. " K/
.K/ )
5:/
\50 K$
+ ? 9/ 5
G % 91 )*
= 5) 70 9) ", < @) K 3# I6
&
+(
7)
3#
M:&
) K < .&/
<<P 5$V GK
& " )*
A >0, 7)
< !
5$, .K
.&
A
J 5
7/ /? G
A